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Abstract 
 
The heart is controlled by the sympathetic and parasympathetic limbs of the 
autonomic nervous system with inhibitory signalling mechanisms recruited in both 
limbs. This study aimed to determine the role of inhibitory G proteins in the 
mechanisms underlying autonomic control of the heart. Mice with conditional 
deletion of G protein GαO in the cardiac conduction tissue and the central nervous 
system (CNS) were generated to determine the effect of specific GαO deletions on 
autonomic control and electrophysiological properties of the heart. 
 
Mice with conditional deletion of GαO in the cardiac conduction tissue demonstrated 
normal diurnal heart rate (HR) profile and heart rate variability (HRV). Mice with 
conditional deletion of Gαi2 displayed higher daytime HR and selective loss of the 
high frequency component of HRV, suggesting that signalling mediated by Gαi2 (but 
not by GαO) is important for the parasympathetic control of the sinoatrial node. 
 
GαO deletion in the presympathetic area of the rostral ventral lateral medulla (RVLM) 
was not associated with changes in HR or the arterial blood pressure (BP) at rest 
(home cage, normal behaviour). However, exposure to stressful conditions (novel 
environment, hypoxia or hypercapnia) in these mice was associated with profoundly 
exaggerated heart rate responses and an increased baroreflex gain when studied 
under urethane anaesthesia. This was associated with a reduced ventricular 
effective refractory period and lower ventricular tachycardia threshold. This 
phenotype was reversed by systemic administration of a beta-adrenoceptor blocker 
atenolol, suggesting that GαO loss in the RVLM increases central sympathetic drive. 
 
The data obtained suggest that GαO-mediated signalling within the presympathetic 
circuits of the RVLM but not at the level of the cardiac conduction system 
contributes to the autonomic control of the heart. GαO deficiency in the RVLM is 
associated with exaggerated cardiovascular responses to stress, altered 
cardiovascular reflexes and electrical properties of the heart. 
 4 
Table of Contents 
 
Abstract …………………………………………………………………… 3 
 
Table of contents ………………………………………………………… 4  
 
List of figures ……………………………………………………..……... 9 
 
List of tables ……………………………………………………………... 11 
 
Commonly used abbreviations ………………………..………………. 12 
 
Acknowledgements ……………………………………..……………… 14 
 
Publications and abstracts ……………………………..……………… 15 
 
Chapter 1 General introduction …………………………………….. 16 
 
1.1 Autonomic regulation of the heart …………………………………. 19 
 
1.2 Central nervous mechanisms of autonomic control of the heart .. 20 
1.2.1 Vagal preganglionic neurones ………………………….. 20 
1.2.2 Pre-sympathetic circuits in the brainstem ……………… 22 
 1.2.3 RVLM and the cardiovascular system …………………. 23 
1.2.4 The sympathetic baroreceptor reflex pathway ………… 25 
 
1.3 G-proteins …………………………………………………………….. 29 
 1.3.1 Inhibitory G proteins and autonomic modulation of heart 
  rate ……………………………………………………..... 31 
 1.3.2 G proteins specificity …………………………………….. 35 
 
1.4 Contributory effect of inhibitory G proteins signalling in the central 
 nervous system …………………………………………………. 37 
 1.4.1 Inihibitory G proteins in the central nervous system …. 37 
 1.4.2 Inhibitory G protein signalling in the RVLM …………… 38 
 1.4.3 In vivo evidence supporting the role of inhibitory  
  G proteins and central nervous mechanisms 
  of autonomic regulation of the heart …………………. 40 
 
1.5 Summary …………………………………………………………….. 42 
 
1.6 Hypothesis and aims ……………………………………………….. 44 
 1.6.1 Hypothesis ………………………………………………... 44 
 1.6.2 Aims ……………………………………………………….. 44 
 
Chapter 2 Materials and methods …………………………………… 45 
 
2.1 Introduction …………………………………………………………... 46 
2.1.1 The transgenic mouse model ………...................……... 46 
2.1.2 Autonomic and electrophysiological phenotyping 
of transgenic mouse models ………………..………… 49 
2.1.3 Limitations ……………………….…………………..…... 51 
2.1.4 Objectives ………………………………………………... 52 
 5 
 
2.2 Mice strains and generation of conditional knockout mice.......... 53 
2.2.1 Transgenic mouse lines and breeding strategy……….. 53 
2.2.2 Conditional deletion in the cardiac conduction 
tissue ………………………………………………..….. 53 
2.2.3 Targeting gene deletion in the central nervous 
system ………………………………………………….. 54 
2.2.4 Targeted gene deletion in the central nervous 
system using Cre expressing viral vectors………….. 55 
 2.2.5 Genotype procedure …………………………………….. 56 
 2.2.6 Quantification of gene expression in tissues by 
  quantitative real time PCR (RT-PCR) ………………. 59 
 2.2.7 Immunohistochemistry ………………………………….  59 
 
2.3 ECG and BP telemetry in conscious mice ………………………. 60 
 2.3.1 General surgical preparation …………………………… 61 
 2.3.2 Implantation of the ECG telemetry probes ……………. 61 
 2.3.3 Implantation of the BP telemetry probes ……………… 62 
 2.3.4 Serial HR/BP measurements and circadian rhythm …. 62 
 2.3.5 Assessment of heart rate variability …………………… 63 
 2.3.6 Time domain analysis …………………………………… 64 
 2.3.7 Frequency domain analysis …………………………….. 65 
 2.3.8 Pharmacological manipulations ………………………... 69 
 
2.4 Whole body plethysmography …………………………………….. 72 
 
2.5 Anaesthetised in vivo preparations ………………………………. 75 
 
2.6 Analysis of baroreflex function …………………………………….. 75 
 
2.7 In vivo cardiac programmed electrical stimulation …………….... 80 
2.7.1 Invasive cardiac electrophysiological study protocol … 81 
 
2.8 Statistical analysis ………………………………………………….. 88 
 
Chapter 3 Results I: Heart rate dynamics in mice with conditional deletion of 
GαO and Gαi2 in the cardiac conduction tissue ………………….. 89 
 
3.1 Introduction …………………………………………………………… 90 
 
3.2 Cardiac conduction tissue specific deletion of GαO and Gαi2 …… 91 
 
3.3 HR profile in mice with deletion of GαO and Gαi2 in the cardiac 
 conduction tissue ………………………………………………… 93 
 
3.4 Heart rate variability in mice with selective deletion of GαO and Gαi2 in  
the cardiac conduction tissue ……………………………..…… 95 
 
3.5 Heart rate response to pharmacological challenges in mice with selective  
deletion of GαO and Gαi2 in the cardiac conduction tissue … 98 
 
3.6 Intrinsic heart rate in mice with selective deletion of GαO in the cardiac 
 conduction tissue ………………………………………………… 100 
 
3.7 Discsussion …………………………………………………………. 102  
 6 
 3.7.1 HCN4 expression in cardiac conduction tissue  
  and pacemaking cells………………………………….. 102 
 3.7.2 Higher heart rate during daytime and loss of circadian variation  
  of heart rate in mice with Gαi2 deletion in the cardiac conduction 
  tissue ……………………………………………………. 102 
3.7.3 The effect of selective Gαi2 deletion in the cardiac conduction tissue  
 on heart rate variability…………………………………….. 103 
 3.7.4 No effect of selective deletion of GαO proteins in the cardiac  
  conduction tissue on HR and HRV …………………….. 104 
 3.7.5 Comparison of heart rate phenotype in mice with conditional  
  deletion in cardiac conduction tissue versus global deletion 
  of Gαi2 and GαO proteins ………………………………… 105 
 3.7.6 Limitations …………………………………………………… 105 
 3.7.7 Summary …………………………………………………….. 106 
 
Chapter 4 Results II: Generation of mice with conditional deletion of GαO in the 
central nervous system …………………………………………….... 107 
 
4.1 Introduction …………………………………………………………….. 108 
 
4.2 Nestin Cre approach ………………………………………………….. 109 
 4.2.1 GαO flx/flx nestin Cre mice display growth retardation and 
  poor survival ……………………………………………… 109 
 4.2.2 Nestin Cre expression in brain and other organs ……… 111 
 4.2.3 GαO protein expression in brain and other organs ……. 111 
 
4.3 Targeted approach using Cre expressing adenoviral vector …….. 114 
 4.3.1 Validation of RVLM coordinates by microinjection of  
  fluorescent beads ………………………………………… 114 
 4.3.2 Targeting the RVLM with adenoviral constructs ………… 114 
 4.3.3 RT-PCR to validate deletion of GαO proteins and determine 
  titres of adenoviral construct to be used ……………….. 118 
 4.3.4 Generation of mice with GαO deletion in the RVLM of the  
  branstem and controls for in vivo experiments ………… 120 
4.4 Discussion ………………………………………………………………. 122 
 4.4.1 Choice of adenoviral vector to target Cre expression …… 122 
 4.4.2 Limitations ……………………………………………………. 122 
 4.4.3 Summary ……………………………………………………… 123 
 
Chapter 5 Results III: Cardiorespiratory phenotype of mice with conditional 
GαO deletion in the RVLM ……………………………………………. 124 
 
5.1 Introduction ………………………………………………………….. 125 
 
5.2 Recordings of BP in conscious freely moving GαO floxed brainstem Cre 
 and control mice ……………………………………………………. 126 
 5.2.1 Normal diurnal heart rate and blood pressure profile in mice  
with conditional deletion of GαO in the brainstem ……… 126 
 
5.3 Haemodynamic and respiratory responses to hypoxia ……………… 129 
 5.3.1 Haemodynamic and respiratory responses to hypoxic challenge 
in mice with conditional deletion of GαO in the brainstem.. 131 
 
 
 
 7 
5.4 Haemodynamic and respiratory responses to hypercapnia …… 135 
 5.4.1 Haemodynamic and respiratory responses to hypercapnic challenge 
in mice with conditional deletion of GαO in the brainstem.. 137 
 
5.5 Discussion ………………………………………...………………… 141 
5.5.1 No effect of GαO deletion in the RVLM on HR and BP profile in 
 conscious freely moving mice housed  
in standard conditions ………………………………… 141 
5.5.2 Mice with GαO deletion in the RVLM display elevated HR 
and BP in a novel environment(plethysmography chamber) 142 
5.5.3 Haemodynamic and respiratory responses to hypoxia and 
hypercapnia in control mice ………………………….. 142 
5.5.4 Altered haemodynamic responses to hypoxia in mice with 
conditional deletion of GαO in the brainstem ….……. 143 
5.5.5 Altered haemodynamic responses to hypercapnia in mice 
with conditional deletion of GαO in the brainstem…... 145 
5.5.6 Summary …………………………………….....………... 146 
 
Chapter 6 Results IV: Baroreflex sensitivity and electrophysiological 
properties of the heart in mice with GαO deletion in the RVLM .. 147 
 
6.1 Introduction …............................................................................. 148 
 6.1.1 Baroreflex sensitivity and alterations in sympathovagal 
  tone ……………………………………………………… 148 
 6.1.2 In vivo cardiac electrophysiology assessed by programmed 
  electrical stimulation …………………………………… 148 
 
6.2 Resting cardiovascular parameters in GαO floxed brainstem Cre mice 
and controls under urethane anaesthesia …………........…………… 150 
 
6.3 HR changes in urethane anaesthetised mice following autonomic 
blockade ……………………………………………………....…………. 154 
 
6.4 Baroreflex sensitivity in GαO floxed brainstem Cre mice and controls 156 
 
6.5 Programmed electrical stimulation in GαO floxed brainstem Cre mice 
and controls ……………………………………………………...……… 159 
 
6.6 Discussion …………………………………………………………… 162 
6.6.1 Autonomic tone during urethane anaesthesia ……..… 162 
6.6.2 Increased HR and baroreflex sensitivity in mice with conditional 
deletion of GαO in the brainstem ……………………….. 162 
6.6.3 Reduced VERP and increased susceptibility to VT in mice with 
conditional deletion of GαO in the brainstem ………….. 163 
6.5.4 Limitations ………………………………………………….. 164 
6.5.5 Summary …………………………………………………… 164 
 
Chapter 7 General discussion ………………………………………… 165 
 
7.1 Summary of findings …………………………………………………. 166 
 
7.2 Findings in the context of what is currently known ………...…… 167 
 
7.3 Insights into cardiovascular regulation in man…………………… 169 
 
 8 
7.3 Limitations …………………………………………………………… 170 
 
7.4 Future directions ……………………………………………………. 172 
 
7.5 Conclusion …………………………………………………………… 172 
 
 
Bibliography ……………………………………………………………… 173 
 
 
Appendix ………………………………………………………………..... 189 
 
Appendix 1 Matlab script developed by Varuna De Silva used to obtain best fit 
sigmoidal baroreflex curve …………………………………………….. 190
 9 
List of Figures 
 
1.1 Location and principal projections of the rat RVLM/C1 neurones 27 
 
1.2 Schematic drawing of main peripheral and central pathways involved in 
autonomic cardiovascular regulation      28 
 
1.3 Interplay between membrane and the calcium ‘clock’ in regulation of SAN 
automaticity          33 
 
1.4 A simplified schematic for the mechanism of heart rate regulation by inhibitory G 
proteins         34 
 
2.1 Conditional gene deletion by Cre recombinase    48 
 
2.2 PCR products identified during genotyping procedure   58 
 
2.3.1 Representative plot of RR interval against time and power spectral density 
transformation         67 
 
2.3.2 HR response to pharmacological challenge    71 
 
2.4.1 Plethysmography experimental set-up     74 
 
2.6.1 Tracings obtained from urethane anaesthetised in vivo preparation used to 
determine baroreflex function       78 
 
2.6.2 Derivation of baroreflex curve      79 
 
2.7.1 Equipment used for programmed electrical stimulation  83 
 
2.7.2 Intracardiac electrograms showing correct placement of electrodes in the right 
heart          84 
 
2.7.3 Intracardiac electrograms during right ventricular pacing   85 
 
2.7.4 Determination of ventricular effective refractory period (VERP) 86 
 
2.7.5 Burst pacing protocol to determine ventricular tachycardia threshold 87 
 
3.2.1 Conditional deletion of GαO and Gαi2 in the SAN   92 
 
3.2.2 Day and night HR profile in mice with selective deletion of GαO and Gαi2 in the 
conduction tissue of the heart      94 
 
3.2.3 Loss of HF component of HRV in mice with selective deletion of Gαi2 in the 
cardiac conduction tissue       96 
 
3.2.4 Assessment of HR responses to carbachol and CCPA in mice with selective 
deletion of GαO and Gαi2 in the cardiac conduction tissue   99 
 
3.2.5 Combined pharmacological autonomic blockade with atropine and propranolol 
in GαO floxed conduction Cre mice to determine intrinsic heart rate  101 
 
 10 
4.2.1 GαO flx/flx nestin Cre mouse at 5 weeks of age   110 
 
4.2.2 PCR products of DNA samples obtained from tissues of a GαO flx/wt nestin 
Cre mouse          112 
 
4.2.3 GαO expression in GαO floxed nestin Cre mice and controls  113 
 
4.3.1 Determination of stereotaxic coordinates using fluorescent beads 116 
 
4.3.2 Targeting RVLM with AVV constructs to express GFP  117 
 
4.3.3 GαO expression using different concentrations of AVV constructs 119 
 
4.3.4 Distribution of RVLM C1 neurones expressing Cre/GFP  121 
 
5.2.1 Diurnal haemodynamic profile of a control mouse    127 
 
5.2.2 Summary data of averaged HR and systolic BP during the day and night in 
mice with conditional deletion of GαO in the brainstem and control  128 
 
5.3.1 Representative recording of haemodynamic and respiratory responses of a 
control mouse to hypoxic challenge (10% of O2 in the inspired air)  130 
 
5.3.2 Haemodynamic response to hypoxic challenge (10% inspired O2) in GαO 
floxed brainstem Cre mice and controls     133 
 
5.3.3 Respiratory response to hypoxic challenge (10% inspired O2) in GαO floxed 
brainstem Cre mice and controls      134 
 
5.4.1 Representative recording of haemodynamic and respiratory responses of a 
control mouse to hypercapnic challenge (3% and 6% CO2)   136 
 
5.4.2 Haemodynamic response to hypercapnic challenge in GαO floxed brainstem 
Cre mice and controls        139 
 
5.4.3 Respiratory response to hypercapnic challenge in GαO floxed brainstem Cre 
and controls         140 
 
6.2.1 HR of mice with conditional deletion of GαO in the RVLM compared to controls 
during conscious and urethane anaesthetised experiments   152 
 
6.2.2 Systolic BP of mice with conditional deletion of GαO in the RVLM compared to 
controls during conscious and urethane anaesthetised experiments 153 
 
6.3.1 HR of mice with conditional deletion of GαO in the RVLM compared to controls 
following pharmacological autonomic blockade    155 
 
6.4.1 HR and systolic BP baroreflex response of mice with conditional deletion of 
GαO in the RVLM compared to controls     157 
 
6.5.1 Programmed electrical stimulation in mice with conditional deletion of GαO in 
the RVLM and controls       160 
 
6.5.2 VERP750 in mice with conditional deletion of GαO in the RVLM compared to 
controls pre and post atenolol      161 
 11 
List of Tables 
 
1.1 The 4 major classes of Gα subunits     30 
 
2.1 Summary of methodologies for in vivo study of cardiac  
electrophysiology         50 
 
2.2 Time domain indices of HRV analysis      66 
 
2.3 Frequency domain indices of HRV analysis    68 
 
2.4 Drugs used for pharmacological manipulations of autonomic influences to the 
heart          70 
 
3.1 Summary data of ECG and HRV parameters in GαO and Gαi2 floxed conduction 
Cre mice and their respective controls      97 
 
5.1 Summary data of hypoxia-induced changes in haemodynamic and respiratory 
variables recorded in control (n=4) and GαO floxed brainstem Cre mice (n=6) pre- 
and post- viral injections       132 
 
5.2 Summary data of hypercapnia-induced changes in haemodynamic and 
respiratory variables recorded in control (n=4) and GαO floxed brainstem Cre mice 
(n=6) pre- and post- viral injections      138 
 
6.1 Summary data of HR, systolic BP (SBP) and ECG parameters of control and 
GαO floxed brainstem Cre mice studied under urethane anaesthesia 151 
 
6.2 Summary data of parameters derived from mean baroreflex curves for mice with 
conditional deletion of GαO in the RVLM compared to controls  158 
 
 12 
Commonly used abbreviations 
 
AC   Adenylyl Cyclase 
 
Ach   Acetylcholine 
 
AVV   Adenoviral vector 
 
BP   Blood pressure 
 
BRS   Baroreflex sensitivity 
 
cAMP   Cyclic adenosine monophosphate 
 
CCPA   2-Chloro-N6-cyclopentyladenosine 
 
CMV   Cytomegalovirus 
 
CVLM   Caudal ventrolateral medulla 
 
DVMN   Dorsal vagal motorneurone 
 
GABA   Gamma-amino butyric acid 
 
GIRK   G protein coupled inwardly rectifying K+ channel 
 
GFP   Green fluorescent protein 
 
GPCR   G protein coupled receptor 
 
HR   Heart rate 
 
HRV   Heart rate variability 
 
HF   High frequency 
 
IML   Intermediolateral cell column 
 
IPSP   Inhibitory post synaptic potential 
 
KO   Knock out 
 
LF   Low frequency 
 
NA   Nucleus ambiguous 
 
NTS   Nucleus tractus solitarius 
 
PKA   Protein kinase A 
 
PLC   Phospholipase C 
 
PTX   Pertussis toxin 
 
 13 
PVN   Paraventricular hypothalamic nucleus 
 
RGS   Regulator of G protein signalling 
 
RR   Respiratory rate 
 
RVLM   Rostral ventrolateral medulla 
 
SAN   Sinoatrial node 
 
SR   Sarcoplasmic reticulum 
 
TH   Tyrosine hydroxylase 
 
VERP   Ventricular effective refractory period 
 
VLF   Very low frequency 
 
VT   Ventricular tachycardia 
 
 14 
Acknowledgements 
 
 
The work described in this thesis was generously supported by the Medical 
Research Council through the award of a Clinical Research Training 
Fellowship. 
 
This work would not have been possible without the excellent supervision 
and support of my supervisors Professors Andy Tinker and Alex Gourine. 
Thank you both for putting up with me over these years and Alex, for making 
me appreciate Pink Floyd. 
 
I would also like to extend my heartfelt gratitude to all my colleagues and 
friends during my time in the Tinker and Gourine labs. In the Tinker lab: 
Sonia Sebastian, who showed me the ropes initially and whom I collaborated 
with for some of the work described in Chapter 3, the ‘wise heads’ of Qadeer 
Aziz, Steve Harmer, Alison Thomas and Muriel Nobles, and of course my 
clinical colleagues and friends Aaisha Opel and Malcolm Finlay. In the 
Gourine lab: Nephtali Marina who kept me going, my ‘partners in crime’ Asif 
Machhada and Isabel Christie, and to Alla Korsak, Vitaly Kasimov, Marina 
Basalay, Svetlana Mastitskaya, Stefan Trapp and Anastassios Karagiannis. 
Special thanks also to Professor Andrew Rammage for taking the time out to 
help me with my experiments. 
 
Finally, and most importantly, to my long-suffering wife Jane. Thank you for 
holding the fort. 
 
And to my Mum and my late Father. This is for you. 
 
 15 
Publications and abstracts derived from work 
described in this thesis 
 
 
Publications 
 
 
Ang, R., Opel, A. & Tinker, A., 2012. The Role of Inhibitory G Proteins and 
Regulators of G Protein Signaling in the in vivo Control of Heart Rate and 
Predisposition to Cardiac Arrhythmias. Frontiers in physiology, 3, p.96. 
 
Sebastian, S. Ang R. et al., 2013. The in-vivo regulation of heart rate in the 
murine sinoatrial node by stimulatory and inhibitory heterotrimeric G-proteins. 
AJP: Regulatory, Integrative and Comparative Physiology, 305(4), pp. R435-
42 
 
 
Abstracts 
 
Ang, R., Birnbaumer L., et al 2013. Tachycardia and increased baroreflex 
sensitivity in mice with conditional deletion of GalphaO in the pre-sympathetic 
area of the brain stem. 37th Congress of IUPS (Birmingham, UK) Proc 37th 
IUPS, PCC063 
 
Ang, R., Birnbaumer L., et al 2013. The role of Galpha-O mediated signaling 
in the central nervous mechanisms controlling sympathetic outflow to the 
heart. European Society of Cardiology. European Heart Journal,  
34 (Abstract Supplement), pp. 928 
 
Ang, R., Birnbaumer L., et al 2013. Loss of inhibitory G protein GαO in the 
pre-sympathetic area of the brainstem leads to increased sympathetic tone to 
the heart and predisposes to ventricular arrhythmia. Heart Rhythm Congress. 
Europace, 15 (Suppl_4), pp. iv 31
 16 
 
 
 
 
 
 
 
 
 
 
Chapter 1 
 
General 
Introduction 
 
 
 
 
 17 
In vertebrates, the autonomic nervous system is essential to support a broad 
range of bodily functions and maintain homeostasis. Autonomic regulation of 
the cardiovascular activities ensures adequate perfusion and oxygenation of 
the end organs in health. Autonomic dysfunction is associated with a wide 
range of cardiovascular diseases, including hypertension, heart failure and 
cardiac arrhythmias.  
 
Hypertension is one of the major risk factors associated with the 
development of many cardiovascular diseases. The pathophysiology of 
essential hypertension is complex and multifactorial. There is significant 
evidence from animal studies and hypertensive patients that autonomic 
dysfunction, specifically activation of the sympathetic nervous system, is 
linked to the development and maintenance of this condition (Malpas 2010).  
 
Heart failure, irrespective of underlying aetiology, result in reduced end-organ 
perfusion. Complex changes in autonomic function occur to compensate for 
this and result in overall increase in sympathetic outflow to the heart and 
peripheral vasculature with reduction in vagal outflow (Grassi et al. 1995; 
Floras 2009). In the short-term these changes have an adaptive effect. 
However, in the longer term they are maladaptive, resulting in increased 
myocardial oxygen consumption, promote adverse cardiac re-modeling and 
increases the likelihood of ventricular arrhythmias (Milner et al. 1999; 
Frenneaux 2004). Reduced heart variability (HRV) and baroreflex sensitivity 
(BRS), both markers of reduced vagal tone and resulting sympathovagal 
imbalance, have been shown to be independently associated with increased 
cardiac mortality in a large cohorts of patients followed up following 
myocardial infarction (La Rovere et al. 1998) and with chronic heart failure 
(Nolan et al. 1998). Reduced BRS has also been independently associated 
with an increase in lethal arrhythmic events following myocardial infarction 
(Farrell et al. 1992). 
 
Autonomic precipitants are also well recognized to trigger arrhythmias 
outside of the context of heart failure. Increased vagal tone has been shown 
to precipitate atrial fibrillation (Bettoni & Zimmermann 2002) and sympatho-
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vagal imbalance can trigger ventricular arrhythmia in patients with inherited 
‘channelopathies’ such as the long QT syndrome, Brugada syndrome and 
catecholaminergic polymorphic ventricular tachycardia (Verrier & 
Antzelevitch 2004).  
 
Although progress has been made in the diagnosis and management of 
these conditions, there remains a significant morbidity and mortality burden. 
For example, only approximately half of patients show satisfactory response 
to current available treatment for hypertension (Go et al. 2013). Despite 
contemporary pharmacological and device treatment for heart failure, 5-year 
survival remains poor at about 50% (Cleland et al. 2014). The limited efficacy 
of current management strategies may be due to the fact that only 
downstream peripheral mechanisms are targeted and not the underlying 
primary factors responsible for the development and maintenance of the 
condition. 
 
It is increasingly recognised that autonomic dysfunction is not just a marker 
of disease progression but also a modifier of the underlying pathology and 
therefore a target for therapeutic interventions. Renal denervation (Myat et al. 
2013), vagal nerve stimulation (De Ferrari et al. 2011) and baroreceptor 
stimulation (Heusser et al. 2010) are among interventions currently 
undergoing clinical evaluation for the treatment of cardiovascular diseases. 
 
However, the initial results reported from renal denervation for hypertension 
and vagal nerve stimulation for heart failure trials have not delivered on the 
initial promise from preliminary studies (Bhatt et al. 2014; Zannad et al. 
2014). It would appear that much remains to be learned regarding the 
autonomic regulation of the heart to allow for more precise targeting of future 
therapeutic interventions. 
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1.1 Autonomic regulation of the heart  
 
The autonomic nervous system maintains homeostasis and coordinates 
physiological responses in the body via its two functional limbs: the 
sympathetic and parasympathetic nervous systems. The heart is regulated in 
this manner within the cardio-respiratory system.  Afferent nerves convey 
baroreceptor and chemoreceptor inputs to the cardio-respiratory centres 
within the brainstem and integrated reflex responses are mediated by the 
sympathetic and parasympathetic efferents to the heart, blood vessels and 
other effector organs such as the adrenal glands. Sympathetic efferents 
cause an increase in heart rate (HR), blood pressure (BP), and diversion of 
visceral blood flow to skeletal muscles and metabolic changes that mobilises 
energy stores, with generally opposite effects mediated by the 
parasympathetic fibres.  
 
Although the sympathetic and parasympathetic effects are largely opposing 
in nature, the balance between sympathetic and parasympathetic activity is 
not a simple see–saw effect as co-activation also occurs (Koizumi & Kollai 
1981; Koizumi et al. 1982). It appears that ‘protective’ responses such as 
diving, peripheral chemoreflex, startle, noxious, ocular and defense reflexes 
activate both autonomic limbs simultaneously to the heart (Paton et al. 2005). 
For example in the diving reflex, activation of the parasympathetic limb 
results in slowing of the heart via its action on the sinoatrial node whilst 
activation of the sympathetic nervous system results in increased contractility 
of the heart. Co-activation of both limbs of the autonomic nervous system 
would also allow for precise control of dynamic range and gain of the 
response, with the direction of the response determined by the dominating 
limb. Since the dynamic range and the gain of the response are restricted, 
this leads towards stabilization of the functional state of the target organ. This 
is important in protective reflexes where the operating range needs to be 
confined but precisely controlled. In contrast, reciprocal control may be better 
suited for homeostatic regulatory responses such as the baroreflex response 
where the range and gain can oscillate in either direction due to the 
synergism of both limbs of the system (Berntson et al. 1991). 
 20 
Both sympathetic and parasympathetic systems are made up of central and 
peripheral components. The central component consists of cell groups in the 
brain and spinal cord, and myelinated preganglionic neurons. It is 
responsible for maintenance of autonomic tone, and integration of afferent 
inputs to generate appropriate autonomic activites. Much of the basic 
structure involved in the reflex control of the cardiovascular system is 
contained within the medulla oblongata. Integrated and behaviorally 
appropriate responses also require reciprocal connections between the 
medulla oblongata, pons, midbrain and the hypothalamus (Spyer 1994). The 
peripheral components consist of ganglia and unmyelinated postganglionic 
afferent and efferent fibres innervating the heart and associated effector 
organs (eg: blood vessels). 
 
In this thesis, I shall concentrate on the central autonomic control of the 
heart. 
 
1.2 Central nervous mechanisms of autonomic control of the heart 
 
The central circuits responsible for autonomic regulation of the heart consist 
of the vagal preganglionic groups of neurones near the dorsal surface of the 
medulla oblongata and within the nucleus ambiguus which project via the 
vagus nerve to the heart, and the sympathoexcitatory (presympathetic) 
networks within the brainstem and hypothalamus which provide tonic 
excitatory drive to the sympathetic preganglionic neurones in the spinal cord 
which in turn innervate the heart. 
 
1.2.1 Vagal preganglionic neurones 
 
Electrophysiological and histological studies using tracer dyes injected 
retrogradely into the heart ganglia or anterogradely into the medullary 
neurones respectively showed that the vagal preganglionic cardiac neurones 
mainly arise from the posterior ventrolateral nucleus ambiguous (NA) and the 
dorsal vagal motor nucleus (DVMN) (reviewed in Coote 2013).  
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The larger NA group of vagal preganglionic neurones receive phasic 
baroreceptor and chemoreceptor input and projects via myelinated B fibres 
whilst the smaller group of DVMN neurones conducts via the slower non-
myelinated C fibres and have a more irregular non-respiratory dependent 
discharge pattern independent of baroreceptor and chemoreceptor input 
(Jones et al. 1995; Garcia Perez & Jordan 2001; Jones 2001).  
 
There is some disagreement with regards to the innervation of these fibres at 
the level of the heart. Using different fluorescent tracers, Cheng et al showed 
that DVMN and NA terminals target separate populations of neurones in the 
intrinsic cardiac ganglion (Cheng et al. 2004). However, Jones (Jones 2001) 
has suggested that B and C fibres converge on the same postganglionic 
neurones but at present there is no direct evidence supporting this. 
Postganglionic efferents synapse via cholinergic muscarinic receptors to the 
atria and cardiac conduction tissue of the heart including the sinoatrial node 
(SAN) and atrioventricular node. There is increasing evidence that the 
ventricular myocardium is also innervated by parasympathetic cholinergic 
(Deighton et al. 1990; Syrota et al. 1985) and non-cholinergic efferents 
(Brack et al. 2007; Brack et al. 2011) directly influencing ventricular rhythm 
and contractility (Casadei 2001). Selective stimulation of the unmyelinated C 
fibres of the DVMN affects atrioventricular conduction and force of ventricular 
contraction and also reduces heart rate, but it has a slower onset and 
different pharmacology to that seen following stimulation of the B fibres in the 
vagus nerve (Jones et al. 1995; Garcia Perez & Jordan 2001; Jones 2001). 
 
Cardiac and respiratory functions are integrated centrally. Respiratory related 
fluctuations in heart rate, also known as respiratory sinus arrhythmia, are the 
result of respiratory modulation on the activity of NA either via direct input 
from central respiratory neurons or by reflex inputs that are activated by lung 
inflations (Spyer & Gilbey 1988). 
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1.2.2 Pre-sympathetic circuits in the brainstem 
 
Sympathetic vasomotor activities are generated by the sympathetic 
preganglionic neurones in the spinal cord, which receive inputs from 
sympathoexcitatory (presympathetic) networks within the brainstem and the 
hypothalamus. Neurones in the presympathetic network include, from rostral 
to caudal, the paraventricular nucleus of the hypothalamus, the A5 cell group 
of the pons, the raphe nuclei, the rostral ventrolateral medulla (RVLM), 
rostral ventromedial and midline medulla, and the A1 cell group (Strack et al. 
1989, Granata et al. 1986). This network of neurones integrates peripheral 
sensory and central command inputs, relay between each other and signal in 
descending pathways to the sympathetic preganglionic neurones in the IML. 
In this manner, they regulate sympathetic activity in response to a variety of 
physiological and behavioural states (Spyer 1994). For example, the raphe 
nuclei have been shown in rats to project directly to sympathetic 
preganglionic neurones in the IML (Bacon et al. 1990) and cause 
sympathetic activation of brown adipose tissue and vasoconstriction in tail 
artery to effect thermogenesis in response to pyogenic stimuli (Nakamura 
2005).  
 
The RVLM is the best studied of all the presympathetic vasomotor neurones. 
It consists of a chemically heterogenous group of cells. The largest group is 
the C1 cells which are catecholaminergic as they contain tyrosine 
hydroxylase (TH) and phenylethanolamine N-methyl transferase, enzymes 
required for the synthesis of adrenaline (Ross et al. 1981, Ross et al. 1983). 
RVLM neurones are also immunoreactive for a number of other peptides 
including 5-hydroxytryptamine (5-HT), neuropeptide Y (NPY), substance P, 
enkaphalin and thyrotrophin releasing hormone (Charlton et al. 1987, Helke 
et al. 1993, Hirsch & Helke 1988, Sasek & Helke 1989, Strack et al. 1989). 
The proportion of C1 cells in the RVLM has been estimated at about 70% 
(Schreihofer et al. 1997, Sartor & Verberne 2003).  
 
The other presympathetic neurones containing PNMT but not TH are the 
noradrenergic A5 and A1 groups of cells. The A5 group is located rostral to 
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the RVLM in the pons and is one of the main sources of noradrenergic input 
to the sympathetic preganglionic neurones (Byrum and Guyenet 1987, 
Bruinstroop et al. 2012). It is thought to play a role in mediating 
cardiorespiratory response to activation of the hypothalamic defence area 
(Lopez-Gonzalez et al. 2013) and to nociception (Clark & Proudfit 1993). The 
A1 group of cells are noradrenergic neurones located at the caudal half of 
the ventral lateral medulla (CVLM) extending down to the spinomedullary 
junction (Ross et al. 1981). They are interspersed with C1 neurones. The A1 
cells project predominantly to a number of supraspinal sites including the 
RVLM and PVN (Woulfe et al. 1990) and are involved in glucoprivic feeding 
(Li et al. 2009), and central fluid and cardiovascular homeostasis  (West et al. 
1981) (Figure 1.1).  
 
1.2.3 RVLM and the cardiovascular system 
 
The RVLM is a source of dense projection to the intermediolateral cell 
column (IML) (Amendt et al. 1979, Dampney et al. 1982) and contributes 
significantly to the generation of sympathetic vasomotor tone since in 
anaesthetised experimental animals acute bilateral inactivation or ablation of 
the RVLM neurones leads to a fall in arterial pressure and sympathetic 
activity to the levels observed after transection of the spinal cord or during 
ganglionic blockade (Guertzenstein & Silver 1974; Feldberg & Guertzenstein 
1976). Conversely, activation by electrical stimulation or chemical excitation 
of this region profoundly increases sympathetic nerve activity and the arterial 
blood pressure (Dampney et al. 1982; Guyenet 2006). In addition, 
baroreceptor stimulation inhibited RVLM activity and this correlated to 
reductions in sympathetic vasomotor activity (Barman & Gebber 1985, Brown 
& Guyenet 1985). A large fraction of these neurones were later identified as 
C1 cells by intracellular and juxtacelular labeling methods (Lipski et al. 1995, 
Schreihofer & Guyenet 1997).  
 
The specific role of C1 neurones to arterial pressure control was studied in 
conscious rats after administration of ribosome inactivating toxin anti-
dopamine beta hydroxylase-saporin (anti-DβH-sap), which causes selective 
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destruction of catecholaminergic cells, to the RVLM (Madden & Sved 2003, 
Madden et al. 2006). Only modest reductions of mean arterial pressure (~10 
mmHg) were observed in conscious rats despite very large reductions in C1 
cell numbers (~80%) and substantial collateral damage to the A5 
noradrenergic neurones (Madden & Sved 2003). In these rats, plasma 
catecholamine levels were only marginally lower than in controls, suggesting 
a small drop in resting sympathetic tone. However, following hydralazine-
induced hypotension there was a substantial attenuation in the rise of plasma 
norepinephrine, vasopressin, and oxytocin. There was also significant 
attenuation in HR and arterial pressure response to baro- and chemoreflex 
challenges. These findings suggest that the RVLM contributes significantly in 
sympathoexcitatory reflexes such as the baroreceptor reflex, and the carotid 
chemoreceptor reflex. A seperate group replicated these findings in rats with 
presympathetic C1 neurons (and A5 neurons) destroyed by injecting the 
same toxin into the spinal cord (Schreihofer et al. 2005), sparing the 
bulbospinal barosensitive non-C1 RVLM neurons (Schreihofer & Guyenet 
2000). In these rats, there were no significant effects on resting arterial 
pressure or HR. However, sympathoexcitatory responses evoked by 
electrical stimulation of the RVLM were signficantly attenuated, as were the 
baroreflex and the increase in sympathetic nerve activity elicited by carotid 
body stimulation (Schreihofer & Guyenet 2000). Taken together, these 
studies demonstrate that chronic lesions of the C1 neurons with anti-DβH-
sap only modestly decreases resting arterial pressure and resting 
sympathetic nerve activity, but permanently and substantially reduces the 
neuroendocrine response to hypotension and hypoxia. 
 
The RVLM has also been implicated in cardiovascular pathologies such as 
hypertension and heart failure. For example, the development of 
hypertension in spontaneous hypertensive rats (SHRs) was attenuated when 
the activity of the RVLM was depressed using a lentiviral construct (Geraldes 
et al 2014). Marina et al used a different lentiviral vector to disrupt purinergic 
signaling in the RVLM in rats with myocardial infarction-induced heart failure 
(Marina et al 2013). They found that expression of the viral construct 
bilaterally in the RVLM led to lower plasma noradrenaline concentration and 
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attenuated the progression of LV remodelling and heart failure secondary to 
myocardial infarction. 
 
1.2.4 The sympathetic baroreceptor reflex pathway 
 
The baroreceptor reflex describes the changes in sympathetic outflow in 
response to perturbations in arterial BP and is often used to study the central 
neurotransmitter system regulating sympathetic outflow.  
 
The contribution of the RVLM to the baroreflex operation (the sympathetic 
cardiac, respiratory, and neuroendocrine responses elicited by hypotension 
via a reduction in the activity of arterial baroreceptors) is summarised in Fig. 
1.2. Baroreceptor afferent neurons terminate at the nucleus tractus solitaries 
(NTS), which process and integrate these inputs and projects via 
glutamatergic neurons to the CLVM.  
 
CVLM is the site at which the excitatory signals from baroreceptor afferent 
nerves are converted to inhibitory inputs to the RVLM. CVLM neurons are 
tonically active, even in the absence of baroreceptor input and use GABA as 
a neurotransmitter. These sympatho-inhibitory interneurons project rostrally 
and bilaterally to the RVLM and generate inhibitory post-synaptic potentials 
(IPSP)s (reviewed in Pilowsky & Goodchild 2002). 
 
Sympatho-activation secondary to hypotension is hence due to a process of 
‘disinhibition’ of RVLM C1 cells via a pathway that consists minimally of three 
neurons: baroreceptor afferent neurons, glutamatergic neurons located in the 
NTS and projecting to the CVLM and CVLM GABAergic interneurons which 
synapse with C1 neurons (Figure 1.2).  
 
Both the CVLM and the RVLM also receive inputs from nearby respiratory 
(Botzinger) regions and respiratory modulation of sympathetic activity is 
known to occur (Pilowsky et al. 1996; Miyawaki et al. 2002). Hypotension 
also activates breathing by stimulating the central respiratory pattern 
generator and triggers the corticotrophin releasing hormone (CRH) 
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/adrenocorticotropic hormone (ACTH)/corticosterone cascade, presumably 
through direct projections from RVLM C1 neurons to the PVN  (Guyenet et 
al. 2013).  
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Figure 1.1 Location and principal projections of the rat RVLM/C1 
neurones 
 
(A) Schematic representation of the location and main axonal projections of 
the RVLM/C1 neurons (parasagittal view). (B) Higher resolution view of the 
pontomedullary region outlined in (A) showing the location of the C1 cells in 
relation to nearby anatomical structures. The C1 neurons (in green) project to 
lower brain stem noradrenergic neurons (A1, 5 in blue), selected 
serotonergic neuron-rich regions (dorsal raphe), the dorsal vagal complex 
(nucleus of the solitary tract and dorsal vagal motor nucleus, NTS/DVMN), 
and the intermediolateral cell column (IML). The main rostral targets are the 
periacqueductal grey matter (PAG), and, in the hypothalamus, the 
paraventricular nucleus (PVH). RVLM, rostral ventolateral medulla; FN, facial 
motor nucleus; NA, nucleus ambiguus; tpz, trapezoid body; CVLM, caudal 
ventrolateral medulla; PNS, parasympathetic nervous system; SNS, 
sympathetic nervous system. (Adapted from Guyenet et al. 2013) 
 
A 
B 
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Figure 1.2 Schematic drawing of main peripheral and central pathways 
involved in autonomic cardiovascular regulation 
 
 (A) Sympathetic baroreflex arm: Baroreceptor afferent neurons in the 
periphery transmit baroreceptor information via a glutamatergic synapse to 
the nucleus tractus solitaries (NTS) in the dorsal medulla oblongata. NTS 
neurons project to and excite inhibitory neurons in the caudal ventrolateral 
medulla (CVLM). CVLM neurons in turn project and inhibit (via a GABAergic 
synapse) presympathetic neurons in the rostral ventrolateral medulla 
(RVLM). Spinally projecting presympathetic RVLM neurons make direct 
connections with sympathetic preganglionic neurons in the intermediolateral 
(IML) spinal column, which generate sympathetic outflow to the effector 
organs. (B) Parasympathetic control of heart rate: NTS neurons receive 
baroreceptor information and relay it via a glutamatergic pathway to the 
nucleus ambiguus (NA). Cardioinhibitory neurons in the NA project to the 
heart via the vagus nerve, which mediates its effect via muscarinic receptors 
in the heart (adapted from Pilowsky & Goodchild 2002). 
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1.3 G-proteins 
 
G-proteins mediate signal transduction for the G-protein coupled receptors 
(GPCRs), which make up the majority of mammalian membrane-bounded 
receptor systems. GPCRs are key modulators of disease pathogenesis and 
some 30-40% of all therapeutic agents used in clinical practice target certain 
GPCRs.  
 
Heterotrimeric G-proteins are composed of β-subunits, which dynamically 
interact with GPCRs within the plasma membrane, as part of the G-protein 
cycle. Heterotrimeric G proteins can be divided into 4 primary families based 
on their  subunits: Gi/o, Gs,  Gq/11 and G12/13. Gs and Gq/11 are 
excitatory G proteins that act predominantly via adenlyate cyclase (AC) and 
phospholipase C (PLC) respectively. Gi/o subunit are known as inhibitory G 
proteins, are sensitive to pertussis toxin, and can be further subdivided into 4 
main subtypes based on their  subunit isoforms: Gi1, Gi2, Gi3 and GO 
(‘O’ for other). G12/13 proteins predominantly activate the small G protein 
Rho and through RhoA and its downstream effectors affect the actin 
cytoskeleton, cell migration and invasion and other complex cellular 
processes (reviewed in Birnbaumer 2007a)(Table 1.1).  
 
GPCRs can also be modulated at the receptor or effector level; for instance, 
members of the regulator of G-protein signaling (RGS) family of proteins can 
accelerate activation or deactivation of G-proteins, and may alter receptor-
effector coupling (Birnbaumer 2007b) 
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Gα subunit 
classes 
Main 
subclasses 
Gene Expression Effectors 
GαS class GαS GNAS Ubiquitous AC 
Gαi/o class Gαi1 GNAI1 Widely distributed AC  (directly regulated) 
GIRK , VDCC  
Various other effectors regulated 
by Gβγ subunit 
 Gαi2 GNAI2 Ubiquitous 
 Gαi3 GNAI3 Widely distributed 
 GαO GNAO Neuronal, neuroendocrine 
Gαq/11 class Gαq GNAQ Ubiquitous PLC  
 Gα11 GNA11 Almost ubiquitous 
Gα12/13 class Gα12 GNA12 Ubiquitous PDZ-RhoGEF/LARG, Btk, 
Gap1m, cadherin 
 Gα13 GNA13 Ubiquitous P115RhoGEF, PDZ-
RhoGEF/LARG, radixin 
 
Table 1.1 The 4 major classes of Gα subunits 
Abbreviations:  increase in activity;  decrease in activity; AC, adenylyl cyclase; GIRK, G protein regulated inward rectifier 
potassium channel; VDCC, voltage dependant Ca2+ channel; PLC, phospholipase C; RhoGEF, Rho guanide nucleotide exchange 
factor. Adapted from (Wettschureck & Offermanns 2005) 
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1.3.1 Inhibitory G proteins and autonomic modulation of heart rate 
 
Heart rate modulation via adrenergic and muscarinic mechanisms operating 
at the level of the heart is well studied. The current paradigm for the 
mechanism underlying SAN automaticity involves a complex interaction 
between activity of the voltage-gated ion channels/exchangers in the plasma 
membrane (also referred to as the ‘membrane clock’) and the rhythmic 
calcium release from the sarcoplasmic reticulum (the ‘calcium clock’) 
(Lakatta & DiFrancesco 2009). The key membrane ion channel thought to be 
involved in pacemaker setting is the hyperpolarisation activated cation 
currents or ‘funny’ currents (Ih/If) channel (DiFrancesco 2010), and 
pacemaker activity is further modulated by K+, Na+ and Ca2+ currents. In 
addition, recent studies suggest that rhythmic local calcium releases from the 
sarcoplasmic reticulum (SR) modulated by protein kinase A (PKA) also 
contribute to pacemaker activity by activating inward Na+/Ca2+ exchanger 
currents during late diastolic depolarisation (Maltsev & Lakatta 2008) (Figure 
1.3). GPCRs can hence modulate heart rate by acting directly on the Ih/If 
channel or by regulation of intracellular calcium cycling.  
 
The release of noradrenaline from the sympathetic nerve endings or the 
release of adrenaline from the adrenal medulla into the circulation modulates 
activity of the SAN by binding to β-adrenoreceptors. The stimulatory cascade 
mediated by Gs is activated and this leads to stimulation of AC and the 
generation of cyclic adenosine monophosphate (cAMP). Increased cAMP 
can directly modulate Ih/If leading to increased rate of pacemaker 
depolarisation. However, increased cAMP can also activate PKA, which can 
modulate intracellular calcium handling proteins such as phospholamban and 
the ryanodine receptor to modulate rate. Both of these actions will increase 
the heart rate. 
 
Acetylcholine (ACh) is released from the terminals of the vagal 
postganglionic neurones and binds to the muscarinic (M2) receptors, leading 
to the activation and dissociation of inhibitory G-protein heterotrimers. The 
resulting βγ-dimer directly activates the G-protein coupled inward rectifying 
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potassium (GIRK) channel to cause membrane hyperpolarisation, slowing 
pacemaker depolarisation and sinus rate. Furthermore, the activation of the 
inhibitory G subunit will inhibit AC and thus modulate Ih/If and the calcium 
handling proteins as detailed above. RGS proteins interact with the inhibitory 
G subunit to switch off this pathway through GTPase accelerating protein 
(GAP) activity and allow the heterotrimer to reform (Figure 1.4). 
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Figure 1.3 Interplay between the membrane and the calcium ‘clock’ in 
regulation of SAN automaticity 
 
 
Schematic illustration of the interplay of Ca2+, basal Ca2+-activated adenylyl 
cyclase (Basal A Cyclase), GPCR activated adenylyl cyclase (GPCR 
Activated A Cylcase), cyclic AMP (cAMP) and protein kinase A (PKA), in the 
context of sarcoplasmic reticulum Ca2+ cycling (modulated by activities of 
ryanodine receptor (RyR), phospholamban (PLB) and sarco/endoplasmic 
reticulum Ca2+-ATPase (SERCA)), hyperpolarization activated cation/funny 
current (If), L-type Ca
2+ (ICa,L), Na
+/Ca2+ (INCX) exchanger, and inward rectifier 
K+ (IK) and acetylcholine mediated inward rectifying K
+ (GIRK) membrane 
currents. Spontaneous but rhythmic local submembrane Ca2+ releases during 
late diastolic depolarisation (DD) activate INCX, causing the DD to increase 
exponentially to achieve the threshold for ICa,L activation and the generation 
of the next AP. Modulatory actions of GPCR signaling via β adrenergic and 
muscarinic cholinergic receptors are shown by green (stimulatory) and red 
(inhibitory) arrows. Adapted from (Lakatta & DiFrancesco 2009). 
 
GIRK 
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Figure 1.4 A simplified schematic for the mechanism of heart rate 
regulation by inhibitory G proteins  
 
Acetylcholine (Ach) released from the vagus nerve binds to the muscarinic 
(M2) receptor, which is coupled to the inhibitory G protein. The α-subunit 
inhibits cyclic AMP (cAMP) whilst βγ-dimer activates the G protein coupled 
inward rectifying potassium (GIRK) channel to slow the sinus rate, and 
decrease the action potential duration. Regulators of G protein signaling 
(RGS) interact with the α-subunit to switch off this pathway through GTPase 
accelerating protein activity and allow the heterotrimer to reform. AC, 
adenylyl cyclase; cAMP, cyclic AMP; PKA, protein kinase A; HCN, 
hyperpolarization-activated cyclic nucleotide-gated channel (from Ang 2012). 
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1.3.2 G-proteins specificity 
 
Do specific G-proteins carry out unique functional roles or does the system 
have significant redundancy? Inhibitory G-proteins are characterised by their 
sensitivity to PTX, which adenosine di-phosphate (ADP) ribosylates the 
proteins and uncouples them from receptors. In vitro studies using PTX 
insensitive Gαi/o isoforms suggest that most GPCR’s couple well with a 
number of isoforms (Leaney et al. 2000). 
 
Zuberi et al studied whether specific isoforms of the inhibitory G-proteins 
differentially modulate heart rate in vivo (Zuberi et al. 2008). Mice with global 
knock out (KO) of Gαi1 and Gαi3 combined, Gαi2 and GαO were implanted with 
telemetry probes. Heart rate dynamics were then analysed in the time and 
frequency domain in awake and unrestrained mice. The influences exerted 
on the heart by the autonomic nervous system can be measured indirectly by 
the analysis of the beat-to-beat variation of heart rate (“heart rate variability”, 
HRV). In man R-R interval shows characteristic patterns of variability with a 
low frequency (LF) component (> 6 second cycle length) determined by 
sympathetic and parasympathetic drive and a high frequency (HF) 
component (2.5 to 6 second cycle length) governed by parasympathetic input 
(Stauss 2003). Such analysis has also been applied to the mouse but there 
is less agreement on the contribution of the different arms of the autonomic 
nervous system to the frequency components (Thireau et al. 2007). Gαi2 
deficient mice were found to be generally tachycardic with preservation of 
diurnal variation, had loss of HF power when HRV was analysed and 
displayed patterns similar to that seen after application of GIRK channel 
blocker TertiapinQ or muscarinic receptor blocker atropine. There was also 
an attenuated bradycardic response to muscarinic receptor agonist 
carbachol. Mice with global deficiency in Gαi1,3 were similar to wild type (WT) 
but GαO showed a different phenotype that is discussed below.  
 
These observations correlated with the findings by Fu et al, where mice with 
a G184S knockin point mutation in the switch I region of Gαi2, preventing the 
binding of RGS proteins and deactivation of Gαi2, displayed marked 
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enhancement of muscarinic agonist-induced bradycardia (Fu et al. 2007). 
There is, however, one conflicting study suggesting that GαO but not Gαi2 
mediates muscarinic influences on the heart (Duan et al. 2007). 
 
Gαi2 and GαO–mediated signalling has also been implicated in the muscarinic 
inhibition of β-adrenoreceptor activated voltage gated L-type calcium 
channels in the heart. Using a model of ventricular myocytes isolated from 
global Gαi2 and Gαi3 knockout mice, Nagata et al demonstrated reduced 
calcium channel currents with carbachol following isoproterenol stimulation in 
Gαi3 knockout mice and littermate controls but not in Gαi2 knockout mice 
(Nagata et al. 2000). Using a similar experimental strategy in GαO knockout 
mice, Valenzuela demonstrated similar impaired muscarinic regulation of L-
type calcium channels in ventricular myocytes lacking GαO but no difference 
in potassium current compared to wild type controls (Valenzuela et al. 1997). 
 
Differential coupling of G protein subtypes to adenosine A1 and muscarinic 
M2 receptor mediated heart rate slowing was also demonstrated in vitro 
using RGS insensitive GαO and Gαi2 ES derived cardiomyocytes (Fu et al. 
2006). The RGS-insensitive GαO homozygous knock-in cells demonstrated 
enhanced adenosine A1 and muscarinic M2 receptor-mediated bradycardic 
responses. In contrast, RGS-insensitive Gαi2 homozygous knock-in cells 
showed enhanced responses to activation of M2 but not A1 adenosine 
receptors. Blocking GIRK channels largely abolished the mutation-induced 
enhancement of the M2 receptor-mediated response but had a minimal effect 
on A1 responses.  
 
Taken together, the evidence suggests that M2 mediated GIRK channel 
activation is coupled preferentially to the Gαi2 subunit whereas coupling to 
voltage gated L-type calcium channel appears to be less specific with both 
GαO and Gαi2 implicated.  
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1.4 Contributory effect of inhibitory G proteins signalling in the central 
nervous system 
 
As described above, in vitro and in vivo studies appear to suggest inhibitory 
G protein specificity at the level of the heart. What is less known is the role 
and specificity of inhibitory G proteins in the central nervous mechanism of 
cardiovascular autonomic regulation.  
 
1.4.1 Inhibitory G proteins in the central nervous system 
 
Gαi1, Gαi2 and Gαi3 are ubiquitously expressed in all tissues of the body but 
GαO protein expression is restricted mainly to the central and peripheral 
nervous systems, endocrine cells and cardiomyocytes (Wettschureck & 
Offermanns 2005). Expression of GαO is greatest in the brain where it is 
estimated to constitute around 1% of all membrane proteins (Sternweis & 
Robishaw 1984). Mice lacking the α subunit of GO are smaller and weaker 
than their littermates, have greatly reduced life expectancy and display 
numerous neurological abnormalities including hyperalgesia, tremors, 
seizures, and increased motor activity with an extreme turning behavior 
(Jiang et al. 1998).  Gαi/o coupled receptors can cause pre- or post-synaptic 
inhibition either via GIRK channels or by inhibiting calcium channels to 
mediate an effect on the central nervous system (van den Pol 2012). 
 
GIRK channels are widely distributed in neuronal and endocrine tissues and 
play key roles in generating late IPSPs and modulating hormone release in 
addition to their cardiac functions described above. In the central nervous 
system, GIRK channels hyperpolarize neurons in response to activation by 
peptides and neurotransmitters including GABA, adenosine, somatostatin, 5-
Hydroxytryptophan (5-HT) and opioids, and are composed of 
heterotetramers of Kir3.1, Kir3.2 and Kir3.3 and homotetramers of Kir3.2 
(Lüscher et al. 1997; Lüscher & Slesinger 2010).  
 
The regulation of neurotransmitter release at presynaptic terminals is another 
important mechanism underlying the modulation of synaptic transmission in 
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the nervous system. Inhibitory regulation of neurotransmitter release occurs 
via Gαi/o-coupled receptors such as GABA-B receptors, α2-adrenoceptors, 
adenosine A1, μ- and δ-opioid receptors, or endocannabinoid CB1-receptors. 
The Gβγ subunit of these receptors directly inhibits the presynaptic calcium 
channels to block action potential-evoked Ca2+ entry (Dolphin 2003). There is 
some evidence showing selectivity of inhibitory G-protein coupling to voltage-
gated Ca2+ channels in the central nervous system (Ewald et al. 1989; 
Caulfield et al. 1994).  
 
Finally, signalling via GαO has also been implicated in vesicular glutamate 
transporter within the central nervous system (Winter et al. 2005) and GAP43 
receptor signalling for neuronal path finding (Strittmatter et al. 1990). 
 
1.4.2 Inhibitory G protein signalling in the RVLM 
 
As described previously, there is a tonic GABAergic input to RVLM neurons 
which is mediated via CVLM neurones. GABA can mediate its inhibitory 
actions on the RVLM via the ionotropic GABA-A receptor or the Gαi/O linked 
metabotropic GABA-B receptor. The distribution Gα proteins in the rostral C1 
cells of the RVLM, and the noradrenergic A1 and A5 groups of 
presympathetic neurones was studied by Parker et al (Parker et al. 2012). 
Using quantitative RT-PCR, the most ubiquitously expressed Gα proteins 
after GαS were the inhibitory G proteins Gαi2 and GαO. Both Gαi2 and GαO 
were found to be expressed in around 80%, 90% and 100% of C1, A1 and 
A5 cells respectively.  
 
Initial studies focused on GABA-A mediated inhibitory mechanisms in the 
RVLM. Electrophysiological findings indicate that GABA exerts its inhibitory 
action on RVLM neurons preferentially via ionotropic GABA-A receptor 
activation. Pharmacological blockade of GABA-A receptors in the 
sympathoexcitatory region of the RVLM almost entirely eliminates the action 
of the caudal inhibitory vasomotor neurons and results in a large increase in 
sympathetic activity and blood pressure (Tagawa et al. 2000; Schreihofer et 
al. 2005). Conversely, bilateral microinjection of the GABA-A agonist, 
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muscimol, into the RVLM in anesthetized rats results in a large fall in mean 
arterial pressure, HR and sympathetic activity (Willette et al. 1983; Horiuchi & 
Dampney 1998; Fontes et al. 2001; Schreihofer et al. 2005), suggesting that 
GABA-A receptors mediate a powerful inhibitory input over RVLM neurons.  
 
However, the discovery of specific, high affinity GABA-B antagonists (Dutar & 
Nicoll 1988)  has led to an emerging body of evidence demonstrating its 
physiological role in the CNS (Misgeld, Bijak & Jarolimek 1995). In 
anaesthetised rats, iontophoresis of the GABA-B agonist, baclofen, inhibits 
RVLM bulbospinal barosensitive cells (Li & Guyenet 1995) and produces 
significant hypotension (Amano & Kubo 1993). Moreover, GABA-B receptor 
specific antagonists 2-hydroxy-saclofen and CGP-35348 were shown to 
induce a reversible increase in HR and BP when microinjected into the 
RVLM and were able to antagonise the depressor response of the GABA-B 
specific agonist baclofen but not the GABA-A specific agonist muscimol 
(Avanzino et al. 1994). These data suggest that the Gαi/o linked GABA-B 
receptor may play a role in the inhibitory signalling to the RVLM. 
 
The α2a adrenoceptor, which also signals via Gαi/O, is also expressed in the 
RVLM and at least in part mediates the hypotensive effect of centrally acting 
antihypertensive agents such as clonidine (Link et al. 1996, McMillan et al. 
1996). Electron microscopy study using dual immuno-labelling of α2a 
adrenoceptor and tyrosine hydroxylase (TH) expressing cells in the RVLM 
have shown that α2a adrenoceptor is mainly expressed on non-
catecholaminergic cells and may act as a heteroceptors providing inhibitory 
pre-synaptic input to C1 neurones of the RVLM (Milner et al. 1999). 
 
Finally, inhibitory influence on the RVLM may also be mediated by adenosine 
A1 receptors (Thomas & Spyer 1996), δ opioid receptors (Hood & Woods 
2004) and endocannabinoid CB-1 receptors (Li et al. 1995). It is likely that 
the co-expression of inhibitory ionotropic and metabotropic receptors in the 
RVLM allows for both phasic and tonic regulation of sympathetic output given 
the differences in receptor kinetics (Misgeld, Bijak & Jarolimek 1995). The 
different neurotransmitter and neuromodulators involved in inhibitory 
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signaling may also reflect the different synaptic inputs projecting to the RVLM 
as detailed above.  
 
It is important to note that the concept of Gαi/O signaling at the RVLM as a 
purely restraining inhibitory influence on excitatory inputs maybe an overly 
simplistic one. For example, pre-synaptic inhibition of GABA-ergic inputs 
would result in disinhibition and an overall increase in RVLM discharge. This 
may in part explain the paradoxical excitatory actions of exogenously applied 
adenosine to the RVLM, which can be blocked by the ionophoresis of 
bicuculline, a specific GABA-A antagonist (Thomas & Spyer 1999). 
 
1.4.3 In vivo evidence supporting the role of inhibitory G proteins and 
central nervous mechanisms of autonomic regulation of the heart 
 
In vivo studies manipulating the expression of inhibitory G proteins and its 
subtypes either directly with knockout models or indirectly by manipulation of 
their regulatory proteins such as the RGS proteins have shed some light on 
their physiological importance and relative contribution to the central nervous 
control of the heart. Autonomic balance in-vivo has been quantified by 
indirect methods such as catecholamine sampling and analysis of HRV. The 
baroreceptor reflex is the prototypical cardiovascular reflex studied and its 
sensitivity is commonly assessed experimentally by computation of 
baroreflex set point and gain from ambulatory BP recordings, although more 
direct methods have been described (Young & Davisson 2011; Ma et al. 
2002).  
 
Interestingly, mice overexpressing RGS insensitive Gαi2 were tachycardic 
during the daytime, have enlarged heart and increased contractile function 
on echocardiography. Along with reduced viability, growth retardation and 
multiple neurological deficits, the cardiovascular phenotype observed in 
these mice was attributed to increased central sympathetic tone (Huang et al. 
2006). To study the cardiac specific effect of enhanced Gαi2 signalling, 
isoproterenol-stimulated beating isolated perfused hearts of these mice were 
 41 
studied and showed the expected enhancement of muscarinic mediated 
bradycardia (Fu et al. 2007).  
 
Mice deficient in RGS2 were found to be hypertensive but with normal HR 
suggestive of resetting of baroreceptor sensitivity. There was an associated 
increase in urinary catecholamine secretion and reduction in both low-
frequency and high-frequency power of HRV suggesting increased central 
sympathetic tone (Gross et al. 2005). This along with data on the RGS 
insensitive Gαi2 mice described above implies that overactivity of inhibitory G 
proteins may contribute to increased central sympathetic tone.  
 
Albarran-Juarez et al studied the haemodynamic response of anaesthetized 
mice with global KO of Gαi1, Gαi2 and Gαi3 receptor subtypes to the α2a 
receptor agonist medetomidine (Albarran-Juarez et al. 2009). There was no 
difference in HR and BP response and correspondingly no difference in 
noradrenaline release from the prefrontal cortex or the cardiac atria 
suggesting functional redundancy of the receptor subtypes investigated in 
modulation of α2a receptor signaling. 
 
In Zuberi et al’s study of a limited number of global GαO knockout mice 
(Zuberi et al. 2008), in addition to the neurological abnormalities previously 
described, the mice were found to be tachycardic with loss of diurnal rhythm 
and fairly selective loss of the LF component of HRV with preserved total 
power. However, carbachol still had a negative chronotropic effect.  This is 
suggestive of increased central sympathetic tone. 
 
There hence appears to be a contradictory effect of over- and under-
expression and function of inhibitory G proteins and its effect on sympathetic 
tone and central autonomic regulation of the heart. This is not surprising 
given the complex effects of inhibitory G protein signalling in the central 
autonomic circuits as described above and the global nature of the knockout 
models used in previous studies.  
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Mice with global deletion of a particular G protein often have reduced viability 
and are difficult to work with and it can be unclear at which level 
compromised signaling is contributing to the phenotype observed. Use of 
more refined temporal and spatial conditional deletion strategies would 
circumvent some of the problems and help define the relative role of 
inhibitory G proteins and its subtypes in the central and peripheral autonomic 
control of the heart. For example, by inducing conditional deletion of GαO in 
the cardiac conduction tissue and central nervous system of the adult mice 
the developmental issues faced in global knockouts are circumvented. In 
addition, generation of mice with specific central autonomic phenotype would 
also allow the investigation of the role of central autonomic tone per se in 
mediating cardiac pathophysiology such as ventricular arrhythmia and 
circumvent the problem of compensation. 
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1.5 Summary 
 
It is clear that actions of inhibitory G proteins and their associated RGS 
proteins at multiple levels play a critical role in the mechanisms of autonomic 
control on the activity of the cardiovascular system. There is also an 
emerging body of evidence demonstrating isoform specificity of these G 
proteins in vivo. Gαi2 is implicated in mediating parasympathetic influences 
on the heart, most likely by coupling M2 receptors at the level of the 
conduction tissue of the heart.  
 
What is less clear is their role in autonomic traffic in the central autonomic 
circuits. There is conflicting evidence with regards to G proteins specificity in 
the central nervous system and if so, the identity and location of the isoform 
which is important centrally. 
 
From limited in vivo studies, it appears that inhibitory G proteins have an 
important role in mediating sympathetic tone to the heart, with loss of 
inhibitory G protein signalling resulting in increased sympathetic tone and 
sympatho-vagal imbalance and GαO being implicated as possibly an 
important subtype in the central nervous system. There is a large body of 
evidence supporting the importance of the RVLM in autonomic regulation of 
the cardiovascular system and cardiovascular reflexes in health and disease 
states. The RVLM receives inhibitory inputs and there is evidence that 
inhibitory G proteins are involved. 
 
We hence postulate that signalling via GαO in the RVLM may be important in 
central autonomic regulation of cardiovascular control. For comparison, we 
would first study the role of GαO signalling in the cardiac conduction tissue. 
 
Cardiac excitability and susceptibility to arrhythmia appears to be influenced 
by the prevailing autonomic tone and is currently an area of intense clinical 
interest. Therefore we would also aim to study whether altered GαO signalling 
in the RVLM also lead to alterations in cardiac excitability if it does indeed 
have an effect on autonomic regulation of cardiovascular control. 
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1.6 Hypothesis and aims 
  
1.6.1 Hypothesis 
 
GαO-mediated signalling within the presympathetic circuits of the rostral 
ventrolateral medulla oblongata (RVLM) but not in the cardiac conduction 
tissue, contributes to autonomic control of the heart. GαO deficiency in the 
RVLM alters cardiovascular reflexes and electrical properties of the heart. 
 
1.6.2 Aims 
 
1. To determine the role of GαO-mediated signalling at the level of the 
cardiac conduction system in regulation of heart rate. 
 
2. To determine the role of GαO-mediated signalling within the 
presympathetic circuits of the RVLM in the central nervous 
mechanisms of autonomic control of the heart. 
 
3. To determine whether loss of GαO-mediated signalling within the 
presympathetic circuits of the RVLM leads to changes in cardiac 
excitability and predisposes the heart to ventricular arrhythmias. 
 
In the following chapters, I shall first describe the methods used to generate 
mice with specific knockout of GαO proteins in tissues of interest and the 
experiments used to profile their cardiovascular autonomic and 
electrophysiological phenotypes. I will then present and discuss the data 
obtained to address the aims stated above.  
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Chapter 2 
 
Materials and methods 
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2.1 Introduction 
 
2.1.1 The transgenic mouse model 
 
Whilst in vitro methodologies such as patch clamping has contributed greatly 
to our understanding of molecular and cellular mechanisms of arrhythmia 
(Benians et al. 2003; Leaney et al. 2004), these technologies do not address 
how modification of cellular events affect ‘complex’ electrophysiological 
properties that occur in the setting of integrated animal physiology such as 
neuro-cardiac feedback within the autonomic nervous system. Transgenic 
technology allows for manipulation of gene expression and the study of 
cardiovascular physiology and pathophysiology at the molecular level in a 
whole intact organism, allowing a more integrated approach in the 
understanding of cardiovascular function compared to the ‘reductionist’ 
approach of studying cell and tissue cultures.  
 
In this respect, the mouse has become the transgenic animal model of 
choice. Two complementary strategies are used to engineer the transgenic 
mice. The first approach involves injection of transgene constructs directly 
into the nucleus of fertilized single cell embryos. Thus the endogenous gene 
is not affected, and the expected phenotype will not be detectable unless the 
product of the transgene is dominant. In addition, neither insertion site nor 
copy number can be controlled and this can lead to insertional mutagenic 
events or atypically high levels of expression. An alternative method relies on 
homologous recombination of electroporated DNA sequences into pluripotent 
embryonic stem (ES) cells. The modified DNA sequence is inserted into the 
endogenous genetic site and replaced the normal sequence. The genetically 
modified ES cells are then selected out and introduced into blastocysts in 
order to generate chimeric embryos. Mice incorporating genetic modification 
into the germline then act as founders to transmit the engineered genetic 
modification into subsequent progeny. Although much more expensive and 
time consuming, the genetic event is precise and occurs at a single site, 
allowing for recessive mutations and null or site-specific mutant alleles to be 
studied under the control of the endogenous promoters (Yutzey & Robbins 
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2007). This approach has been applied extensively to study the function of 
G-proteins as most of them can be fully inactivated or human mutations can 
be incorporated into the mouse genome (Jiang et al. 1998; Boknik et al. 
2009). 
 
Limitations associated with these approaches are mainly due to the 
pluripotent nature of germline mutation resulting in the targeted defect being 
present in all cell types that express the gene (so called ‘global’ knock out or 
knock in). As a result, the resulting phenotype studied may not be solely due 
to genetic modification in the cells/tissue/organs of interest. In addition, as 
these mutated genes are expressed from the embryonic stage of 
development, long term compensatory changes/gene remodelling may 
potentially mask the role of a particular gene/protein of interest (gene 
redundancy) (Stieber et al. 2003) or in some cases result in embryonic 
lethality (Jiang et al. 1998). 
 
To overcome these problems, temporal and spatial gene targeting 
approaches have been developed to produce genetic manipulation driven by 
promoters which are tissue and time specific. A commonly used technique to 
achieve this is the Cre-LoxP technology (Sauer 1998). Briefly, the gene of 
interest is flanked by LoxP constructs which in the presence of Cre 
recombinase enzyme results in deletion of the gene (Figure 2.1). Temporal 
and spatial specificity can then be achieved by targeted expression of Cre 
recombinase. Various approaches have been used to produce specific Cre 
recombinase expression such as using tissue specific promoters in 
combination with drug inducible constructs (Hoesl et al 2008; DeGeorge et 
al. 2008) and the use of viral vectors (Marina et al. 2011).  
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Figure 2.1 Conditional gene deletion by Cre recombinase 
 
Crossing a loxP-modified mouse with a Cre transgenic generates a double-
transgenic mouse in which the loxP-modified gene has been deleted in those 
tissues where Cre transgene has been expressed. In the diagram above, Cre 
is expressed in the ears (shaded) of the Cre transgenic so that deletion of the 
loxP-modified target gene is confined solely to the ears (white) of the double 
transgenic. Adapted from (Sauer 1998) 
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2.1.2 Autonomic and electrophysiological phenotyping of transgenic 
mouse models 
 
Increasingly sophisticated methods of integrative physiological investigations 
and analyses have permitted the investigation of complex neurocardiac-
regulatory and cardiac eletrophysiological processes in ways not possible 
before.  
 
The central nervous system is important in both short- and long-term control 
of arterial BP. Many investigators have focused on the central mechanisms 
and brain regions involved in the neurogenic control of blood pressure as a 
way to study central autonomic regulation of the cardiovascular system. This 
involves direct and indirect methods of measuring arterial BP and baroreflex 
sensitivity (Young & Davisson 2011).  
 
Electrophysiological phenotyping of transgenic mice has contributed 
significantly to our understanding of cardiac impulse propagation and 
arrhythmogenesis (Gehrmann & Berul 2000), complementing existing 
techniques of cellular imaging, patch clamping and molecular biology to give 
us a broad range of experimental tools to study cardiac electrophysiology. 
 
Studying murine cardiac electrophysiology has required the miniaturization of 
instruments and techniques originally developed for human studies. These 
include the recording of surface electrograms, programmed electrical 
stimulation of the heart in the whole mouse and electrophysiological mapping 
in perfused mouse hearts.  
 
Table 2.1 provides summary of the main experimental approaches currently 
used for the in vivo assessment of neuro-cardiac regulatory control and 
cardiac electrophysiological phenotyping in the mouse. 
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Table 2.1 Summary of experimental methodologies for in vivo study of cardiac electrophysiology 
 
Reviewed in (Young & Davisson 2011) and (Gehrmann & Berul 2000). R, Recoverable; C, Conscious experimental model (without 
use of any sedation or anaesthetic agents); PES, programmed electrophysiological stimulation. 
Modality Technique R C Notes Pros Cons 
Electrocardiogram Surface ECG electrodes Yes No Needle electrodes placed on surface of 
chest to record surface ECG.  
Cheap, readily available Unable to obtain data from 
conscious freely moving 
animal 
Implantable telemetry probes Yes Yes Small re-usable probes implanted into 
the subcutaneous space or peritoneal 
cavity. Can be used to record surface 
ECG or other biological parameters such 
as BP. 
Data from conscious freely 
moving animal 
Expensive. 
Need time for adequate 
recovery post surgery. 
Programmed electrical 
stimulation 
Transoesophageal catheters Yes No Placement of bipolar electrodes in the 
oesophagus directly behind the atria 
allows for PES of the atria and induction 
of arrhythmia.  
Able to repeat in recovered 
animal. Relatively cheap. 
Large stimulus artefacts. 
Unable to study ventricle. 
Epicardial catheters No No Placement of electrodes directly onto the 
epicardial surface of the atria and 
ventricle for PES and arrhythmia 
induction. Open chest surgery required. 
Assessment of atria and 
ventricle. Relatively cheap. 
Not recoverable. Very invasive 
and high mortality. 
Endocardial catheters No No Placement of closely spaced multipolar 
electrodes endovascularly into the 
atrium and ventricle for PES and 
arrhythmia induction. 
Less invasive. Assessment 
of all chambers. 
Not recoverable. Technically 
challenging. Expensive. 
Electrical mapping of the 
perfused  heart 
Optical dye mapping No No Optical dye mapping in isolated 
Langendorff perfused heart 
Highest spatial and temporal 
resolution. 
Technically challenging. Use 
of exciation-contraction 
uncouplers may confound. 
Low sensitivity of the voltage 
sensitive dyes. In vitro 
conditions. 
Multi-electrode array No No High density mapping using an array of 
closely spaced bipolar electrodes. 
Direct recording of cellular 
electrical activity. Can 
combine with optical imaging 
(eg calcium imaging). 
Expensive. 
Relatively lower spatial 
resolution. Limited array size. 
 51 
2.1.3 Limitations  
 
It is important to note that different mouse strains show considerable 
differences in baseline autonomic and electrocardiographic parameters 
(Wehrens et al. 2000; Waldeyer et al. 2009) and in processes such as 
baroreflexes and chemoreflexes in (Tankersley et al. 2000; Campen et al. 
2004). Hence, it is important to use appropriate controls with similar genetic 
background in assessing the role of a genetically modified gene.  
 
In addition, given the difference in body size, mass and basal metabolic rate, 
the cardiac index in mice is ten folds higher than in humans with resultant 
scaling of cardiac indices such as HR, stroke volume and blood volume 
although mean arterial pressure is the same (Janssen & Smits 2002). 
However, differences in murine cardiac physiology cannot be explained 
simply by scaling. For example, mice can only raise their maximum cardiac 
output over a small range whereas humans can increase theirs by a factor of 
5-6. This is because murine heart is operating close to the maximum limit 
even at baseline (Kaese & Verheule 2012).  
 
Although similar ion channels are expressed in mice and human hearts, their 
contributions to cardiac pacemaking and action potential morphology may 
also be different. For example, in the human ventricle, the rapid and slow 
delayed outward rectifier K+ currents are predominantly responsible for 
phase 3 repolarization whilst in mice it is mediated by transient outward K+ 
currents, a slowly inactivating K+ current, and a non-inactivating steady state 
current resulting in much faster repolarization (reviewed in Kaese & Verhaule 
2012). 
 
It is hence important to take these differences into account when interpreting 
data obtained from mouse models.  
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2.1.4 Objectives 
 
In this methods chapter, I aim to: 
 
1. Describe the transgenic mouse lines developed and used, the 
strategies used to generate conditional knockout models in the heart 
and the brain, the PCR based genotyping method, the real time PCR 
method used for gene expression quantification, and 
immunohistochemistry techniques used. 
 
2. Describe ECG and BP telemetry hardware and its application to study 
heart rate dynamics and BP profile under both physiological resting 
conditions and during pharmacological treatments. 
 
3. Describe the methods of whole body plethysmography in conjunction 
with BP telemetry recordings to assess respiratory and cardiovascular 
responses evoked by hypoxic and hypercapnic stimuli. 
 
4. Describe the methods of baroreflex sensitivity assessment in an in 
vivo anaesthetised preparations. 
 
5. Describe the methods of programmed electrical stimulation of the 
heart to evaluate ventricular effective refractory period and 
susceptibility to ventricular arrhythmias. 
 53 
2.2 Mice strains and generation of conditional knockout mice 
 
2.2.1 Transgenic mouse lines and breeding strategy 
 
Mice were maintained at the UCL animal core facility under the U.K. Home 
Office guidelines relating to animal welfare. All breeding programs and 
procedures were in accordance to the Animals (Scientific Procedure) Act 
1986. All experimental work was covered by project licences 70/6732 and 
70/6630 and personal licence PIL 70/23104.  
 
All mice were kept in a temperature controlled environment (21-23°C) with 
12hr day/12hr night light cycle. Animals were allowed access to standard 
rodent chow and water ad-libitum. Mice were studied between 10-12 weeks 
of age weighing between 20-30 grams. 
 
The Cre/LoxP approach described previously (Sauer 1998) was used to 
target the gene of interest in mice. Mice on a Sv129 background with coding 
exons 5 to 6 of the GαO allele on chromosome 8 (here on referred to as GαO 
flx/flx) and exons 2 and 4 of the Gαi2 allele on chromosome 9 (here on 
referred to as Gαi2 flx/flx) flanked by loxP sites were obtained from our 
collaborator Professor Lutz Birnbaumer. These mice were initially generated 
using homologous recombination techniques in mouse ES cells. Gene 
targeting strategies and confirmation of selective deletion of GαO and Gαi2 at 
protein level from various tissues including the brain and the heart using 
western blot approaches have previously been published (Ustyugova et al. 
2012). 
 
2.2.2 Conditional gene deletion in the cardiac conduction tissue 
 
The hyperpolarisation activated cyclic nucleotide gated cation channel 
(HCN4) gene codes for the channel responsible for pacemaker currents Ih/If 
and is expressed in cardiac conduction tissue with high specificity (Herrmann 
et al. 2011). Mice on a C57/Bl6 background expressing a tamoxifen inducible 
Cre driven by the HCN4 promoter (here on referred to as HCN4-KiT Cre) 
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were kindly donated by Professor Andreas Ludwig. Briefly, the tamoxifen-
inducible CreERT2 construct was ‘knocked in’ into the pacemaker HCN4 
locus. After administration of tamoxifen, highly selective and efficient 
recombination is triggered in the sinoatrial and atrioventricular node as 
demonstrated by Hoesl et al using western blot analysis and 
immunohistochemistry (Hoesl et al. 2008).This allows highly specific spatial 
and temporal (by timing tamoxifen administration) targeting of gene deletion 
in cardiac conduction tissue. 
 
By intercrossing HCN4-KiT Cre with GαO flx/flx mice, heterozygotes (GαO 
flx/wt) mice containing the HCN4-KiT Cre transgene were produced. These 
were then crossed with GαO flx/wt mice to obtain Go flx/flx HCN4-KiT Cre 
mice and all other genetic combinations were used as controls. Gαi2 flx/flx 
HCN4-KiT Cre mice were derived using the same process. 
 
To activate Cre expression in mice with the HCN4-KiT allele, tamoxifen 
(1mg/25g/day made up in sunflower oil, i.p.) was administered for 5 days and 
the experiments were performed after 10 days to allow for adequate Cre 
recombinase activity (Hoesl et al. 2008). 
 
2.2.3 Targeting gene deletion in the central nervous system 
 
Using a similar strategy as above, we sought a Cre line that is expressed in 
the central nervous system. Nestin is a class 6 intermediate filament primarily 
expressed by neural stem cells. It is expressed from day 7 of intrauterine 
development and is also expressed in other organs and tissues including 
striated muscle, cardiac muscle, the adrenals, and others (Gilyarov 2008). 
Due to a lack of a better alternative at the time, we compromised with this 
Cre line as an initial approach. 
 
Mice on a C57/Bl6 background expressing Cre driven by the nestin promoter 
were obtained from the Jackson’s Laboratory (ME, USA) (Tronche et al. 
1999) and were crossed using a similar strategy as above to generate 
Goflx/flx nestin Cre mice and controls. 
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2.2.4 Targeted gene deletion in the central nervous system using Cre 
expressing viral vectors 
 
Due to limitations of the nestin Cre approach as discussed above, we used a 
parallel strategy with direct delivery of Cre expressing viral vectors to the 
brainstem. This allows precise spatial and temporal targeting. 
 
Mice were anaesthetised with a mixture of ketamine (75 mg/kg, i.p.) and 
medetomidine (1 mg/kg, i.p.). Animals were placed in a stereotaxic apparatus 
(Kopf Instruments, CA, USA) in a prone position. The position of the head 
was adjusted in a flexed position and incision and blunt dissection was 
performed to expose the atlanto-occipital membrane. An incision was then 
made to the atlanto-occipital membrane to allow direct visualization of the 
calamus scriptorius, which was used as the reference point, and the viral 
vectors were delivered to the desired anatomical location.  
 
Microinjections were made through glass micropipettes pulled through 
capillary tubing (WPI Inc, FL, USA) using a P-97 Flaming/Brown micropipette 
puller (Sutter Instruments, CA, USA) with the settings Pressure=500, 
Heat=500, Pull=50, Velocity=20 and Time=90. The tip of the glass 
micropipette was broken off using a Dumont 5-SF forcep (WPI Inc, FL, USA) 
and heat treated over a flame. Solutions were ejected using pressurized air 
delivered using a 10ml syringe and volumes determined by observation of 
movement of the fluid meniscus using a microscope fitted with an eye-piece 
graticule. Volumes injected were between 100 to 150 nanolitres delivered 
over 5 minutes per injection site. The co-ordinates used were determined in 
dedicated preliminary trials using microinjections of fluorescent beads with 
subsequent histological analysis to verify the sites of delivery and is detailed 
in Chapter 4. 
 
The viral vector chosen was an adenoviral vector, Ad Cre/GFP, to drive the 
expression of Cre and green fluorescent protein (GFP) under the control of a 
cytomegalovirus (CMV) promoter (Cre/GFP AVV) (López et al. 2008). A 
similar adenoviral viral vector, VQAd CMVeGFP-2.6del, to drive the 
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expression of GFP only (GFP AVV) (LaVallie et al. 2006) was used as a 
control. Both viral vectors were purchased from Viraquest (IA, USA). Titres of 
the Cre/GFP AVV and control GFP AVV stock used were 6 × 1010 pfu and 3 
× 1010 pfu respectively. The stock solution was diluted prior to the injections 
(titre of injected virus were determined in a separate set of experiments 
detailed in Chapter 4). 
 
Anaesthesia was reversed with atipemazole (1 mg/kg, i.p.). The mice were 
studied 7 to 14 days after the injections as Cre expression should reach 
maximal in this period when AVV constructs are used (Haskell et al. 2003). 
 
2.2.5 Genotype procedure 
 
Mice were ear marked and tail tips (~2mm) were snipped with scissors after 
application of local anaesthesia by spraying with ethyl chloride and the 
samples were placed in 1.5 ml eppendorf tubes. Lysis buffer (150 μl; 3.35ml 
2M Tris-HCL pH 8.8, 1.66ml 1M (NH4)2SO4, 1.34ml 0.5M MgCl2, 0.5ml Triton 
X-100, 92.2ml H20, 1ml β-mercaptoethanol) was added and the samples 
were heated to 100oC for 10 minutes to denature proteins. Samples were 
then cooled and 5 μl of proteinase K (20 mg/ml) was added at 55oC for 12 
hours to cause protein digestion. Samples were then re-heated to 100oC for 
a further 10 minutes to terminate proteinase activity and then spun down at 
10000 rpm for 5 minutes to sediment tail debris. For PCR genotyping 1-2μl of 
sample (containing genomic DNA) was used. 
 
GO loxP (floxed allele) genotyping was performed using the following 
primers:  
 
GNAoF1B  5’- AAGAA TAGAA CCTAG GACTG GAGG - 3’ and 
GNAoR  5’- GCAGA CAAGT GAACA AGTGA AACCC - 3’.  
 
A hotstart PCR strategy was used to detect the presence of a 1868bp band 
corresponding to WT GO, a 2142bp band corresponding to the GO loxP 
(floxed) allele and a 442bp band produced after Cre recombinase activation.  
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Gi2 loxP (floxed allele) genotyping was performed using the following 
primers:  
 
Gi2LOXF  5’ – GGAGCCTGGACTTTGCTTCTGACC - 3’, 
Gi2LOXR  5’- GGCTATGATCCCAAAACTCCCCG - 3’ and  
Gi2LOXF2  5’- GTGGTAAGCCTGTGTGTTTGTGAGAG - 3’.  
 
A hotstart PCR strategy was used to detect the presence of a 400bp band 
corresponding to WT Gi2, a 500bp band corresponding to the Gi2 loxP 
(floxed) allele using Gi2LOXF and Gi2LOXR respectively, and a 400bp 
band produced after Cre recombinase activation, using Gi2LOXF2 and 
Gi2LOXR. 
 
Identification of HCN4-Kin Cre expression was determined using the 
following primers:  
 
CreF  5’- ATGAC AGACA GATCC CTCCT ATCTC C - 3’ and  
CreR  5’- CTCAT CACTC GTTGC ATCAT CGAC - 3’.  
 
The presence of the Cre transgene was determined by the presence or 
absence of a 300bp band.  
 
Identification of nestin Cre expression was determined using the following 
primers: 
 
oIMR1084 5’- GCGGT CTGGC AGTAA AAACT ATC - 3’ and 
oIMR1085 5’- GTGAA ACAGC ATTGC TGTCA CTT - 3’, 
 
The presence of Cre transgene was determined by the presence or absence 
of a 100bp band. 
 
This is summarised in Figure 2.2. 
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Figure 2.2 PCR products identified during genotyping procedure  
 
(A) Gαi2 floxed Cre mice; (B) GαO floxed Cre mice; (C) HCN4-Kin Cre mice 
and; (D) nestin Cre mice.  
A B 
C D 
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2.2.6 Quantification of gene expression in tissues by quantitative real 
time PCR (RT-PCR) 
 
Mice were terminally anaesthetised (ketamine, 100mg/kg, i.p.; xylazine, 
10mg/kg, i.p.), tissues under study were harvested and immediately 
immersed in RNAlater solution (600 µl) (Qiagen, CA, USA). RNA was then 
extracted using the RNAeasy Mini Kit (Qiagen, CA, USA) and converted to 
cDNA using the high capacity RNA-to-cDNA reverse transcriptase kit 
(Applied Biosystems, CA, USA). Quantitative PCR (qPCR) was then 
performed on the cDNA samples using the TaqMan gene expression assay 
kit (Applied Biosystems, CA, USA) with primers directed to exon 5 of GO, 
exons 2 to 3 of Gi2 and GAPDH, which was chosen as the reference house-
keeping gene. Relative gene expression was quantified using the 
comparative CT method (Schmittgen & Livak 2008). 
 
For mice injected with Cre/GFP and GFP AVV viral constructs in the 
brainstem, the location of injection was confirmed by the presence of green 
fluorescence near the ventral surface of the brainstem (visualized using 
395nm light) and the tissue was then punch biopsied with a Uni-Core device 
(core diameter 1.25mm; Harris, USA) and processed as described above. 
Further details and images are provided in Chapter 4. 
 
2.2.7 Immunohistochemistry 
Mice were perfused transcardially with 0.9% NaCl solution followed by 50 mL 
of 4% paraformaldehyde (PFA). Brainstems were then removed, post-fixed 
for 12 h in 4% PFA at 4°C and cryoprotected in 30% sucrose. Medulla 
oblongata was sectioned using a freezing microtome, and a series of coronal 
sections (30 μm) was collected and stored in an anti-freeze solution at -20°C 
for subsequent histological processing. Sections were immunostained for 
detection of tyrosine hydroxylase (TH; marker of catecholaminergic 
neurones). Tissue was incubated in sheep anti-TH antibody for 24 h (1:250; 
Abcam, Cambridge, UK). Secondary antibodies were donkey anti-sheep 
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Alexa Flour 568 (1:1000; Invitrogen, CA, USA). The slices were examined 
and images were taken using a confocal microscope. 
 
2.3 ECG and BP telemetry in conscious mice  
 
Surface ECG and arterial BP recordings were obtained from mice using 
surgically implanted telemetry devices (Data Sciences International, MN, 
USA). Using this technology, continuous ECG and BP measurements can be 
obtained in freely moving animals, removing potential confounders of animal 
restraint and anaesthesia, under normal physiological conditions, following 
drug provocation or under hypoxic/hypercapnic conditions in a 
plethysmography chamber. 
 
ECG signal reflects the electrical potential difference between two adjacent 
electrode pairs. This bio-potential signal was sampled at 2000Hz from 
electrode pairs placed in an ECG lead II configuration and transmitted to a 
receiver mat by radio-wave and digitised using the PowerLab platform 
(ADInstruments, Dunedin, NZ). Commercially available software (Dataquest 
ART v3.0, Data Sciences International, MN, USA and LabChart Pro v4.0, 
ADInstruments, Dunedin, NZ) was used to analyse ECG recordings to obtain 
ECG parameters including PR, QRS and corrected QT intervals. Heart rate 
(HR) was calculated from the R-R interval, and heart rate variability (HRV) 
was derived by fast fourier transformation (FFT) analysis of HR over a pre-
determined time period (described in more detail below).  
 
Systemic arterial BP was continuously sampled at 2000Hz by gel filled 
catheters with the tip placed in the aorta. Systolic, diastolic and mean arterial 
blood pressures were obtained. HR was also obtained from the intervals 
between systolic peaks, although these measurements are not as accurate 
as that obtained from ECG tracings. 
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2.3.1 General surgical preparation 
 
Surgery was performed in mice of at least 20g in weight, as survival was 
found to be compromised in smaller animals. Anaesthesia was induced with 
5% isoflurane entrained with oxygen-enriched air and then maintained with 
1.7% isoflurane delivered via a nose cone. Analgesia (10mg/kg Rimadyl 
[Carprofen], i.p, Pfizer Animal Health, NY, USA) and prophylactic antibiotics 
(5uL 1% enorfloxacin, i.p.) were given. The mice were then secured with a 
masking tape in a supine position on a sterile drape rested on a heating mat 
set to support animal’s body temperature at ~37°C. The area of incision was 
swabbed with 70% ethanol solution as disinfectant. The mice were then 
draped and surgery was then carried out in an aseptic manner. After the 
surgery, 200-300μL of warm 0.9% NaCl solution was given i.p. for post-
operative hydration. The mice were then returned to their individual cages 
placed on warming mats for surgical recovery. Additional analgesia was 
administered 8-12 hourly after the surgery as necessary.  
 
2.3.2 Implantation of the ECG telemetry probes 
 
A midline laparotomy was performed, with the skin, muscle layer and 
peritoneum carefully divided by blunt dissection with due care to haemostasis 
throughout. A murine telemetry probe (model TA-F20, Data Sciences 
International, MN, USA) was then placed in the abdominal cavity taking care 
not to disturb or compress bowel loops or other visceral organs. Attached to 
the main probe housing are two insulated electrodes and the device was 
implanted within the peritoneal cavity with the leads exiting the body of the 
device in rostral direction. Two small stab incisions were made within the 
peritoneal membrane either side of the midline incision to allow for the 
extrusion of the electrodes out of the peritoneal cavity and the peritoneal 
membrane was sutured close. Two further incisions were then made in the 
overlying skin of the chest, one in the anterior right shoulder position and 
another near the cardiac apex to allow for placement of the ECG leads in a 
lead II configuration. The ends of the electrodes were cut to an approximate 
length to allow for placement of the positive lead near the right shoulder and 
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the negative lead at the level of the cardiac apex. A small sheath of insulation 
was removed from the electrode tips to expose the wire within. The leads 
were then subcutaneously tunnelled from the abdomen to their respective 
positions and the bare wire of the electrode tips was sutured onto the 
exposed chest wall muscle, ensuring good contact with the tissue. All 
incisions were then closed with interrupted sutures. 
 
2.3.3 Implantation of the BP telemetry probes 
 
A midline anterior cervical incision was made and the underlying salivary 
glands were carefully parted by blunt dissection. The left sternocleidomastoid 
muscle was then retracted to expose the left carotid artery. The left carotid 
artery was carefully dissected out and 2 silk ties were placed at the cranial 
and caudal end of the artery. The artery was tied off at the cranial end just 
distal to the bifurcation and blood flow in the artery was transiently occluded 
by gentle retraction of the tie sling at the caudal end. The carotid artery was 
then cannulated with the gel-filled catheter of the BP telemetry probe (model 
PA-C10, Data Sciences International, MN, USA) and the tip of the catheter 
was slowly advanced by about 5 mm (so that the tip of the catheter was 
placed within the aorta) and the catheter was then carefully secured. A 
subcutaneous pocket was then created in the abdomen and the body of the 
probe was then tunnelled into this pocket via the same cervical incision. The 
wound was then closed. 
 
2.3.4 Serial HR/BP measurements and circadian rhythm 
 
All animals were allowed to recover for a minimum of 10 days prior to 
recording (Thireau et al. 2007). Experiments were performed in a 
temperature-controlled environment (21-23°C) with 12hr/12hr light/dark cycle 
and the animals were allowed to acclimatise to the experimental conditions 
for at least 48 hours prior to experiments. Housing cages were placed onto 
receiving mats and telemetry probes were turned on with the aid of a 
magnetic wand. For serial HR/BP measurements, 15s samples were taken 
every 30 minutes over 2 days using a ‘scheduled sampling’ protocol. From 
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this data set, it was possible to evaluate diurnal changes in HR/BP between 
day and night and also calculate the mean HR/BP. HR can be derived from 
BP recordings by the following equation: 
 
HR= 60000/pulse interval (interval between successive systolic peaks in 
milliseconds) 
 
2.3.5 Assessment of heart rate variability 
 
Heart rhythm shows beat-to-beat variations between successive R-R 
intervals and is largely due to autonomic modulation of the pacemaker 
activity of the sino-atrial node. Heart rate variability (HRV) is the measure of 
such R-R interval variability and can be used as a non-invasive 
measurement of autonomic tone, and can be used specifically to determine 
the parasympathetic contribution to HRV (Wickman et al. 1998). 
Measurement of HRV has prognostic implications (Stauss 2003).  
 
HRV recordings were taken between 12-2 pm only (during “lights on” to 
simulate daylight). Mice being nocturnal animals are active during the night 
and rest/sleep during the day. Therefore, we determined HRV during 
‘midday’ in order to evaluate heart rate dynamics at a time when 
parasympathetic tone is expected to be highest. 
 
Changes in R-R intervals were assessed from ECG tracings continuously 
streamed over 20 minutes (divided into ten 2 min-long epochs) at 2000Hz. 
Data was then imported into LabChart v4.0 (ADInstruments, Dunedin, NZ) 
and analysed using a HRV analysis extension module. Raw tracings were 
carefully inspected and recording artefacts were manually removed. A 
threshold R-wave-sensing algorithm was then applied to detect all R-R 
intervals. Ectopic beats were defined as those that were 2 times above or 
below the average R-R interval; these beats were excluded from the analysis, 
while averaged or interpolated beats were not used to replace them. The 
data set of consecutive R-R intervals (typically over 12000 sinus beats per 
recording) was then mathematically analysed both the linear time and 
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frequency domains, as has been applied by others to analyse HRV in the 
mouse (Ecker et al. 2006, Gehrmann et al. 2000; Uechi et al. 1998). 
 
2.3.6 Time domain analysis 
 
Time domain measurements (Table 2.2) determine simple variance of R-R 
intervals over the entire length of recording. Although relatively simple, time 
domain analysis has been equated prospectively with clinical outcome in 
man (Nolan et al. 1998). 
 
2.3.7 Frequency domain analysis  
 
Frequency domain analysis was performed using fast fourier transform (FFT) 
using 1024 spectral points and a half overlap within a Welch window. 
Conversion of R-R intervals by FFT produces a power spectral density (PSD) 
plot which reports frequency ranges (x-axis) plotted against the total number 
of events occurring at a particular individual frequency (y-axis). 
 
Frequencies previously demonstrated to be accurate for the analysis of 
mouse ECG were used to divide signal into three major components, very 
low frequency (VLF < 0.4 Hz), low frequency (LF 0.4–1.5 Hz), and high 
frequency (HF 1.5–4.0 Hz), which are scaled up 10x from frequencies used 
in humans (Gehrmann et al. 2000, Just A et al. 2000). Variability for 
individual frequency components is determined by integral sum of the area 
under the curve between pre-specified frequency cut-offs and is also 
described as the ‘power’ of the respective frequency ranges. Normalization to 
exclude VLF was also performed. Normalized low frequency (nLF) = LF/(TP-
VLF) x 100 and normalized high frequency (nHF) = HF/(TP-VLF) x 100. 
 
There has been controversy regarding the physiological significance of the 
different frequency bands. In humans, there is general acceptance that the 
HF component is reflective of parasympathetic tone modulating HR variation 
with respiration and LF component reflects combined sympathetic and 
parasympathetic influences (Pagani et al. 1986, Malliani et al. 1991, Stauss 
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et al. 2003). Guidelines recommending standard HRV analysis techniques 
have been established for humans in (Task Force of the European Society of 
Cardiology and the North American Society of Pacing and Electrophysiology 
1996). 
 
The data available in mice however appears conflicting. Experiments using 
pharmacological challenges and transgenic methods have shown that 
attenuation of parasympathetic tone or increase in sympathetic activity leads 
to a general decrease in power across the spectral range including both HF 
and LF components (Gerhmann et al. 2000, Uechi et al. 1998). Wickman et 
al studied HRV in GIRK4 knockout mice with loss of vagal mediated GIRK 
channel function and found selective loss of LF power (Wickman et al. 1998). 
Interestingly, in these studies mice were found to have little or no resting 
vagal tone and high resting mean HR (ranging from 580 to 724 beats per 
minute). All mice were studied less than 1 week after surgical 
instrumentation. 
 
In contrast, a number of studies have shown selective loss of HF component 
with attenuation of parasympathetic tone (Baudrie et al. 2007, Just et al. 
2008, Zuberi et al. 2008). Mice were allowed to recover for greater than a 
week and it was noted that they have significant resting parasympathetic 
tone and lower resting mean HR (ranging from 400 to 662 beats per minute) 
compared to studies described above. 
 
It is hence important to interpret HRV data in the context of experimental 
conditions. Variables including surgical recovery time, sampling time and 
duration, housing conditions and ambient temperature can all affect 
autonomic tone and resulting HRV parameters (Thireau et al. 2007, Swoap 
et al. 2008). Frequency domain indices used in this study are summarised in 
Table 2.3 and have previously been validated (Zuberi et al. 2008). 
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Variable Unit Statistical measure 
SDNN ms Standard deviation of all NN intervals. 
SDANN ms Standard deviation of the averages of NN intervals in 
all 5 min segments of the entire recording. 
RMSSD ms The square root of the mean of the sum of the 
squares of differences between adjacent NN 
intervals. 
SDNN index ms Mean of the standard deviations of all NN intervals 
for all 5 min segments of the entire recording. 
SDSD ms Standard deviation of differences between adjacent 
NN intervals. 
NN50 count  Number of pairs of adjacent NN intervals differing by 
more than 50ms in the entire recording. Three 
variants are possible counting all such NN intervals, 
pairs or only pairs in which the first or the second 
interval is longer. 
pNN50 % NN50 count divided by the total number of all NN 
intervals. 
 
 
 
Table 2.2 Time domain indices of HRV analysis 
Summary of indices obtainable using time domain analysis for heart rate 
variability (HRV). NN is the normal-to-normal intervals between successive 
QRS complexes during sinus rhythm obtained during a continuous ECG 
recording. Adapted from (Malik et al. 1996). 
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Figure 2.3.1 Representative plot of RR interval against time and power spectral density transformation 
Screenshots showing (A) plot of RR interval against time and (B) power spectral density transformation. The R-R interval data set is 
converted into frequency domain by fast fourier transform to generate a power spectral density plot. Characteristic frequency peaks 
can be seen in both the LF (0.4-1.5 Hz) bandwidth and in the HF (1.5-4.0 Hz) range. The HF band is a selective marker of 
parasympathetic tone. 
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Power (ms2) 
 
 
Frequency 
range (Hz) 
 
 
Interpretation 
 
 
Total Power (TP) 
 
 
<4.0 
 
Total variability over all defined 
frequency ranges 
 
 
Very Low Frequency 
(VLF) 
 
 
<0.4 
 
Significance unclear in the 
mouse 
 
Low Frequency (LF) 
 
0.4-1.5 
 
Combined sympathetic and 
parasympathetic influence 
 
High Frequency (HF) 
 
 
1.5-4.0 
 
Parasympathetic modulation 
 
 
Table 2.3 Frequency domain indices 
 
Table summarises the frequency bandwidths obtained from power spectral 
density analysis used in this thesis.
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2.3.8 Pharmacological manipulations 
 
Pharmacological manipulations to antagonize or activate parasympathetic 
and sympathetic influences were employed to determine their relative 
contributions to the modulation of heart rate and heart rate dynamics. Table 
2.4 summarises the drugs and doses used. All drugs were administered 
intra-peritoneally between 12 to 2 pm. The prevailing autonomic tone is 
dependent on the time of day with vagal tone highest during the daytime 
when mice are resting. This specific period was chosen for drug 
administration to standardise experimental conditions at a time when murine 
vagal tone should be highest.  
 
HR and BP recordings were taken before and after administration of the 
compounds, as described previously. A baseline of 30 minutes recording was 
obtained prior to administration of a particular drug and a further 60 minutes 
recording was then obtained after the drug was given. The raw traces 
obtained before and after drug administration were manually inspected. An 
average over 5 minute of stable recording was taken for the baseline and an 
average over 5 minute during the peak effect after administration of the drug 
was taken as the post drug reading (Figure 2.3.2). 
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Drug Dose Route Mode of action 
Carbachol 0.5mg/kg ip Muscarinic M2 receptor agonist 
2-Chloro-N6-
cyclopentyladenosine 
(CCPA) 
0.1mg/kg ip A1 receptor agonist 
Atropine 0.5-1 
mg/kg 
ip Non-specific muscarinic 
receptor antagonist 
Propranolol 1 mg/kg ip Non-specific β adrenoceptor 
antagonist 
Atenolol 1 mg/kg ip β adrenoceptor antagonist 
which is more selective for β1 
receptor 
 
 
 
 
Table 2.4 Drugs used for pharmacological manipulation of autonomic 
influences to the heart 
 
Summary of drugs used for pharmacological manipulations to antagonize or 
activate parasympathetic and sympathetic influences to the heart. ip, 
intraperitoneal. 
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Figure 2.3.2 HR response to pharmacological challenge 
A representative raw tracing obtained from ECG telemetry recording of HR plotted over time before and after pharmacological 
challenge with carbachol 0.5mg/kg ip. Red arrow indicates time of drug administration. Note stress-induced increase in HR when 
animal is handled during drug administration. Shaded areas represent intervals where averaged values of HR pre and post drug 
administration were obtained. 
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2.4 Whole body plethysmography 
 
Mice with telemetry probes implanted were also subjected to hypoxic and 
hypercapnic conditions and respiratory rate (fR, breaths minute
-1) and tidal 
volume (VT, ml kg
-1) were measured by whole body plethysmography as 
described in detail previously (Onodera et al. 1997; Rong et al. 2003). 
Simultaneous continuous recordings of BP, HR, fR and VT data during hypoxic 
and hypercapnic challenges were obtained. 
 
All experiments were performed at room temperature (22-24°C). The mouse 
was placed in a Plexiglass recording chamber (~200ml) that was flushed 
continuously with a mixture of 79% nitrogen and 21% oxygen (unless 
otherwise required by protocol) at a rate of ~1 L min-1. Concentrations of O2 
and CO2 in the chamber were monitored on-line using a fast-response 
O2/CO2 monitor (Morgan Scientific, MA, USA). The plethysmography 
chamber was placed on top of a telemetry receiving mat and simultaneous 
telemetry data was obtained as described above. Figure 2.4.1 shows the 
experimental set-up used. 
 
The animals were allowed at least 20 minutes to acclimatise to the chamber 
environment at normoxia/normocapnia (21% O2, 79% N2 and <0.3% CO2) 
before measurements of baseline ventilation and BP telemetry data were 
taken. Hypoxia was induced by lowering the O2 concentration in the inspired 
air down to 10% for 5 minutes. After 5 minutes, the O2 concentration was 
then brought back up to 21% for a further 5 minutes. In separate 
experiments, normoxic hypercapnia was induced by titrating CO2 into the 
respiratory mixture up to a level of 3% or 6% (lowering N2 accordingly) for 5 
minute at each CO2 level. 
 
The chamber pressure signal was amplified, filtered and recorded and 
analysed offline using the Spike 2 software (Cambridge Electronic Design, 
Cambridge, UK). The measurements of fR and VT were taken during the last 
2 minutes before exposure to the stimulus and during the 2 minute period at 
the end of each stimulus, when breathing has stabilized. Hypoxia- or 
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hypercapnia- induced changes in the fR, VT and minute ventilation (VE) ((fR x 
VT)/1000; L min
-1 kg-1) were averaged and expressed as means ± SEM. 
Similarly, the BP and calculated HR data measurements were taken during 
the same time intervals, averaged and expressed in the same manner.  
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Figure 2.4.1 Plethysmography experimental set-up 
From left to right; 1. CO2 analyser; 2. Signal digitiser, amplifier and filter; 3. 1401 interface console; 4. Plexiglass plethysmography 
chamber; 5. Telemetry receiver mat; 6. Gas humidifier chamber; 7. Gas mixer. 
 
4 
5 
1 
2 
3 
7 
6 
 75 
2.5 Anaesthetised in vivo preparations 
 
Mice were anaesthetised with urethane (1.3 mg/kg i.p.) and the depth of 
anaesthesia was monitored using the stability of BP, HR, and lack of flexor 
responses to a paw-pinch with supplemental doses of anaesthesia given as 
required. Body temperature was maintained at 37.0±0.2°C using a servo-
controlled heating pad. Needle electrodes were placed in a lead II 
configuration to record surface ECG (sampled at 2 kHz, amplified x50-100, 
and filtered to a bandwidth between 5 to 100 Hz with 50Hz notch filtering).  
 
A cervical midline incision was performed and trachea was cannulated with 
polyethylene tubing (PE-90) to facilitate ventilation in spontaneously 
breathing mice. For the assessment of baroreflex sensitivity, the right and left 
internal jugular veins were cannulated with polyethelene tubing (PE-10) for 
administration of test drugs. The left internal carotid artery was cannulated 
with saline filled polyethylene tubing (mechanically stretched PE-10 
connected to PE-50) connected to a pressure transducer to measure the 
arterial blood pressure (sampled at 2kHz).  
 
In some mice undergoing in vivo cardiac electrophysiological studies, the 1.1 
french size EPR-800 catheter (described below) was introduced into the 
heart via the right internal jugular vein with the tip of the catheter located at 
the right ventricular apex. Correct placement of the catheter tip was 
confirmed by the presence of ventricular signals recorded from the distal 
electrical bipoles of the catheter. 
 
2.6 Analysis of baroreflex function 
 
Two main methods to determine the baroreflex sensitivity in man and 
experimental animal models which include analysis of contributions from all 
the arterial baroreceptors are the ramp and the steady state methods. The 
ramp method estimates the slope of the reflex sensitivity from a linear fit of a 
unidirectional fast ramp change in arterial BP, usually assessed by injecting a 
vasopressor drug (Smyth et al. 1969). However, there are limits to the extent 
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HR can be altered by changes in the arterial BP which is not recognized by 
this method. Ultimately, HR reaches a plateau and changes in the slope can 
occur from movement of the basal BP-HR point in relation to this plateau. 
The second, steady state approach takes into consideration the change in 
slope of the baroreflex curve as HR reaches plateau in response to both 
increases and decreases in BP. By extending the limits of BP changes in 
both directions from the basal value this method describes a sigmoidal 
relationship between changes in HR and BP. The advantage of this method 
is that the slope is estimated from the centre of the curve and is therefore 
independent of changes to basal HR. In addition, it provides information 
about the effector responses i.e. the contributions of both the sympathetic 
and the parasympathetic influences (Head & McCarty 2002). A modification 
of the steady state protocol developed by Head and McCarty was used. 
 
Changes in systemic arterial BP were induced by boluses of phenylephrine 
(0.5-2.5 mg kg-1 iv in 2-10 μL normal saline) or sodium nitroprusside (0.1-1 
mg kg-1 iv in 1-10μL normal saline). The drugs were administered by varying 
the volume of injection delivered via two separate venous catheters in the left 
and right internal jugular veins respectively. Using this method, the need to 
flush the catheter was avoided and very small volumes of injectate were 
used to minimise the effect of volume on the haemodynamic response.  
 
After surgical preparation as described above, the animal was allowed to 
stabilize over a 30-minute period. Randomly selected doses of the two drugs 
were then sequentially given to evoke increases in arterial BP (with 
phenylephrine) followed by BP decreases (with nitroprusside). The doses of 
both drugs were adjusted to produce changes in BP that were small (5-20 
mmHg), medium (21-35 mmHg) or large (36-50 mmHg) with sufficient time 
between injections to allow both BP and HR to return to baseline. Increases 
in blood pressure greater than 50 mmHg were avoided as this can evoke 
vagal bradycardia, which has been shown (in rabbits) to involve cardiac 
rather than arterial baroreceptor activation (Hood & Woods 2004).  
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Data were recorded using a 1401 interface and Spike 2 software. The peak 
changes in arterial BP and HR were determined following application of each 
drug and in total, 10-15 data points were obtained across the range of BP-
HR for each the animal (Figure 2.6.1). The changes from basal values (ΔBP-
ΔHR) were then calculated for each pair of data points and scaled back to 
absolute BP and HR by the average of all basal values recorded. This allows 
for best fit as described by Head et al (Head & McCarty 2002).   
 
The data points were then fitted to the following logistic equation with MatLab 
R2010b (MathWorks, MA, USA) using a least squares interative routine 
developed by Varuna De Silva at University of Surrey (Appendix A): 
 
HR = P1 + P2 / [1 + eP3(BP-P4)] 
 
where P1 = lower HR plateau, P2 = HR range, P3 = a curvature coefficient 
which is independent of range and P4 = BP50, i.e. the BP at half the HR 
range. The average baroreflex gain (BRG) or slope of the curve between the 
two inflection points is given by BRG = -P2 ×P3/4.56 and the upper plateau = 
P1 + P2 (Figure 2.6.2). 
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Figure 2.6.1 Tracings obtained from urethane anaesthetised in vivo preparation used to determine baroreflex function 
Screenshot of tracings obtained during urethane anaesthetised in vivo preparation. From top to bottom (A) HR averaged over 10 
seconds derived from RR interval of ECG trace; (B) ECG trace obtained from surface electrode; and (C) arterial BP trace obtained 
invasively from a fluid filled cannula in the right internal carotid artery over time in seconds. The peaks and troughs on the arterial 
BP trace follows alternating administration of intravenous phenylephrine and sodium nitroprusside. 
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Figure 2.6.2 Derivation of baroreflex curve 
 
Screenshot of MatLab program used to derive a best fit sigmoidal curve to 
the HR and BP data points obtained from the urethane anaesthetised in vivo 
preparation. The Y axis represents HR-HR min, and the X axis represents 
arterial systolic BP. The program solves for the equation y = K./(1+exp(-G*(x-
Dm))) with the solution shown in the red box. The baroreflex gain (BRG) or 
slope of the curve between the two inflection points is hence given by  
BRG= -K x G/4.56. 
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2.7 In vivo cardiac programmed electrical stimulation 
 
The minimally invasive cardiac electrophysiological (EP) assessment is a 
procedure performed in clinical cardiology and involves the placement of 
electrophysiological catheters capable of recording and delivering electrical 
stimuli directly onto cardiac endo- or epicardial surfaces.  
 
Cardiac pacing can be performed where an external electrical stimulus is 
applied directly to the myocardium adjacent to catheter between the 
electrode bipoles. The electrical current delivered can be modulated by the 
voltage and pulse duration. When sufficient energy is delivered (i.e. when 
‘threshold’ is reached), localised myocardial depolarisation will occur (i.e. 
‘electrical capture’) and an electrical wavefront can then spread via cardiac 
gap junctions from the field of stimulation to the rest of the heart. Provided 
the pacing stimulus rate is faster than the intrinsic heart rate, externally 
controlled cardiac pacing will occur.  
 
Pacing at different locations within the heart can provide important 
information regarding cardiac conduction and electrophysiological properties. 
Cardiac pacing can also be delivered in a programmed manner (programmed 
electrical stimulation, PES) where a basic pacing train delivered at a fixed 
interval is then supplemented with one or multiple extra stimuli at 
progressively shorter intervals. 
 
The cardiac EP study protocols and PES have recently been adapted by our 
laboratory (Zuberi et al. 2010) to study in vivo cardiac electrophysiology in 
transgenic mice following earlier work by other groups (Gehrmann & Berul 
2000; Kovoor et al. 2001). The recording system is based on the Powerlab 
platform (Figure 2.7.1). All electrical inputs are delivered to the Powerlab 
receiver hardware, which shows a multichannel display of various inputs on 
the Labchart v4.0 software interface. Surface ECG signals in the lead II 
configuration are filtered and amplified using an amplifier (BioAmp). 
Intracardiac electrograms are recorded using an EPR-800 
electrophysiological catheter (ADInstruments, Dunedin, NZ). EPR-800 has 8 
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equally spaced electrode poles and each pole is attached to an individually 
insulated micro-wire with a unique input/output connection. Pacing generated 
by the S88 Grass stimulator (Grass, USA) can also be delivered using the 
EPR-800. Two separate bipole recordings can be obtained simultaneously or 
one bipole can be used to record an intracardiac signal whilst the other pair 
is used to deliver pacing. Recordings are filtered and amplified using a 
separate dual Bioamp connected to the Powerlab device. When correctly 
placed within the right heart, the distal poles of the catheter are in the right 
ventricle whilst the more proximal poles are in the right atrium and this can 
be seen from the recorded local intracardiac electograms (Figure 2.7.2).  
 
2.7.1 Invasive cardiac electrophysiology study protocol 
 
Once suitable catheter position is obtained the S-88 stimulator is turned on 
and pacing is attempted. When reliable electrical capture is obtained, the 
stimulator output voltage is reduced whilst keeping the pulse duration fixed at 
10 ms until capture is lost and then voltage is increased incrementally until 
reliable capture is obtained again. This is the threshold (the minimum output 
required for reliable capture) and pacing output is then set at twice the pacing 
threshold voltage to ensure reliable electrical capture throughout the study 
(Figure 2.7.3). 
 
Next, cardiac pacing protocol is performed. I am interested in studying the 
electrical properties of the ventricular myocardium, specifically changes in 
the ‘excitability’ of the myocardium following autonomic manipulations. For 
this purpose, the ventricular effective refractory period (VERP), which is 
defined as the minimum coupled cycle length at which ventricular pacing (at 
a rate of 750 bpm/ cycle length of 80 msec) can no longer result in ventricular 
capture as the ventricular myocardium is in a refractory state. A train of 10 
S1 pulses with a cycle length of 86 msec is delivered followed by an S2 
impulse at the end of the S1 train. The interval between S1-S2 was 
progressively shortened until the point at which pacing fails to produce 
ventricular capture (Figure 2.7.4) 
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Finally, a ventricular tachycardia (VT) stimulation by burst pacing was 
performed in order to determine susceptibility of the myocardium to 
ventricular tachycardia (VT) or ventricular fibrillation (VF) (Maguire et al. 
2003). This was achieved by delivering a train of 15 S1 beats at increasingly 
shorter intervals from 80 ms to 50 ms (12.5 to 20 Hz) in 5 ms increments. A 
successful study was defined as induced VT that consisted of at least 4 
consecutive QRS complexes with different morphology to that recorded in 
sinus rhythm (Gellen et al. 2008). In some cases, we were also able to detect 
dissociation of ventricular and atrial electrograms from intracardiac 
electrograms as an additional marker of VT (Figure 2.7.5).  
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Figure 2.7.1 Equipment used for programmed electrical stimulation 
 
A. Bench set-up for programmed electrical stimulation. B. Close up of EPR-800 octapolar electrophysiological catheter next to a 1 
pence coin and a murine heart for size comparison. 
A B 
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Figure 2.7.2 Intracardiac electrograms showing correct placement of electrodes in the right heart 
Screenshot showing: (A) Surface ECG; (B) Atrial (A) and ventricular (V) electrograms in the proximal poles and; (C) Much larger 
local V electrograms seen in the distal pole. 
A 
B 
C 
A V 
A V 
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Figure 2.7.3 Intracardiac electrograms during right ventricular pacing 
Screenshot showing: (A) surface ECG; (B) Atrial (A) and ventricular (V) electrograms in the proximal pole. (C) Trace showing 
delivery of pacing (P) stimuli. The distal pole of the catheter is used to pace the right ventricle and ventricular capture can be seen 
on the surface ECG with broad QRS complexes and also on the recorded local electogram. 
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P P P P P P P P P P P P P P P P P P P P P P 
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Figure 2.7.4 Determination of ventricular effective refractory period (VERP) 
A train of 9 S1 beats (coupling interval 80ms) is delivered followed by an S1-S2 coupling interval of 40ms which still captures the 
ventricle. The S1-S2 is then further shortened to 38ms. The S2 now fails to capture the ventricle. VERP at 80ms coupling interval, 
or 750bpm, steady state pacing (expressed as VERP750) is hence 38ms. 
80ms  80ms 80ms 80ms 80ms 80ms 80ms 40ms 
80ms 80ms  80ms  80ms 80ms 38ms 80ms 
80ms 
80ms 80ms 
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Figure 2.7.5 Burst pacing protocol to determine ventricular tachycardia threshold 
An example of burst pacing at 20 Hz from the right ventricle used to induce VT. The induction protocol results in polymorphic 
ventricular tachycardia. Evidence of AV dissociation can be seen from the regular atrial activation (marked with *) signal recorded 
simultaneously from the right atrial intracardiac electogram. 
* * * * * 
100ms 
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2.8 Statistical analysis 
 
Data are reported as means ± standard error of measurement (SEM) unless 
stated otherwise. For determination of statistical significance between 
groups, 2 tailed Student’s t tests were used for parametric data with a normal 
distribution and the Mann-Whitney U Test was used for non-parametric data. 
Data with repeated sampling between groups was analysed using analysis of 
variance (ANOVA) with post-hoc Kruskal-Wallis test to estimate the 
difference between groups. For data with repeated sampling between 
multiple groups of unequal sizes or in the presence of missing values, mixed 
modelling using both fixed and random effects was used to compare the 
mean effect of each group. All statistical computation was performed using 
SPSS version 21 (IBM, NY, USA). In all instances, P<0.05 was considered 
significant. 
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Chapter 3 
 
Results I 
Gαi2 and not GαO protein mediates parasympathetic 
influences on cardiac conduction tissue 
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 3.1 Introduction 
 
As discussed in Chapter 1, pacemaker setting in the SAN is thought to be an 
interplay between a membrane and a calcium ‘clock’. The membrane ‘clock’ 
involves cyclical depolarisation generated by HCN channels (also known as 
If/Ih), whilst the calcium ‘clock’ involves the cyclic release of Ca
2+ from 
intracellular stores via ryanodine receptors, increasing inward sodium-
calcium exchanger currents during diastolic depolarization (Lakatta & 
DiFrancesco 2009). 
 
Vagal input via M2 receptor activation slows down the rate of SAN 
depolarization by inhibiting AC, leading to a reduction in cAMP level which in 
turn inhibits the If/Ih channel. Reduced cAMP level also leads to negative 
modulation of downstream effectors such as intracellular Ca2+ handling 
pathways for example phospholamban and the ryanodine receptor, resulting 
in reduced cycling of intracellular Ca2+. In addition, the free Gβγ subunit 
released from Gαi\o directly activates the GIRK channel leading to membrane 
hyperpolarization. These responses are all predicated on signaling via the 
inhibitory Gαi\o but current evidence supporting these pathways is largely 
based on ex-vivo studies of the sinoatrial node and pacemaker cells 
(Monfredi et al. 2010). 
 
There is currently limited in vivo data available on the physiological role and 
the molecular identity of the inhibitory G protein subtype(s) responsible for 
mediating parasympathetic influences on the SAN. Previous study using 
mice with global knockout of Gαi1/3, Gαi2 and GαO genes have showed 
altered autonomic regulation of HR, but only in mice with global GαO and Gαi2 
deletions (Zuberi et al. 2008). The relative contribution of these G protein 
subtypes to autonomic regulation of the SAN activity remains unknown. 
 
In this chapter, I present and discuss the results of the experiments aimed to 
address the relative contributions of GαO and Gαi2-mediated signaling on the 
activity of SAN and by extension on autonomic regulation of heart rate. 
Conscious freely moving mice with conditional deletion of GαO and Gαi2 in 
 91 
the conduction system of the heart were used to determine the role of these 
subunits. Heart rate profile and dynamics were recorded over a 48-hour 
period, and heart rate responses to autonomic blockade were determined. 
 
3.2 Cardiac conduction tissue specific deletion of GαO and Gαi2 
 
GαO flx\flx HCN-KiT Cre+, Gαi2 flx\flx HCN-KiT Cre+ (here on referred to as 
GαO floxed conduction Cre and Gαi2 floxed conduction Cre, respectively) 
mice and their littermate controls were generated. Tamoxifen (1mg/25g/day, 
i.p.) was administered as previously described. RNA was then extracted from 
the SAN and ventricular tissues 10 days post administration of tamoxifen and 
quantitative RT-PCR performed to confirm selective deletion of the 
respective gene in the cardiac conduction tissue only. Measurements 
obtained in these mice were normalized to the expression of levels detected 
in control mice (both after administration of tamoxifen) in the ventricle and the 
SAN.  
 
There was a significant reduction in relative GαO and Gαi2 expression in the 
SAN but not the ventricle (GαO floxed conduction Cre SAN relative 
expression compared to WT = 0.27 (95%CI 0.17- 0.45) ventricle= 0.86 
(95%CI 0.71-1.04), and Gαi2 floxed conduction cre SAN relative expression 
compared to WT = 0.11 (95%CI 0.09- 0.24), ventricle= 1.04 (95%CI 0.80-
1.36); n=3 mice respectively in triplicate for all groups. Genomic DNA was 
also isolated from the tail, cardiac ventricle and the SA node and PCR was 
performed which confirmed Cre recombinase mediated deletion of exons 5-6 
of GnaO and exons 2-4 in Gnai2 in the SA node but not in the ventricle or tail 
(Figure 3.2.1). 
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Figure 3.2.1 Conditional deletion of GαO and Gαi2 in the SAN  
(A) PCR products of DNA obtained from GαO (left) and Gαi2 (right) floxed 
conduction Cre mice after tamoxifen treatment, where the presence of a 
~400bp band in the SA node reveals the Cre mediated deletion of floxed 
allele whilst the other bands from the tail and ventricle samples reveals the 
non-deleted floxed Cre alleles. (B) Quantitative RT-PCR of SAN and 
ventricular tissues after tamoxifen treatment for 5 days in GαO floxed 
conduction Cre and Gαi2 floxed conduction Cre mice compared to controls 
(n=3 in all groups). Data presented as mean ± 95% CI. 
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3.3 HR profile in mice with selective deletion of GαO and Gαi2 in the 
cardiac conduction tissue 
 
Mice are nocturnal animals and display peak activity during the night and 
they normally sleep during the day. This pattern of activity is reflected in a 
clear diurnal variation of heart rate. The 48-hour heart rate profile of GαO and 
Gαi2 floxed conduction Cre mice and their respective controls before 
tamoxifen treatment were similar and demonstrated this circadian variation 
(Figure 3.2.2 A). 
 
The heart rate profile of GαO floxed conduction Cre mice remained 
unchanged following tamoxifen treatment when compared to control with 
preserved circadian variation (450±20 bpm day, 570±20 bpm night; vs 
468±16 bpm day, 557±16 bpm night, p=0.922, n=5 in both groups). It 
appears that tamoxifen lowers HR in the GαO group. However the HR profile 
is similar between GαO floxed conduction Cre mice and controls suggesting 
that the effect is non-specific. 
 
In contrast, daytime heart rate of Gαi2 floxed conduction Cre mice was 
significantly higher when compared to the level observed before tamoxifen 
treatment (546±16 v 499±16 bpm, p=0.009, n=12) and to the level recorded 
in control mice receiving tamoxifen treatment (546±16 v 474±15 bpm, 
p=0.008, n=12 and 9 respectively). There was a corresponding loss of 
circadian variation of heart rate in Gαi2 floxed conduction Cre mice (546±16 
bpm day; 564±15 bpm, p=0.094, n=12), These data are summarized in 
Figure 3.2.2 B. 
 
There were no significant differences in ECG parameters including PR 
interval, QRS duration and QTc interval between experimental groups before 
and after administration of tamoxifen (Table 3.1).  
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Figure 3.2.2 Day and night HR profile in mice with selective deletion of 
GαO and Gαi2 in the conduction tissue of the heart. 
 
(A) Representative HR profile measured in six hourly intervals over a 48-hour 
period for an individual GαO floxed conduction Cre (top) and an individual 
Gαi2 floxed conduction Cre mouse (bottom) compared to a control mouse 
before and after tamoxifen treatment. (B) Summary data of mean heart rate ± 
SEM in GαO (left) and Gαi2 (right) floxed conduction Cre mice and their 
controls before and after tamoxifen treatments. NS p≥0.05; ** p < 0.01. 
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3.4 Heart rate variability in mice with selective deletion of GαO and Gαi2 
in the cardiac conduction tissue 
 
In Gαi2 floxed conduction Cre mice, treatment with tamoxifen resulted in a 
clear disturbance in the normal pattern of HRV with selective loss of high 
frequency power (nHF 43.35±3.09 nu before tamoxifen vs 30.21±1.24 nu 
after tamoxifen treatment, p=0.013) but preserved low frequency and overall 
total power (Figure 3.2.3 and Table 3.1).  There was no effect of Gai2 deletion 
when HRV was analysed in time domain (Table 3.1).  
 
In contrast, there was no significant difference in HRV of the GαO floxed 
conduction Cre mice both before and after tamoxifen treatment when HRV 
was analysed by power spectral density analysis or in the time domain 
(Table 3.1). 
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Figure 3.2.3 Loss of HF component of HRV in mice with selective 
deletion of Gαi2 in the cardiac conduction tissue.  
 
(A) Representative power spectrum density traces of HRV in Gαi2 floxed 
conduction Cre mice before and after tamoxifen treatment. (B) Mean 
normalised HF component power of Gαi2 floxed conduction Cre (n=12) and 
control (n=9) mice before and after tamoxifen administration. 
 
A 
B 
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 PR (ms) QRS (ms) QTc (ms) RR (ms) SDnn (ms) RMSSD 
(ms) 
TP (ms
2
) LF (ms
2
) HF (ms
2
) nLF (nu) nHF (nu) 
GαO flx cre pre tam 
 
35 ± 1 8 ± 1 56 ± 2 126 ± 7 27 ± 16 23 ± 10 172 ± 29 40 ± 12 66 ± 19 38 ± 1 63 ± 1 
GαO flx cre post tam 
(n=5) 
37 ± 1 9 ± 1 57 ± 4 116 ± 13 18 ± 8 20 ± 8 118 ± 42 26 ± 13 53 ± 20 40 ± 4 60 ± 4 
GαO control pre tam 
 
36 ± 1 9 ± 1 66 ± 6 125 ± 5 25 ± 5 30 ± 14 181 ± 25 48 ± 8 52 ± 11 49 ± 8 51 ± 8 
GαO control post tam 
(n=5) 
33 ± 1 9 ± 1 60 ± 4 118 ± 5 22 ± 4 35 ± 20 147 ± 73 46 ± 19 70 ± 32 39 ± 4 61 ± 4 
Gαi2 flx cre pre tam 
 
33.1±0.5 10.2±0.6 70 ± 5 120 ± 3 24 ± 8 12 ± 3 215 ± 81 56 ± 9 50 ± 6 48 ± 6 43 ± 3 
Gαi2 flx cre post tam 
(n=12) 
34 ± 1 10 ± 1 69 ± 3 110 ± 4* 31 ± 7 14 ± 6 130 ± 43 45 ± 8 31 ± 7 45 ± 6 30 ± 1* 
Gαi2 control pre tam 
 
35 ± 1 10 ± 1 62 ± 4 120 ± 10 12 ± 5 8 ± 1 134 ± 46 25 ± 5 22 ± 6 37 ± 6 33 ± 2 
Gαi2 control post tam 
(n=9) 
36 ± 1 10 ± 1 62 ± 4 124 ± 3 6 ± 6 7 ± 1 218 ± 56 27 ± 3 36.2±7.2 35.4±8.3 48.0±3.6 
 
Table 3.1 Summary data of ECG and HRV parameters in GαO and Gαi2 floxed conduction Cre mice and their respective 
controls.  
The comparisons are between mice pre and post tamoxifen (tam) in the each group (repeated measures one way ANOVA).  
* p<0.05 
 98 
3.5 Heart rate responses to pharmacological challenges in mice with 
selective deletion of GαO and Gαi2 in the cardiac conduction tissue  
 
To determine the role of GαO and Gαi2 in mediating responses triggered by 
muscarinic and adenosine receptor activation in the cardiac conduction 
tissue, the chronotropic responses of GαO and Gαi2 floxed conduction Cre 
mice and their respective controls were assessed after administration of 
carbachol or 2-Chloro-N6-cyclopentyladenosine (CCPA), before and after 
treatment with tamoxifen. Both drugs were administered between 12 to 2 pm. 
 
Carbachol (0.5mg/kg, ip), a non-specific muscarinic agonist, and CCPA 
(0.1mg/kg, ip), a specific A1 receptor agonist, both reduced the heart rate in 
wild type mice. Similar reductions in heart rate were observed in both GαO 
floxed conduction Cre mice and controls (n=5 both groups) and cardiac Gαi2 
floxed conduction Cre mice (n=12) and controls (n=9) following 
administration of carbachol or CCPA before and after tamoxifen treatment in 
conscious animals (Figure 3.2.4). No specific conduction block or 
arrhythmias were observed after administration of either carbachol or CCPA. 
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Figure 3.2.4. Assessment of heart rate responses to carbachol and 
CCPA in mice with selective deletion of GαO and Gαi2 in the cardiac 
conduction tissue. 
 
Summary data illustrating changes in heart rate in GαO floxed conduction Cre 
(n=5) and control (n=5) mice (left panel) and in Gαi2 floxed conduction Cre 
(n=11) and control (n=9) mice (right panel) induced by carbachol (panel A) 
and CCPA administration (panel B). Bars represent mean ± S.E.M. 
A 
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GαO floxed conduction Cre Gαi2 floxed conduction Cre 
Response to carbachol 
Response to CCPA 
GαO floxed conduction Cre Gαi2 floxed conduction Cre 
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3.6 Intrinsic heart rate in mice with selective deletion of GαO in the 
cardiac conduction tissue 
 
Intrinsic heart rate was determined in GαO floxed conduction Cre mice by 
combined pharmacological blockade of parasympathetic and sympathetic 
influences using atropine and propranolol, respectively. Atropine (0.5mg/kg, 
ip) was first administered and peak change in heart rate was recorded. This 
was followed by propranolol (1mg/kg, ip) administration and after 30 minutes 
when the heart rate has stabilized the intrinsic heart rate was determined. 
Drugs were given between 12 to 2 pm. There was no significant difference 
between GαO floxed conduction Cre mice and control animals following 
pharmacological autonomic blockade with atropine and propranolol, either 
before or after tamoxifen treatment (Figure 3.2.5).  
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Figure 3.2.5 Combined pharmacological autonomic blockade with 
atropine and propranolol in GαO floxed conduction Cre mice to 
determine intrinsic heart rate. 
 
(A) Changes in heart rate of GαO floxed conduction Cre (n=5) and control 
(n=5) mice induced by atropine and after combined atropine (0.5mg/kg, ip) 
and propranolol (1mg/kg, ip) treatment. (B) Summary data illustrating heart 
rates of GαO floxed conduction Cre and control mice before and after 
pharmacological autonomic blockade. Bars represent mean ± S.E.M. 
Baseline Atropine Propranolol 
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3.7 Discussion 
 
The aim of the experiments described in this chapter was to determine the 
role of GαO and Gαi2 protein-mediated signalling in the cardiac conduction 
tissue in the control of heart rate. It was found that mice with selective 
deletion of Gαi2 in the cardiac conduction system were tachycardic during the 
daytime and displayed a loss of circadian variation of heart rate and HF 
component of HRV. Selective deletion of GαO in the cardiac conduction 
system had no effect on heart rate and HRV in mice. Negative chronotropic 
effects of muscarinic and adenosine receptor activation (systemic injections 
of carbachol and CCPA) were not affected by GαO or Gαi2 deletions in the 
cardiac conduction system. The intrinsic heart rate was also not affected by 
GαO deletion.  
 
3.7.1 HCN4 expression in cardiac conduction tissue and pacemaking 
cells 
 
Within the murine heart, HCN4 (along with HCN1) was found to be the 
predominant isoform expressed in cardiac conduction tissue including the SA 
node (SAN), AV node and His-Purkinje tissues (Herrmann et al 2011). Hence 
using HCN4 as the promoter to drive Cre expression is expected to result in 
deletion of Gαi2 or GαO along the entire axis of the cardiac conduction 
system. However, as the SAN is responsible for pacemaking in sinus rhythm, 
this strategy would still allow us to study the effects of Gαi2 or GαO deletion in 
the SAN on heart rate modulation. Indeed, inspection of ECG traces in our 
mice has shown sinus rhythm throughout the recordings.  
 
3.7.2 Higher heart rate during daytime and loss of circadian variation of 
heart rate in mice with Gαi2 deletion in the cardiac conduction tissue 
 
In mice with conditional deletion of Gαi2 in the cardiac conduction tissue, HR 
was higher during the daytime with complete loss of its circadian variation. 
We interpret this as being due to lack of parasympathetic influences. It is 
traditionally thought that in mice sympathetic tone dominates the control of 
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heart rate with little vagal influence at resting conditions (Uechi et al. 1998, 
Wickman et al. 1998, Gehrmann et al. 2000) . However, autonomic tone is 
also determined by a number of environmental factors including ambient 
temperature and levels of physical activity (Thireau et al. 2007; Swoap et al. 
2008). It is possible that mice have a certain level of vagal tone under a 
variety of conditions and there are reports which demonstrated vagal 
predominance of HR control in mice if appropriate care is taken in housing 
and recovery of the animals after the surgery (Just et al. 2000, Baudrie et al. 
2006, Zuberi et al. 2008). 
 
How does loss of Gαi2-mediated signaling in the SA node result in increased 
HR? There are two likely mechanisms as indicated in the Chapter 1. Firstly, 
loss of inhibitory influence on AC would lead to increased cAMP 
concentration resulting in increased activity of both the If/Ih channel and 
downstream calcium cycling (membrane and calcium ‘clock’ respectively) 
(Robinson & Siegelbaum 2003; Lakatta & DiFrancesco 2009). Secondly, 
reduction in the direct GIRK activation from the inhibitory G protein would 
also lead to increased HR (Logothetis et al. 1987).  
 
3.7.3 The effect of selective Gαi2 deletion in the cardiac conduction 
tissue on heart rate variability 
 
HRV is a widely used non-invasive technique used to estimate the autonomic 
influences on the heart and has been used in humans as a prognostic 
measure in many disparate clinical conditions including ischaemic heart 
disease, hypertension and cardiac arrhythmias (Malik et al. 1996). The high 
frequency (HF) component of the HRV is determined by the magnitude of the 
respiratory sinus arrhythmia and reflects vagal influences whilst the low 
frequency (LF) component reflects the response of heart rate to short term 
variations in blood pressure mediated by both sympathetic and vagal inputs 
(Frenneaux 2004), although the latter assumption remains controversial 
(Stauss 2003). Higher heart rate during the daytime when vagal tone should 
be highest together with selective loss of HF component of the HRV supports 
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a physiological role for Gαi2 signaling in mediating parasympathetic 
influences on the SA node.  
 
Interestingly, the heart rate response to carbachol was preserved in mice 
with conditional deletion of Gαi2 in the cardiac conduction tissue, which 
contrasts with the finding in the global Gαi2 knockout mice where heart rate 
slowing was significantly attenuated (Zuberi et al. 2008). There are a number 
of potential explanations for this. Firstly, the carbachol challenge is a 
significant pharmacological manipulation with the resultant HR reduction well 
below the physiological levels as HR drops by about 70%. It is also known 
that the SAN is quite an extensive and heterogenous structure and that the 
primary pacemaker may move as the strength of the sympathovagal balance 
changes (Monfredi et al. 2010; Shibata et al. 2001). Thus it is possible that 
following Gαi2 deletion the pacemaking site shifts to a small region that is not 
solely dependent on the deleted G-protein or a site in which Cre mediated 
deletion is spared due to the expression of other HCN isoforms such as 
HCN1 (Herrmann et al. 2011).  
 
3.7.4 No effect of selective deletion of GαO proteins in the cardiac 
conduction tissue on HR and HRV 
 
In comparison, there were no differences in HR or HRV in mice with 
conditional deletion of GαO in the cardiac conduction tissue compared to 
control animals both at rest and in response to pharmacological challenges. 
This suggests that the role of GαO-mediated signalling in heart rate regulation 
at the level of the cardiac conduction tissue of the heart is insignificant. 
 
There was no difference in heart rate following combined autonomic 
pharmacological blockade after the administration of atropine and 
propranolol. This lends further evidence that the intrinsic heart rate is not 
determined by events downstream of G protein signaling at the level of the 
conduction tissue of the heart. 
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3.7.5 Comparison of heart rate phenotype in mice with conditional 
deletion in cardiac conduction tissue versus global deletion of Gαi2 and 
GαO proteins 
 
It was previously demonstrated that mice with global deletion of Gα i2 are 
tachycardic and display a clear suppression of HRV in time and frequency 
domain across all three frequency spectra (Zuberi et al. 2008). The effect of 
conditional deletion of Gαi2 in the SA node is consistent, albeit more subtle, 
with daytime tachycardia and selective loss of HF component of HRV only 
after normalization to remove variation in VLF (which accounts for the most 
significant power in the HRV signal). In mice with global deletion of GαO, 
there was increased heart rate with loss of diurnal rhythm accompanied by 
selective loss of the LF component of the HRV with preserved total power 
(Zuberi et al. 2008). In contrast, mice with conditional deletion of GαO in the 
cardiac conduction tissue showed no clear HR and HRV phenotype. 
 
3.7.6 Limitations 
 
These results need to be discussed taking into consideration a number of 
possible caveats. First, non-stationarities in the HRV signal can be a 
confounding factor as physical activities can result in significant changes in 
heart rate and HRV (Thireau et al. 2007). However, efforts were taken to 
minimize this by monitoring the parameters when mice were at rest at 
defined time during the day for a short recording period. Second, it is 
important that the mice were allowed to recover for at least 10 days after the 
surgery and resume normal activity after probe implantation before 
measurements were made (Kramer et al. 1993).  
 
Extra-cardiac expression of HCN4 has also been found in the nervous 
system (Brewster et al. 2007, Cho et al. 2009) including spinal inhibitory 
interneurones (Hughes et al. 2013). Spinal inhibitory interneurons are 
involved in modulation of sympathetic outflow and deletion of inhibitory G 
proteins in this region may potentially contribute to the findings. However, 
given that GαO is also richly expressed in the CNS (Sternweis & Robishaw 
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1984, Parker et al. 2012) and no difference was seen in the HR phenotype of 
HCN4 Cre GαO flx/flx mice, it is unlikely that this is an important confounder. 
 
Considering that all the experiments were performed in standardised 
conditions and taking into account the confounding factors mentioned above, 
the differences in HR and HRV between global GαO and Gαi2 knockouts and 
mice with conditional deletion of GαO and Gαi2 in the cardiac conduction 
system are likely to be real. The likely reason for the observed differences in 
the conditional and global knockout models is the potential role played by the 
respective inhibitory G proteins in other mechanisms which contribute to the 
autonomic control of HR. 
 
3.7.7 Summary 
 
The data presented in this chapter suggest that Gαi2 is an important signaling 
protein which mediates vagal influences on the heart at the level of the 
cardiac conduction tissue, most likely by coupling to M2 cholinoceptors. In 
contrast, GαO appears to play no role at the level of the cardiac conduction 
system and hence the HR phenotype seen in the global GαO knockout mice 
is most likely due to its role in other tissues, most likely in the central nervous 
system, as discussed in Chapter 1. Therefore, I next generated mice with 
conditional deletion of GαO in the central nervous system to determine the 
role of signalling mediated by this protein in the central nervous mechanisms 
which control the heart. 
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Chapter 4 
 
Results II 
Generation of mice with conditional deletion of GαO in 
the central nervous system 
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4.1 Introduction 
 
I have shown in the previous chapter that mice with conditional deletion of 
GαO in the cardiac conduction tissue did not display any abnormalities in 
heart rate profile or HRV. In this chapter, I shall present the results of the two 
strategies described in Chapter 2 used to generate mice with conditional 
deletion of GαO in the central nervous system to investigate its role in the 
central nervous mechanisms of cardiac regulation. 
 
Choice of promoter driving the expression of Cre is critical in determining the 
spatial and temporal specificity of deletion of the target protein when using 
the Cre/LoxP system. A pan-neuronal approach would allow for a more 
global assessment of the role of GαO in the CNS in the generation of 
sympathetic tone. This approach also has the advantage of being technically 
easier as all that is required is the crossing of mice with floxed alleles of the 
gene of interest with the appropriate Cre-expressing mice. However, even 
accounting for issues of non-specificity of deletion and compensation, any 
phenotypic changes would be difficult to attribute to any specific signalling 
pathway within the CNS and the lack of any observable phenotypic changes 
may be due to the effect of deletion in the different pathways cancelling out 
each other given the ubiquity of GαO expression in the CNS. 
 
A targeted approach using viral vectors expressing Cre would allow for 
precise temporal and spatial deletion of the gene of interest and is a very 
powerful approach to study the role of a ubiquitous protein like GαO in 
specific brainstem circuits of interest. However, the approach is technically 
challenging and dependent on efficient transfection of the viral vector.  
 
Given the different strengths and weaknesses of each approach we decided 
to develop and investigate both the pan-neuronal and targeted approaches. 
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4.2 Nestin Cre approach 
 
A pan-neuronal approach was first used by crossing GαO flx/flx mice with 
mice expressing Cre driven by the nestin promoter as described in Chapter 
2.  
 
4.2.1 GO flx/flx nestin Cre mice display growth retardation and poor 
survival  
 
Only a few GO flx/flx nestin Cre pups were obtained after close to a hundred 
littermates were genotyped with the other genotype combinations predicted 
by Mendelian distribution. GO flx/flx nestin Cre mice appeared small, had 
tremors, abnormal gait and did not survive beyond 4-5 weeks of age (Figure 
4.2.1). 
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Figure 4.2.1 GO flx/flx nestin Cre mouse at 5 weeks of age 
 
Morphological appearance of a GO flx/flx nestin Cre mouse at 5 weeks of 
age 
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4.2.2 Nestin Cre expression in the brain and other organs 
 
As GO flx/flx nestin Cre mice were generally non-viable and difficult to 
obtain, I examined whether Cre mediated excision occurred in tissues 
outside the central nervous system in GαO flx/wt nestin Cre mice. DNA was 
extracted from brain cortex, quadriceps muscle, ventricular myocardium, liver 
and tail of euthanized mice and Cre recombinase products were amplified by 
PCR as previously described.  
 
Cre mediated recombination of GnaO product corresponding to removal of 
exons 5-6 was found to be present in the brain, skeletal muscle and heart but 
not in the liver of GαO flx/wt nestin Cre mice (Figure 4.2.2). 
 
4.2.3 GαO protein expression in the brain and other organs 
 
The expression of GαO mRNA in the striated muscle, heart (ventricular 
myocardium) and brain cortex was then investigated by performing 
quantitative RT-PCR as described previously. 
 
Quantitative RT-PCR analysis revealed that GO flx/flx nestin Cre mice had 
significantly reduced expression of GO in the brain (relative expression 0.60, 
95%CI 0.57-0.64) and in the skeletal muscle (relative expression 0.61, 
95%CI 0.58-0.65). Interestingly, GO expression appears to be up-regulated 
in the heart with a relative expression of 1.53 (95%CI 1.50-1.54).  
 
Phenotypically normal appearing heterozygotes (GO flx/WT nestin Cre) mice 
showed similar reduction of GO expression in skeletal muscle (relative 
expression 0.64, 95%CI 0.62-0.66), and the heart (relative expression 0.86, 
95% CI 0.81-0.97), but preserved expression of GO in the brain (relative 
expression 1, 95%CI 0.94-1.08) (Figure 4.2.3). 
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Figure 4.2.2 PCR products of DNA samples obtained from tissues of a 
GO flx/wt nestin Cre mouse 
 
PCR products of DNA obtained from a GαO flx/wt nestin Cre mouse where 
the presence of a ~400bp band reveals the Cre mediated deletion of floxed 
allele whilst the ~2 kb band reveals the non-deleted floxed Cre and WT 
alleles differentially expressed in various tissues. 
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Figure 4.2.3 GαO expression in GαO floxed nestin Cre mice and controls 
 
Quantitative RT-PCR in the muscle, heart and brain tissues of WT, GO 
flx/WT nestin Cre (Het), and GO flx/flx nestin Cre (CKO) mice (n=3 in all 
groups). Data presented as mean ± 95% CI. 
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4.3 Targeted approach using Cre expressing adenoviral vector 
 
As discussed in Chapter 1, the RVLM is important in generating sympathetic 
vasomotor tone, receives inhibitory inputs and is a putative site of action for 
inhibitory G proteins. Hence for the targeted approach, we chose to target 
the RVLM with a Cre expressing adenoviral vector (AVV). 
 
4.3.1 Validation of RVLM coordinates by microinjection of fluorescent 
beads 
 
The exact RVLM coordinates (adapted to our stereotaxic apparatus) in these 
mice were determined in dedicated preliminary trials using microinjections of 
fluorescent beads with subsequent histological analysis to verify the sites of 
delivery, using the brain atlas as reference (Franklin and Paxinos, 2007).  
 
Fluorescent beads (0.2μm FluoSpheres amine-modified microspheres in red 
fluorescence, Invitrogen, CA, USA) diluted in 0.9% Saline at 1:50 
concentration were injected using micropipette as described in Chapter 2 to 
differing depths, distance and angulation relative to the calamus scriptorius 
(Figure 4.3.1). 
 
From the preliminary trials, the optimum co-ordinates to target RVLM with the 
microinjection pipette angled at 10 degrees were found to be: 1.4 mm lateral 
to the midline and 2.4mm ventral from the dorsal surface of the brain (relative 
to the calamus scriptorius). 
 
4.3.2 Targeting the RVLM with adenoviral constructs 
 
One microinjection per side of Cre/GFP AVV (6 x 1010 PFU) or GFP AVV (3 x 
1010 PFU) at 1:50 dilution was delivered using the co-ordinates derived 
above. Mice were then euthanized and brain harvested and fixed in PFA at 7 
to 10 days post injection when expression of AVV has been shown to be 
maximal (Haskell et al. 2003).  
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Histological analysis was then performed as previously described with TH 
staining to identify C1 neurones of the RVLM, looking for co-localisation with 
GFP expression to verify successful delivery and expression of the AVV 
constructs in the RVLM (Figure 4.3.2). 
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A. Bregma -6.2mm, Angulation 11 O, Lateral 1.3mm, Dorsal-ventral 2.4mm  
 
 
 
 
 
 
 
 
 
B. Bregma -6.7mm, Angulation 10 O, Lateral 1.3mm, Dorsal-ventral 2.4mm 
 
 
 
 
 
 
 
 
 
C. Bregma -7.5mm, Angulation 10 O, Lateral 1.3 mm, Dorsal-ventral 2.2mm 
 
 
 
 
 
 
 
 
Figure 4.3.1 Determination of stereotaxic co-ordinates using 
fluorescent beads 
 
Examples of microscopy images (left) and schematic diagrams (right) at 3 
levels of the brainstem showing the locations of fluorescent beads following 
microinjections using different stereotaxic co-ordinates to determine the 
optimum co-ordinates to target RVLM. Scale bar 100 μm. 
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Figure 4.3.2 Targeting RVLM with AVV constructs to express GFP in 
GαO flx/flx mice 
 
Anatomical location of RVLM circled in red in: (A) Line drawing of brainstem 
structures viewed from the ventral surface, and, (B) ventral surface of the 
mouse brain stem. (C) Fluorescence at sites of injections when ventral 
surface of brain stem is illuminated with light at the wavelength of 395nm. 
Confocal images of tyrosine hydroxylase (TH)-positive neurones (red) 
expressing GFP (green) in brain slices injected with GFP AVV (1:50 dilution 
of VQAd CMVeGFP-2.6del 3x1010 PFU) (D), (E), (H), and Cre/GFP AVV 
(1:50 dilution of Ad Cre/GFP 6 x 1010 PFU) (G), (H), (I).  
Bregma level -6.7mm. Scale bar 50μm. 
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4.3.3 RT-PCR to validate deletion of GαO proteins and determine titres 
of AVV construct to be used 
 
WT and GO flx/flx mice were injected with both Cre/GFP AVV (Ad Cre/GFP, 
6 x 1010 PFU) and GFP AVV (VQAd CMVeGFP-2.6del, 3x1010 PFU) at a 
concentration of 1:50 and 1:100 dilutions. Tissue from the injection sites was 
then extracted and RT-PCR performed as described in Chapter 2. 
 
There was around 80% reduction of GO expression in the brainstems of 
GO flx/flx mice injected with Cre/GFP AVV at dilution of 1:50 (relative 
expression 0.16, 95%CI 0.11-0.23) and 1:100 (relative expression 0.21, 
95%CI 0.18-0.25). Relative expression in mice injected with the control GFP 
AVV was 0.51 (95%CI 0.45-0.58) and 0.79 (95%CI 0.75-0.82) at 1:50 and 
1:100 dilutions respectively (Figure 4.3.3). 
 
In summary, there was good knock-down of gene expression achieved with 
both 1:50 and 1:100 dilutions of Cre/GFP AVV. However, at 1:50 dilution, 
there was also some reduction in gene expression with the control GFP AVV. 
This is most likely due to non-specific inflammation with adenoviral vectors 
which is well recognised (Naldini et al. 1996). This is minimised with the 
1:100 dilution of the GFP AVV.  
 
Given the similar efficacy of gene knockdown with lower inflammatory 
effects, the 1:100 dilution of AdV constructs was chosen for subsequent 
experiments to generate mice with knockdown of GαO in the RVLM of the 
brainstem. 
 
 
 
119 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.3 GαO expression using different concentrations of 
adenoviral constructs 
 
Quantitative RT-PCR of brainstem tissue in the brainstem of GαO flx/flx and 
WT mice injected with Cre/GFP AVV and GFP AVV at 1:50 and 1:100 
dilutions (n=3 in all groups). Data presented as mean ± 95% CI. 
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4.3.4 Generation of mice with GαO deletion in the RVLM of the 
brainstem and controls for in vivo experiments 
 
To generate mice with specific deletion of GαO in the RVLM of the brainstem 
(hereon referred to as GαO floxed brainstem Cre mice), Cre/GFP AVV was 
microinjected in 1:100 dilution to the brainstem of GαO flx/flx mice as 
described previously. For controls, GαO flx/flx mice were injected with GFP 
AVV in 1:100 dilution instead. 
 
The mice were allowed to recover and then subsequently studied at 7 to 14 
days (experimental details and results are described in Chapters 5 and 6). 
 
Following the experiments (detailed in Chapters 5 and 6), the mice were then 
euthanized and brainstem fixed, sliced and immunostained to label TH 
positive cells as previously described. 
 
Only mice with good co-localisation of GFP and TH expression (ie: 
transfection of catecholaminergic C1 neurones of the RVLM with adenoviral 
vectors) are included in data analysis in Chapters 5 and 6. 
 
The distribution of transduced neurones in a representative brainstem is 
illustrated in Figure 4.3.4. 
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Figure 4.3.4 Distribution of RVLM C1 neurones expressing Cre/GFP 
(A) Distribution of TH-immunoreactive neurones expressing Cre/GFP in one 
representative mouse brainstem 1 week after microinjection of Cre/GFP AVV 
into the RVLM. Each symbol represents 5 neurones. 7N, facial motor 
nucleus. (B) High magnification images showing co-localisation of GFP 
expression in the nuclei of TH-positive neurones. Scale bar 20μm. 
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4.4 Discussion 
 
In this chapter I discussed the results of two methods used to generate mice 
with conditional knockout of GαO in the central nervous system of GαO flx/flx 
mice. The pan-neuronal Cre approach driven by a nestin promoter was found 
to be a non-viable strategy and associated with poor tissue specificity. 
Targeting the RVLM directly using a Cre/GFP expressing AVV driven by a 
CMV promoter was found to result in good knockdown of GαO expression at 
the RVLM with appropriate controls generated by using GFP AVV. 
 
4.4.1 Choice of adenoviral vector to target Cre expression 
 
Recombinant adenoviruses have been shown to efficiently transduce genes 
into a wide spectrum of non-dividing cells in vivo (Yang et al. 1994). 
However, they are also known to induce an immunogenic response which 
may limit the duration of expression of the viral transgene and may also 
result in non-transgene specific effects secondary to inflammatory response 
(Naldini et al. 1996). 
 
A 1:100 dilution of viral titres was chosen to minimise the non-specific 
inflammatory response. Furthermore, mice were studied at 1-2 weeks post 
injection and hence longevity of transgene expression is not an issue with 
our experimental models. 
 
4.4.2 Limitations 
 
Use of a CMV promoter to drive the expression of Cre/GFP and GFP is non-
specific with regards to the cell type that ultimately expresses the construct. 
 
There are two main implications. Firstly, cells surrounding the region of the 
RVLM including the A5 and A1 groups of cell in CVLM, the nucleus 
ambiguous and the surrounding central respiratory neurones may also be 
transfected by the viral construct, resulting in expression of Cre and 
unintended deletion of GαO protein.  
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Secondly, there are different cell types located within the RVLM. Other than 
the C1 neurones, astrocytes are emerging as important in cardio-respiratory 
regulation within the RVLM via its role in neurovascular coupling. G protein 
mediating signalling specifically via Gαq by neuropeptides such as 
neuropeptide Y (NPY) and also by purines such as adenosine and ATP/ADP 
are implicated in gliotransmission within the RVLM (Gourine et al. 2009). 
Hence, the precise mechanisms underlying any observed phenotype may not 
be simply due to loss of GαO mediated signalling in the C1 neurones of the 
RVLM as discussed in Chapter 1. 
 
The first problem highlighted can be overcome to some degree by using 
small volumes for microinjection and histologically verifying the sites of 
injection as I have done. However, a better solution that would address both 
issues would be use of a promoter which is specifically expressed only by the 
cell population of interest. 
 
In the case of targeting the C1 neurones of the RVLM, an example would be 
to use the PRSx8 promoter which is specific for cells expressing Phox 2a 
and 2b (Marina et al. 2011).  
 
4.4.3 Summary 
 
Despite the limitations outlined above, I have developed a technique to direct 
deletion of GαO proteins in the region of the RVLM. Further experiments 
using this model are described in the following two Chapters. 
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Chapter 5 
 
Results III 
Cardiorespiratory phenotype of mice with conditional 
GαO deletion in the RVLM  
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5.1 Introduction 
 
As described in Chapter 3, mice with conditional deletion of GαO in cardiac 
conduction tissue did not exhibit any HR and HRV phenotype (in contrast to 
GαO global knock out mice) suggesting that it has an extra-cardiac role in 
autonomic regulation of the heart. Given the abundance of GαO expression in 
the brain and the key role played by the vasomotor centre in the brainstem, 
especially the RVLM, in generating sympathetic tone, we postulated that loss 
of the inhibitory influence of GαO to the RVLM may result in changes in 
autonomic tone and account for the phenotype seen in mice with global 
deletion of the protein. In Chapter 4, we described the methods used to 
generate mice with conditional deletion of GαO in the RVLM of the brainstem. 
Specifically, GαO flx/flx mice were injected with Cre/GFP expressing 
adenovirus (Cre AVV) in the RVLM (GαO floxed brainstem Cre) and in the 
control group GαO flx/flx mice were injected with GFP expressing adenovirus 
(GFP AVV) in the RVLM (control).  
 
In this chapter, I present data obtained in experiments using conscious GαO 
floxed brainstem Cre and control mice under baseline physiological 
conditions and exposed to hypoxic and hypercapnic conditions to 
characterise alterations in the central nervous mechanisms of autonomic 
cardio-respiratory control. 
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5.2 Recordings of BP in conscious freely moving GαO floxed brainstem 
Cre and control mice 
 
To determine the effect of GαO deletion in the RVLM in conscious freely 
moving mice, BP radiotelemetry probes were implanted in GαO floxed 
brainstem Cre and control mice and allowed to recover for at least 10 days 
as previously described. All mice were then studied before and 7 to 14 days 
after viral injections.  
 
5.2.1 Normal diurnal heart rate and blood pressure profile in mice with 
conditional deletion of GαO in the brainstem 
 
The mice were first studied under normal conditions to evaluate diurnal HR 
and BP changes as described in Chapter 2. Figure 5.2.1 shows a 
representative BP trace and derived HR tachogram obtained over a 24-hour 
recording period in a control mouse. 
 
The HR profile of GαO floxed brainstem Cre mice was similar to that recorded 
in control mice and was not affected following injections of the viral vectors 
(before the injections: 520±18 bpm day, 610±12 bpm night; vs 540±20 bpm 
day, 620±15 bpm night, p=0.921, n=6 in both groups; and after the injections: 
538±10 bpm day, 622±8 bpm night; vs 540±8 bpm day, 605±12 bpm night, 
p=0.784, n=6 in both groups). 
 
Arterial BP measurements revealed a similar diurnal profile of systolic BP 
changes when comparing GαO floxed brainstem cre mice to control animals 
(before the injections: 108±14 mmHg day, 128±16 mmHg night; vs 110±14 
mmHg day, 130±16 mmHg night, p=0.887, n=6 in both groups; and after the 
injections: 116±6 mmHg day, 140±5 mmHg night; vs 108±4 mmHg day, 
142±16 mmHg night, p=0.727, n=6 in both groups). The data are 
summarised in Figure 5.2.2. 
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Figure 5.2.1.  Diurnal haemodynamic profile of a control mouse 
Representative BP trace (panel A) and derived HR tachogram (panel B) 
obtained from 24 hour recordings in a conscious freely moving control 
mouse. 
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Figure 5.2.2.  Summary data of averaged HR and systolic BP values 
during the day and during the night in mice with conditional deletion of 
GαO in the brainstem and control animals. 
 
Day and night measurements of (A) HR and (B) systolic arterial BP recorded 
using biotelemetry in GαO flx/flx mice pre and post GFP AVV (control mice) 
and Cre AVV (Gαo floxed brainstem Cre mice) injections into the RVLM. 
Data expressed as mean ± SEM, n=6 in all groups.  
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5.3 Haemodynamic and respiratory responses to hypoxia 
 
Hypoxia is known to induce a robust sympathetic response and this is in part 
mediated by increased activity of the C1 neurones of the RVLM (Guyenet et 
al. 2013). We hence tested the cardio-respiratory response to hypoxic 
conditions of the same cohort of GαO floxed brainstem Cre mice (all 6 of 6) 
and control animals (4 of 6) implanted with BP biotelemetry using whole-body 
plethysmography as described previously.  
 
Figure 5.3.1 shows a representative trace of the haemodynamic and 
respiratory responses to hypoxic challenge in a control mouse. Mice 
responded to hypoxia (10% O2) with an increase in the HR but no significant 
change in arterial BP, and an increased respiratory rate and tidal volume. 
During recovery from hypoxia, heart rate decreased close to baseline. There 
was a post-hypoxic depression of respiratory activity with reduced respiratory 
rate below baseline and normalisation of tidal volume. Table 5.1 reports 
summary data of HR, systolic BP, respiratory rate (RR), tidal volume (VT) and 
minute volume (VE) changes recorded in our cohort of GαO flx/flx mice. 
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Figure 5.3.1 Representative recording of haemodynamic and respiratory responses of a GαO flx/flx mouse injected with 
control GFP AVV to hypoxic challenge (10% of O2 in the inspired air) 
 
From top to bottom, heart rate (HR), arterial BP (BP), respiratory rate (RR), and raw respiratory tracings (RESP). Time is 
represented on the X-axis in seconds with the hypoxic period highlighted in pink and recovery period in blue.
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5.3.1 Haemodynamic and respiratory responses to hypoxic challenge in 
mice with conditional deletion of GαO in the brainstem 
 
There were no significant differences in the hypoxia-induced haemodynamic 
and respiratory responses mounted by control mice before and after 
injections of GFP AVV. Post Cre AVV injections, GαO floxed brainstem Cre 
mice were more tachycardic at baseline after acclimatisation to the chamber 
environment (579±10 vs 504±26 bpm, p=0.023) and this difference in heart 
rate is maintained in response to hypoxic challenge with a similar magnitude 
of HR change (721±7 vs 656±10 bpm, p<0.001) and during recovery of heart 
rate in the re-oxygenation period (633±14 vs 560±26 bpm, p=0.049).  GαO 
floxed brainstem Cre mice were also more hypertensive at baseline (152±7 
vs 128±5 mmHg, p=0.025) but this difference is not maintained and systolic 
BP during (132±3 vs 129±5 mmHg, p=0.671) and after hypoxia (124±6 vs 
126±6 mmHg, p= 0.796) were similar pre and post Cre AVV injections. There 
were also no significant differences in the respiratory rate or tidal volume in 
GαO floxed brainstem Cre mice before and after the injections of Cre AVV 
during baseline, hypoxia or recovery. This resulted in a similar profile of 
minute ventilation changes (Table 5.1, Figures 5.3.2 and 5.3.3). 
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 Baseline 10% O2 Recovery 
GFP 
(n=4) 
Cre 
(n=6) 
GFP 
(n=4) 
Cre 
(n=6) 
GFP 
(n=4) 
Cre 
(n=6) 
Heart rate 
(BPM) 
 
Pre 
 
527±13 
 
504±26 
 
665±11 
 
656±10 
 
559±20 
 
560±26 
 
Post 
 
495±28 
* 
579±10  
 
665±16 
*** 
721±7 
 
524±30 
* 
633±14 
Blood 
pressure 
(mmHg) 
 
Pre 
 
129±6 
 
128±5 
 
124±3 
 
132±3 
 
129±4 
 
124±6 
 
Post 
 
135±5 
* 
152±7 
 
126±6 
 
129±5 
 
128±7 
 
126±6 
Respiratory 
rate 
(min-1) 
 
Pre 
 
185±5 
 
199±7 
 
280±6 
 
263±7 
 
145±11 
 
167±10 
 
Post 
 
191±3 
 
199±8 
 
271±3 
 
266±6 
 
153±9 
 
155±9 
Tidal 
volume 
(ml kg-1) 
 
Pre 
 
5.3±0.3 
 
4.5±0.5 
 
12.0±0.4 
 
12.6±0.6 
 
7.4±0.4 
 
7.2±0.8 
 
Post 
 
5.2±0.4 
 
5.6±0.5 
 
12.0±0.7 
 
13.2±0.6 
 
7.0±0.5 
 
8.9±0.5 
Minute 
volume 
(L min-1 kg1) 
 
Pre 
 
1.0±0.1 
 
1.0±0.1 
 
3.4±0.1 
 
3.3±0.2 
 
1.1±0.1 
 
1.2±0.1 
 
Post 
 
1.0±0.1 
 
1.1±0.1 
 
3.2±0.2 
 
3.5±0.2 
 
1.1±0.1 
 
1.4±0.1 
 
Table 5.1  Summary data of hypoxia-induced changes in 
haemodynamic and respiratory variables recorded in Control (n=4) and 
GαO floxed brainstem Cre mice (n=6) pre- and post- viral injections.  
 
Data are expressed as means ± SEM. Values highlighted in bold are 
significantly different when compared to pre-injection values.  
* p<0.05, *** P<0.001 
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Figure 5.3.2 Haemodynamic response to hypoxic challenge (10% 
inspired O2) in GαO floxed brainstem Cre mice and controls 
Heart rate (HR) and systolic blood pressure (BP) pre and post Cre AVV and 
GFP AVV injections. Individual data and means ± SEM are shown.  
indicates significant difference from normoxia; + indicates significant 
difference from post GFP; * indicates significant difference from pre Cre.  
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Figure 5.3.3 Respiratory response to hypoxic challenge (10% inspired) 
in GαO floxed brainstem Cre mice and control. 
Respiratory rate (RR), tidal volume (VT) and minute volume (VE) pre and post 
Cre AVV and GFP AVV injections.  indicates significant difference from 
normoxia.
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5.4 Haemodynamic and respiratory responses to hypercapnia 
 
Respiratory and cardiovascular responses to hypercapnia were determined 
in the same cohort of 6 GαO floxed brainstem Cre mice and 4 controls as 
before. Figure 5.4.1 shows a representative trace of the haemodynamic and 
respiratory responses evoked by an increase in the level of inspired CO2 in a 
control mouse. The control mice responded to 3% and 6% CO2 with a 
decrease in heart rate, accompanied by an increase in arterial BP. 
Hypercapnia also evoked stereotypic increases in respiratory rate and tidal 
volume. Table 5.2 summarises the HR, systolic BP, respiratory rate (RR), 
tidal volume (VT) and minute volume (VE) data recorded in our cohort of GαO 
flx/flx mice during CO2 exposure. 
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Figure 5.4.1. Representative recording of haemodynamic and respiratory responses of a control mouse to hypercapnic 
challenge (3% and 6% CO2 in the inspired air). 
 
From top to bottom, heart rate (HR), arterial BP (BP), respiratory rate (RR), and raw respiratory tracings (RESP) and FiCO2 (CO2). 
Time is represented on the X-axis in seconds. 
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5.4.1 Haemodynamic and respiratory responses to hypercapnic 
challenge in mice with conditional deletion of GαO in the brainstem 
 
No significant differences in CO2-evoked responses (haemodynamic and 
respiratory) of the control mice before and after GFP AVV injections were 
observed. GαO floxed brainstem Cre mice displayed higher heart rate at 
baseline after acclimatisation to the chamber environment (654±16 vs 
587±23 bpm, p=0.012) post Cre AVV injections. HR depression during 3% 
and 6% CO2 was attenuated in GαO floxed brainstem Cre mice after Cre AVV 
injections (3% CO2: 616±23 vs 539±28 bpm, p=0.049; 6% CO2: 633±19 vs 
499±27 bpm, p=0.003). Systolic BP was significantly higher in GαO floxed 
brainstem Cre mice at baseline (159±4 vs 136±6 mmHg, p=0.012). Control 
mice responded to 6% CO2 with significantly elevated systolic BP (164±9 vs 
136±6 mmHg, p=0.005) but this response was attenuated in GαO floxed 
brainstem Cre mice (170±10 vs 159±4 mmHg, p=0.669). Respiratory 
responses to 6% CO2 in GαO floxed brainstem Cre mice were higher (VE  
4.7±0.9 vs 3.0±0.4 L min-1 kg-1, p=0.114) when challenged with 6% CO2 post 
Cre Adv injections but did not reach statistical significance (Table 5.3, Figure 
5.4.2 and Figure 5.4.3). 
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 Baseline 3% CO2 6% CO2 
GFP 
(n=4) 
Cre 
(n=6) 
GFP 
(n=4) 
Cre 
(n=6) 
GFP 
(n=4) 
Cre 
(n=6) 
Heart rate 
(BPM) 
 
Pre 
 
521±41 
 
587±23 
 
518±22 
 
539±28 
 
518±22 
 
499±27 
 
Post 
 
507±24 
* 
654±16 
 
474±26 
* 
616±23 
 
474±26 
** 
633±19 
Blood 
pressure 
(mmHg) 
 
Pre 
 
135±9 
 
136±6 
 
155±14 
 
152±9 
 
169±8 
 
164±9 
 
Post 
 
137±8 
* 
159±4 
 
160±9 
 
163±9 
 
173±10 
 
170±10 
Respiratory 
rate  
(min-1) 
 
Pre 
 
198±4 
 
196±6 
 
218±4 
 
223±8 
 
260±12 
 
269±14 
 
Post 
 
202±7 
 
201±5 
 
229±12 
 
221±11 
 
265±10 
 
307±23 
Tidal volume 
(ml kg-1) 
 
Pre 
 
5.1±0.6 
 
4.7±0.7 
 
8.7±0.9 
 
7.4±0.5 
 
11.2±0.6 
 
11.3±1.6 
 
Post 
 
4.2±.8 
 
5.2±0.5 
 
7.6±0.9 
 
8.5±0.9 
 
11.0±0.8 
 
15.2±2.1 
Minute 
volume  
(L min-1 kg-1) 
 
Pre 
 
1.0±0.1 
 
0.9±0.1 
 
1.9±0.2 
 
1.7±0.1 
 
2.9±0.1 
 
3.0±0.4 
 
Post 
 
0.8±0.2 
 
1.0±0.1 
 
1.7±0.3 
 
1.9±0.3 
 
2.9±0.3 
 
4.7±0.9 
 
Table 5.2  Summary data of hypercapnia-induced changes in 
haemodynamic and respiratory variables recorded in control (n=4) and 
GαO floxed brainstem Cre mice (n=6) pre- and post- viral injections. 
 
Data are expressed as means ± SEM. Values highlighted in bold are 
significantly different when compared to pre-injection values.  
* p<0.05, ** P<0.01 
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Figure 5.4.2 Haemodynamic response to hypercapnic challenge in GαO 
floxed brainstem Cre mice and control. 
 
Heart rate (HR) and systolic blood pressure (BP) pre and post Cre/GFP AVV 
and GFP AVV injections. Individual data and means ± SEM are shown.  
indicates significant difference from normoxia; + indicates significant 
difference from post GFP; * indicates significant difference from pre Cre.  
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Figure 5.4.3 Respiratory response to hypercapnic challenge in GαO 
floxed brainstem Cre mice and control. 
 
Respiratory rate (RR), tidal volume (VT) and minute volume (VE) pre and post 
Cre/GFP AVV and GFP AVV injections. Individual data and means ± SEM 
are shown.  indicates significant difference from normoxia  
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5.5 Discussion 
 
In this chapter, I described the results of experiments aimed to investigate 
the effect of GαO deletion in the presympathetic circuits of the brainstem on 
central cardiovascular control in the conscious mice. GαO flx/flx mice were 
studied in a conscious state before and after Cre AVV and control GFP AVV 
injections into the RVLM, which contains a principal group of 
sympathoexcitatory neurones which generate sympathetic tone. There were 
no differences in 24-hour HR and BP profile in mice when compared before 
and after Cre AVV injections when the animals were studied in the freely 
ambulatory state. However, when the animals were placed in the 
plethysmography chamber, GαO floxed brainstem Cre mice displayed higher 
resting HR and systolic BP, and abnormal HR response to hypoxia and 
hypercapnia. There were no significant changes in respiratory parameters. 
Thus, the exposure to novel environment and stressors in a plethysmography 
chamber reveals the role of GαO in the central nervous mechanisms of HR 
and BP control. 
 
5.5.1 No effect of GαO deletion in the RVLM on HR and BP profile in 
conscious freely moving mice housed in standard conditions 
 
There were no significant differences in HR and BP profile after GαO deletion 
in the presympathetic area of the brainstem in conscious freely moving mice 
housed in standard conditions. This observation is in agreement with findings 
obtained in rats demonstrating that chronic C1 lesions in the conscious state 
is associated with only a modest reduction in BP and no changes in HR 
(Madden et al. 2003, Schreihofer et al. 2000). These data suggested that the 
role of RVLM in HR and BP control under normal resting conditions is at 
most moderate. 
 
As discussed above, the prevailing autonomic tone in mice is dependent on 
ambient temperature, housing conditions and recovery time post surgery. 
When the conditions are optimum, mice exhibit a significant resting vagal 
tone as mentioned in Chapter 3 (Swoap et al. 2008; Just et al. 2000; Zuberi 
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et al. 2008). In this context, another possible explanation for the observations 
made is that the inhibitory influences on the RVLM mediated via GαO do not 
make a significant contribution to the overall autonomic tone to the 
cardiovascular system when vagal tone predominates.  
 
5.5.2 Mice with GαO deletion in the RVLM display elevated HR and BP in 
a novel environment (plethysmography chamber) 
 
When placed in the plethysmography chamber, GαO floxed brainstem Cre 
mice had significantly elevated HR and BP whilst these parameters have 
normalised in control mice towards the end of 20 minutes of acclimatisation. 
There was no difference in the respiratory parameters. 
 
Activation of the RVLM by supramedullary structures including the 
hypothalamic PVN, lateral parabrachial nuclei and midbrain central gray via a 
cholinergic pathway has been shown to occur in response to a variety of 
stress paradigms including emotional or psychological stressors (Li et al. 
1995; Kubo et al. 2000). In a stress-induced model of hypertension, 
microinjection of μ and σ opiod receptor agonists, which are known to signal 
via inhibitory G proteins, have been shown to attenuate the hypertensive 
response (Li et al. 1995). The observed phenotype in our mice with GαO 
deletion may hence be due to loss of inhibitory influence to the RVLM in this 
context. 
 
5.5.3 Haemodynamic and respiratory responses to hypoxia and 
hypercapnia in control mice 
 
Campen et al (Campen et al. 2005) studied the haemodynamic responses to 
hypoxia in different strains of mice and found heterogenous BP and HR 
responses. BP response can range from maintenance of normotension to a 
hypotensive response and an equally variable HR response. In contrast, the 
responses to hypercapnia are more homogenous with a generally 
hypertensive response and corresponding baroreflex-mediated reduction in 
HR.  
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Mice used in this study responded to hypoxia with elevations in HR and no 
significant change in BP. In accord with observations of Campen et al, the 
mice responded to hypercapnia with a reduction in HR associated with an 
increase in BP. 
 
Mammals respond to hypoxia and hypercapnia with increases in minute 
ventilation. However, the respiratory rate and tidal volume components can 
differ significantly between different mouse strains (Teppema & Dahan 
2010). In mice used in this study, there was a vigorous increase in minute 
ventilation to both hypoxia and hypercapnia, with a larger relative increase in 
respiratory rate compared to tidal volume. 
 
5.5.4 Altered haemodynamic responses to hypoxia in mice with 
conditional deletion of GαO in the brainstem 
 
Mice with conditional deletion of GαO in the RVLM respond to hypoxia with 
enhanced HR response to 10% O2 and HR remained elevated during 
recovery with no significant changes to arterial BP.  
 
Hypoxia induces both local and centrally mediated changes to HR and 
arterial BP. Hypoxia stimulates the carotid body peripherally and also central 
chemoreceptors and results in vigorous activation of presympathetic 
barosensitive RVLM neurones resulting in sympathetic activation and this 
response can be modified by the baroreflex (Koshiya et al. 1993) and central 
respiratory generator drive (Mandel et al. 2006). Changes to arterial BP 
during hypoxia are due to a combination of decrease in arteriolar resistance 
due to locally mediated vasodilation and baroreceptor-mediated constriction 
of larger vessels as well changes to HR and contractility due to the altered 
autonomic output (Campen et al. 2004; Ray et al. 2002). 
 
Richter et al. (Richter et al. 1999) studied the release of neurotransmitters 
and neuromodulators in the ventral medullary region of anaesthetised cats 
subjected to 5 minutes of hypoxia (7% O2 in the inspired air) using a 
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microdialysis technique. There was a rapid but transient rise in glutamate 
and GABA concentrations initially, reaching a peak level by 1 minute of 
exposure to hypoxia. This correlated with a period of augmented respiratory 
activity. Subsequently, a delayed rise in 5-HT levels was detected towards 
the end of the hypoxic period followed by a rise in adenosine levels, which 
were thought to contribute to post hypoxic respiratory depression. By using 
the more sensitive amperometric probes in rats, Gourine et al. found that 
acute hypoxia induced a significant increase in adenosine level in the NTS 
and a much smaller increase in adenosine level in the ventral medullary 
region (only about 10 % of that in the NTS) (Gourine et al. 2002). Adenosine 
levels peaked during the reoxygenation period after termination of the 
hypoxic challenge, in agreement with the findings of Richter et al. 
 
GABA, 5-HT and adenosine can all mediate inhibitory influences via Gαi/O 
coupled receptors. Loss of inhibitory signalling via GαO could hence 
potentially explain the augmented HR response during both hypoxia and the 
post hypoxic recovery period. 
 
The co-release of GABA with glutamate with similar temporal kinetics 
(Richter et al. 1999) suggests a role for GABA as a restraining influence to 
the excitatory effects of glutamate during hypoxia. Indeed, there is evidence 
that GABA-ergic inhibitory mechanisms are important in modulating RVLM 
activity during hypoxia in rat neonatal brainstem preparations (Boychuk et al. 
2012).  
 
Inhibitory influences of 5-HT and adenosine have also been shown to 
regulate sympathetic responses in the brainstem region. Activation of 5-HT 
1A receptors in the brain stem which signal via Gαi/O causes a potent and 
selective suppression of the hypertensive and sympathoexcitatory response 
evoked by stimulation of the dorsomedial hypothalamic nucleus (Horiuchi et 
al. 2005). Adenosine has been shown to evoke an increase in arterial 
pressure when injected into rostral areas of the RVLM and also to augment 
increases in BP in response to stimulation of the hypothalamic defense area 
via its action on the RVLM (Thomas & Spyer 1996).   
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Extracellular adenosine can arise during systemic hypoxia either from the 
action of nucleoside transporters or from the breakdown of ATP released 
from neural structures which are then broken down by ectonucleotidases into 
adenosine (Spyer & Thomas 2000). Peripherally, adenosine has been shown 
to have vasodilatory effect on peripheral vasculature (Ray et al. 2002), which 
may counteract the effect on arterial BP resulting from increased sympathetic 
tone and explain the lack of difference seen. 
 
5.5.5 Altered haemodynamic responses to hypercapnia in mice with 
conditional deletion of GαO in the brainstem 
 
Increase in arterial pCO2 elicits a sympathetic response in rodents (Campen 
et al. 2005). The cardiovascular effect is manifested by a predominantly 
pressor response with concomitant baroreflex mediated drop in HR. There is 
hence also co-stimulation of the vagal preganglionic neurones as part of the 
baroreflex arc resulting in increased vagal tone to the pacemaking cells of 
the heart (Paton & Butcher 1998; Spyer & Gilbey 1988).  
 
The RVLM has been implicated with evidence of increased activity during 
hypercapnia in vivo (Seller et al. 1990) and permanent depletion of 
catecholaminergic C1 neurones abolished sympathoexcitation induced by 
activation of peripheral chemoreceptors (Schreihofer et al. 2005) but not from 
central actions of CO2 (Marina et al. 2011). Purinergic signalling involving P2 
receptors have also been implicated as an important mediator in 
chemosensory transduction in the brainstem (Gourine et al. 2005). 
 
GαO deletion in the RVLM attenuated the drop in HR with no significant effect 
on the increase in arterial BP during hypercapnia when compared to control 
mice. Given that there is co-stimulation of both pre-sympathetic and vagal 
preganglionic neurones activated via baroreflex input, it would appear that 
loss of GαO results in either increase in sympathoexcitation and/or decrease 
in activation of vagal preganglionic neurones, or an increase in both 
sympathetic and vagal outputs with the sympathetic output dominating. 
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Given that there was no significant difference in arterial BP concomitant to an 
increase in HR, this would suggest a change in the baroreflex sensitivity 
associated with loss of GαO proteins in the RVLM. 
 
5.5.6 Summary 
 
This chapter described the results of experiments aimed to determine the 
role of GαO in the brainstem mechanisms of cardiovascular control in the 
conscious mice. It was found that mice with conditional deletion of GαO in the 
brainstem displayed similar HR and arterial BP profile to control mice under 
normal physiological resting conditions (conscious, freely-moving in normal 
housing). However, when exposed to novel environment or environmental 
stressors like hypoxia or hypercapnia the same mice demonstrated a 
phenotype consistent with increased sympathetic activity. Taken together, 
loss of inhibitory signaling in the RVLM and the resulting dis-inhibition of pre-
sympathetic circuits under conditions of stress is the likely explanation of the 
cardiovascular phenotype seen in mice with conditional GαO deletion in the 
brainstem.  
 
To investigate this cardiovascular phenotype further and examine the effect 
of increased sympathetic tone on in vivo cardiac electrophysiology and 
predisposition to cardiac arrhythmia, we studied cardiac baroreceptor 
reflexes and performed programmed electrical stimulation on these mice 
using an in vivo anaesthetised preparation. 
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Chapter 6 
 
Results IV 
Baroreflex sensitivity and electrophysiological 
properties of the heart in mice with GαO deletion  
in the RVLM  
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6.1 Introduction 
 
As described above (Chapter 5), mice with conditional deletion of GαO in the 
brainstem appear to have higher sympathetic tone when exposed to novel 
environment or environmental stressors like hypoxia and hypercapnia. This 
Chapter describes the results of experiments aimed to further dissect the 
mechanisms underlying this phenotype by assessing the baroreflex 
sensitivity of these mice using an in vivo anaesthetised preparation. The 
mice were also subjected to pharmacological blockade of vagal and 
sympathetic influences using atropine and atenolol, respectively, to 
investigate the relative contribution of each autonomic arm to the observed 
phenotype. The significance of GαO deletion in the brainstem on in vivo 
cardiac electrophysiology was then studied using the programmed electrical 
stimulation paradigm.  
 
6.1.1 Baroreflex sensitivity and alterations in sympathovagal tone 
 
As discussed previously, arterial BP-HR baroreflex studies can provide an 
indirect assessment of the neural control of the cardiovascular system. 
Alteration in autonomic tone is associated with changes in baroreflex 
sensitivity. In particular, increase in sympathetic tone with resulting 
sympathovagal imbalance is shown in humans and animal models to 
correlate with depressed baroreflex sensitivity and associated with poorer 
prognosis (Nolan et al. 1998). 
 
6.1.2 In vivo cardiac electrophysiology assessed by programmed 
electrical stimulation 
 
By applying methodologies of programmed electrophysiological stimulation 
used in humans to the in vivo mouse model, the effect of alteration in 
autonomic tone on the electrical properties of the ventricular myocardium can 
be studied. In particular, increase in sympathetic tone to the heart is known 
to reduce the ventricular effective refractory period (VERP) with an opposite 
effect mediated by vagal tone (Zipes and Douglas 2013). 
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Burst pacing to induce VT provides a quantifiable and robust measure of 
arrhythmia susceptibility, allowing the examination of how changes in 
autonomic tone to the heart can affect electrical stability (Yoon et al. 1977; 
Kent et al. 1973). 
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6.2 Resting cardiovascular parameters in GαO floxed brainstem Cre 
mice and controls under urethane anaesthesia 
 
A separate cohort of GαO floxed brainstem Cre mice (n=14) and controls 
(n=12) were studied under urethane anaesthesia as described in detail in 
Chapter 2. Baroreflex sensitivity was assessed in five mice from each group 
following cannulation of both jugular veins for administration of test 
compounds, the left internal carotid artery for arterial BP measurement and 
implantation of needle electrodes for surface ECG recordings as described in 
Chapter 2. The remaining animals underwent in vivo cardiac 
electrophysiological study with the EPR-800 catheter inserted to the right 
ventricle via the right internal jugular vein and surface ECG recorded from 
needle electrodes (see section 6.5). 
 
Baseline measurements were obtained 30 minutes after mice were 
anaesthetised and instrumented. Table 6.1 summarises the baseline HR, BP 
and ECG parameters obtained for GαO floxed brainstem Cre mice and 
controls under urethane anaesthesia. Figures 6.2.1 and 6.2.2 summarises 
the HR and systolic BP data for GαO floxed brainstem Cre mice and controls 
when studied under the two different conscious states described in Chapter 5 
and the urethane anaesthetised state. 
 
Under urethane anaesthesia, GαO floxed brainstem Cre mice had 
significantly higher HR compared to controls (614±5 v 587±5 bpm, p<0.001) 
with no difference in systolic BP between GαO floxed brainstem Cre mice and 
controls (86±5 vs 81±5 mmHg, p=0.125). 
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 Control GαO floxed brainstem 
Cre 
 
p value 
HR (bpm) 
(n= 12 v 14) 
587±5 
 
614±5 *** 
 
<0.001 
SBP (mmHg-1) 
(n= 5 v 5) 
81±5 
 
86±5 
 
0.125 
PR (ms) 
(n= 7 v 9) 
33±2 
 
33±2 
 
0.837 
QRS (ms) 
(n= 7 v 9) 
14±1 15±2 0.519 
QTC (ms) 
(n= 7 v 9) 
84±5 95±5 0.150 
 
 
Table 6.1 Summary data of HR, systolic BP (SBP) and ECG parameters 
of control and GαO floxed brainstem Cre mice studied under urethane 
anaesthesia .  
 
Data are expressed as means ± SEM. Values highlighted in bold are 
significantly different when compared to controls. *** P<0.001 
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Figure 6.2.1 HR of mice with conditional deletion of GαO in the RVLM 
compared to controls during conscious and anaesthetised 
experiments. 
 
Summary data comparing HR of GαO floxed brainstem Cre mice and controls 
(all after AVV injections) during conscious and anaesthetised experiments. 
Data expressed as mean ± SEM. NS p≥0.05, *** p<0.001. 
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Figure 6.2.2 Systolic BP of mice with conditional deletion of GαO in the 
RVLM compared to controls during conscious and anaesthetised 
experiments. 
 
Summary data comparing systolic BP of GαO floxed brainstem Cre mice and 
controls (all after AVV injections) during conscious and anaesthetized 
experiments. Data expressed as mean ± SEM. NS p≥0.05, *** p<0.001. 
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6.3 HR changes in urethane anaesthetised mice following autonomic 
blockade 
 
To further study the contribution of the sympathetic and parasympathetic 
limbs of the autonomic nervous system to the HR of urethane anaesthetised 
mice, atenolol (1 mg/kg) followed 30 minutes later by atropine (1 mg/kg) was 
given intraperitoneally to nine GαO floxed brainstem Cre mice and seven 
control mice undergoing in vivo cardiac electrophysiological studies. The HR 
measurements were obtained after a 10 minute period following each drug 
administration and are shown in Figure 6.3.1.  
 
The HR difference between the group was abolished after administration of 
atenolol (450±10 v 440±12, p=0.893) with a small increase in heart rate after 
administration of atropine (460±10 v 455±8, p=0.824) which was not 
significantly different between the groups. 
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Figure 6.3.1 HR of mice with deletion of GαO in the RVLM compared to 
controls following autonomic blockade. 
 
Comparison of HR between GαO floxed brainstem Cre mice and controls at 
baseline and after administration of atenolol 1mg/kg ip followed by atropine 
1mg/kg ip. Data expressed as mean ± SEM. NS p≥0.05, *** p<0.001. 
 
Atropine 
*** 
NS NS 
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6.4 Baroreflex sensitivity in GαO floxed brainstem Cre mice and controls 
 
GαO floxed brainstem Cre mice had elevated HR compared to controls with 
increased minimum HR (604±2 v 575±9 bpm, p=0.028), maximum HR 
(654±6 v 620±4 bpm, p=0.017) and HR at half BP range (629±3 v 598±5 
bpm, p=0.017). This is associated with a greater baroreflex gain compared to 
controls (0.65±0.07 v 0.35±0.01 p=0.012). There were no significant 
differences in the BP parameters.  
 
Figure 6.4.1 summarises the HR-systolic BP baroreflex plots constructed 
from the HR and BP data obtained when GαO floxed brainstem Cre and 
control mice were given iv boluses of phenylephrine (0.5-2.5 mg kg-1 iv in 2-
10 μL boluses) and sodium nitroprusside (0.1-1 mg kg-1 iv in 1-10μL boluses) 
as described in Chapter 2. 
 
Table 6.2 summarises the data derived from the baroreflex curves.  
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Figure 6.4.1 HR and systolic BP baroreflex response curves of mice with conditional deletion of GαO in the RVLM 
compared to controls 
 
 (A) Individual plots of HR and systolic BP for GαO floxed brainstem Cre mice and controls (n=5 for each group) following 
pharmacological challenges with iv phenylephrine and sodium nitroprusside as described. A best fit sigmoidal baroreflex response 
curve is then plotted for each subject. (B) Mean baroreflex curves (bold lines) for GαO floxed brainstem Cre mice and controls. Bold 
points represent mean HR 50 and SBP 50 for each group. 
 A B Control 
GαO floxed 
brainstem Cre 
Control 
GαO floxed 
brainstem Cre 
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 Cre  
(n=5) 
GFP control 
(n=5) 
P value 
HR min (bpm) 604±2 575±9 * 0.028 
HR 50 (bpm) 629±3  598±5** 0.002 
HR max (bpm) 654±6 620±4 * 0.017 
HR range (bpm) 50±6 48±7 0.451 
SBP min (mmHg) 50±4 43±6 0.399 
SBP 50 (mmHg) 115±4 111±2 0.074 
SBP max (mmHg) 155±5 153±5 0.850 
BP range (mmHg) 114±6 117±2 0.325 
BR gain (ms/mmHg) 0.65±0.07 0.35±0.01* 0.012 
 
 
 
 
 
Table 6.2 Summary data of parameters derived from mean baroreflex 
curves for mice with conditional deletion of GαO in the RVLM compared 
to controls 
 
Data are expressed as means ± SEM. Values highlighted in bold are 
significantly different when compared to controls. * P<0.05, ** P<0.01 
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6.5 Programmed electrical stimulation in GαO floxed brainstem Cre mice 
and controls  
 
In a separate experiment, cardiac electrophysiological properties of 9 Cre 
AVV and 7 GFP AVV injected mice were studied using the octapolar EPR-
800 catheter placed in the right ventricle. S1/S2 and burst pacing protocols 
were applied to obtain VERP and to induce VT (Figure 6.5.1) 
 
GαO floxed brainstem Cre mice had a significantly reduced VERP750 
compared to controls (VERP750 48±3 vs 65±4 ms, p<0.001). When VERP750 
measurements were repeated 30 minutes after administration of atenolol 
(1mg/kg ip), the difference in VERP was no longer observed (63±3 vs 61±2, 
p=0.72) (Figure 6.4.2).  
 
The mice were then subjected to burst pacing stimulation protocol. VT was 
induced in 3 out of 9 mice expressing Cre in the RVLM compared to 0 out of 
7 control mice. 
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Figure 6.5.1 Programmed electrical stimulation in mice with conditional deletion of GαO in the RVLM and controls. 
 
(A) Pacing the right ventricle with ventricular capture at a cycle length of 80msec (resulting in ventricular rate of 750bpm). (B) S1-S2 
pacing protocol by pacing the ventricle at a cycle length of 80msec initially for 9 beats and bringing in an S2 beat at a shorter 
coupling interval of 40msec with capture of ventricle at top panel but by reducing S2 coupling interval to 38msec resulted in loss of 
capture at bottom panel. VERP is hence 38msec. (C) Burst pacing at 50Hz induced VT in left panel but not in right panel. ECG: 
surface ECG; Intracardiac: intracardiac electrograms; Stim: pacing stimulus. 
A 
B C 
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Figure 6.5.2 VERP750 in mice with conditional deletion of GαO in the 
RVLM compared to controls pre and post atenolol 
 
Comparison of VERP750 between GαO floxed brainstem Cre mice and 
controls at baseline and after administration of atenolol 1mg/kg ip.  
Data expressed as mean ± SEM. NS p≥0.05, *** p<0.001. 
 
 
*** NS 
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6.6 Discussion  
 
Experiments described in this chapter studied GαO floxed brainstem Cre mice 
in the urethane anaesthetised state and compared them to controls injected 
with GFP AVV. It was found that mice under urethane anaesthesia displayed 
higher HR and lower arterial BP compared to the conscious state. Mice with 
GαO deletions in the RVLM were more tachycardic and had increased 
baroreflex sensitivity compared to controls. They also displayed pro-
arrhythmic phenotype in the cardiac ventricle as evident from a decreased 
VERP and susceptibility to VT during programmed electrical stimulation. The 
differences in HR and VERP between experimental and control animals were 
abolished following administration of atenolol, suggesting that the differences 
observed are due to higher sympathetic activity resulting O deletion 
in the RVLM. 
 
6.6.1 Autonomic tone during urethane anaesthesia 
 
Mice studied under urethane anaesthesia have previously been shown to 
have little vagal tone and have reduced arterial pressure and increased HR 
compared to the conscious state (Paton & Butcher 1998; Desai et al. 1997). 
Similar findings were obtained here with urethane anaesthetised mice being 
significantly more hypotensive and generally more tachycardic. Sequential 
challenges with atenolol and atropine revealed low vagal tone and 
demonstrated that sympathetic activity indeed dominates heart rate control in 
mice under urethane anaesthesia. 
 
6.6.2 Increased HR and baroreflex sensitivity in mice with conditional 
deletion of GαO in the brainstem 
 
GαO floxed brainstem Cre mice display increased heart rate and enhanced 
baroreflex sensitivity compared to controls. Taken together with the fact that 
our mice display a sympathetic predominance under urethane anaesthesia, 
this suggests that in mice with conditional deletion of GαO in the brainstem 
increased sympathetic outflow (rather than vagal withdrawal) is largely 
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responsible for sympathovagal imbalance and autonomic phenotype 
observed. 
  
The finding that there is little vagal tone in our urethane aneasthetised 
preparation may also explain why there is increased and not decreased 
baroreflex sensitivity associated with increased sympathetic outflow as 
normally seen. When sympathetic and vagal influences are both present, 
increased sympathetic outflow is normally associated with reduction in vagal 
tone and as the vagal component usually makes a larger contribution to 
baroreflex sensitivity there is normally a resulting depression of baroreflex 
sensitivity. However, in the absence of a prevailing vagal tone, the 
sympathetic limb is largely responsible for the baroreflex response and 
hence may account for the increase in baroreflex sensitivity seen in mice with 
GαO deletion in the brainstem. 
 
6.6.3 Reduced VERP and increased susceptibility to VT in mice with 
conditional deletion of GαO in the brainstem 
 
On programmed electrical stimulation, GαO floxed brainstem Cre mice had 
significantly reduced VERP and this was associated with an increase in 
susceptibility to VT during burst pacing. A reduction in VERP is pro-
arrhythmic in situations of both re-entry and triggered activity (Zipes and 
Jalife 2009). It is worth noting that the 129/Sv strain is relatively resistant to 
ventricular arrhythmia (Maguire et al. 2003) and we were able to induce VT in 
one third of mice with conditional deletion of GαO in the brainstem but none in 
the controls. The difference in VERP was abolished after administration of 
atenolol. Taken together with previous observations, the change in 
ventricular refractoriness and susceptibility to VT observed in GαO floxed 
brainstem Cre mice appears to be due to increased sympathetic outflow to 
the heart. 
 
It is well known that the autonomic nervous system modulates cardiac 
electrophysiology. Increase in sympathetic tone to the heart has been shown 
to reduce action potential duration with a corresponding increase in 
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conduction velocity, resulting in a change in the restitution properties of 
action potential duration and dispersion of ventricular repolarisation and 
increased susceptibility to ventricular arrhythmia (Zipes and Jalife 2009).  
 
6.6.4 Limitations 
 
Pharmacological measurements of arterial baroreflex sensitivity takes into 
account the entire arterial baroreflex arc, from the input into the system to the 
ensuing end-organ response. Thus the derived baroreflex sensitivity takes 
into account all 3 components of the reflex arc: the arterial baroreflex afferent 
input, central processing, and efferent output. As a result, alterations in one 
limb of the baroreflex network may be compensated for by other areas and 
therefore it may be necessary to investigate the individual pieces of the reflex 
pathway independently to conclude any changes seen is due to alterations in 
central processing. Examples of ways to dissect out the different 
mechanisms would include direct stimulation of the aortic depressor nerve to 
bypass the afferent pathway and directly evaluate central and efferent 
components or recording the efferent sympathetic nerve to directly measure 
the efferent output. These approaches are of course technically very 
challenging. 
 
6.6.5 Summary 
 
In this chapter I have shown that urethane anaesthetised mice are 
tachycardic and hypotensive compared to the conscious state. Deletion of 
GαO in the RVLM leads to increased HR and baroreflex gain. Given that 
sympathetic tone appears to predominate with little vagal input upon dual 
autonomic blockade, it is likely that the changes seen are due to increased 
sympathetic tone due to loss of inhibitory influences to the RVLM. Lastly, this 
increase in sympathetic tone to the heart is associated with shortened VERP 
and an increased predisposition to ventricular arrhythmia on programmed 
electrical stimulation of the heart. 
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Chapter 7 
 
General Discussion 
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 7.1 Summary of findings 
 
In this thesis, I sought to study the role of inhibitory G protein GαO in the 
autonomic regulation of the heart.  
 
I found that Gαi2 and not GαO is important in modulating vagal effects at the 
level of the cardiac conduction tissue. Loss of Gαi2 in the cardiac conduction 
tissue resulted in increased daytime HR association with loss of HF power on 
HRV analysis. This is in contrast to mice with similar loss of GαO in the 
cardiac conduction tissue which had normal HR profile and HRV. 
 
Mice with deletion of GαO in the presympathetic circuits of the brainstem 
(RVLM) had normal HR and arterial BP under normal resting conditions. 
However, when stressed in a novel environment or under urethane 
anaesthesia, these mice developed a pronounced elevation in HR with 
abnormal HR responses during hypoxic and hypercapnic conditions and is 
associated with altered baroreflex sensitivity. Dual autonomic blockade with 
atenolol and atropine suggests that this phenotype is largely due to an 
increase in sympathetic tone. Finally, this increase in sympathetic tone to the 
heart is associated with alterations in ventricular electrophysiology as 
evidenced by reduction in VERP and increased susceptibility to VT during 
burst pacing. 
 
I conclude that GαO plays an important role in mediating inhibitory influences 
in the presympathetic circuits of the brainstem under conditions of ‘stress’. 
Loss of GαO results in increased sympathetic tone to the heart with resulting 
abnormal cardiovascular reflexes and alterations in cardiac 
electrophysiology. 
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7.2 Findings in the context of what is currently known 
 
The findings of this study build on and add on to current understanding in a 
number of areas. Firstly, our data contributes to the increasing body of  
evidence demonstrating G protein subtype specificity in mediating biological 
processes in vivo. Work in our group has previously shown that two subtypes 
of inhibitory G proteins, Gαi2 and GαO appear to be important for the 
autonomic modulation of HR in vivo in global KO mice (Zuberi et al. 2008). I 
have now shown in conditional knockout models that Gαi2 is important in 
modulating vagal tone at the level of the cardiac conduction tissue, probably 
by coupling to M2 receptors, whilst GαO appears to play a role in mediating 
inhibitory influences to the brainstem presympathetic circuits.  
 
Using HCN4 to target the deletion of Gαi2 in the cardiac conduction tissue 
has also lead to several insights. HCN4 and HCN1 were found to be the 
predominant isoforms expressed in murine cardiac SA nodal (SAN) cells 
(Herrmann et al. 2011). Mice with conditional deletion of HCN4 in the SAN 
had frequent sinus pauses but otherwise normal mean heart rate when sinus 
pauses are excluded and preserved circadian rhythm (Herrmann et al. 2007, 
Hoesl et al. 2008). I have now shown that loss of Gαi2 signalling in HCN4 
expressing cells does lead to abnormality of HR phenotype with increased 
daytime HR and loss of circadian rhythm. This suggests that HCN4 
expressing SAN cells are indeed important in cardiac pacemaking. Similar to 
the findings in HCN4 KO mice, I found no differences in the conduction and 
repolarisation intervals on the ECG in mice with conditional KO of Gαi2 in 
HCN4 expressing cells. This could either mean that signalling via Gαi2 is not 
important in determining the conduction and repolarisation properties of other 
tissues in the cardiac conduction system, or that other HCN subtypes such 
as HCN1 can compensate for loss of Gαi2 signalling in these HCN4 
expressing cells. 
 
An increasing body of evidence is accumulating on the importance of the 
presympathetic network, and more specifically the RVLM, in mediating 
responses to a variety of physiological and pathological stressors (Guyenet 
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et al. 2013). Our data adds to the body of evidence of the key role played by 
the RVLM under conditions of stress including hypoxia and hypercapnia. 
 
In addition, it would appear that inhibitory signaling in the brainstem is an 
important mechanism by which sympathetic activity is regulated centrally. For 
example, the RVLM is activated by increased dorsomedial hypothalamus 
activity in response to psychological stressors (Madden & Morrison 2004, 
Nalivaiko & Blessing 2001). This increased sympathetic activity is reversibly 
inhibited by intracisternal and direct administration of selective serotonin-1A 
(5-HT1A) receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-
DPAT) into the medullary raphe region (Ngampramuan et al. 2008, Nalivaiko 
et al. 2005). 5-HT1A receptors are one of many GPCRs in the brainstem that 
signal via inhibitory Gαi/o, with other inhibitory neurotransmitters and 
neuromodulators implicated in a variety of homeostatic and physiological 
responses as discussed previously. I have found in this study that loss of 
inhibitory G protein signaling in the RVLM resulted in a cardiovascular 
phenotype that was apparent only under conditions of stress. This adds to 
the body of literature as it suggests that co-activation of inhibitory inputs to 
the RVLM occurs during sympathoexcitation in response to physiological 
stressors. 
 
Furthermore, this study has contributed to our understanding of the identity of 
inhibitory G protein subtype that is important in mediating inhibitory 
influences in the RVLM. Parker et al (Parker et al. 2012) has previously 
shown that Gαi2 and GαO are the most ubiquitous inhibitory G proteins in the 
rostral C1 cells of the RVLM. In keeping with this, our data suggests an 
important role for GαO. Although we cannot exclude a role for Gαi2 as this was 
not studied directly with a conditional knockout of Gαi2 in the brainstem, it 
would appear that loss of GαO signaling cannot be adequately compensated 
for by other inhibitory G protein subtypes. 
 
Finally, alterations in autonomic tone is well known to contribute to changes 
in cardiac electrophysiology and contribute to arrhythmogenesis (Verrier & 
Antzelevitch 2004, Shen & Zipes 2014). I have shown that increased 
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sympathetic tone due to loss of GαO proteins in the RVLM leads to 
alterations in cardiac ventricular electrophysiology, resulting in a pro-
arrhythmic state. This adds to the body of evidence that alteration in 
autonomic tone has a direct effect on cardiac electrophysiology. 
 
7.3 Insights into cardiovascular regulation in man 
 
It is well recognised in humans that autonomic regulation of cardiac function 
is important in health and disease states. Many of the drugs used in the 
treatment of common cardiovascular diseases target the autonomic nervous 
system. Beta blockers is a good example of a class of drug that has reduced 
mortality in cardiovascular diseases (Al-Gobari et al. 2013).  
 
With the development of techniques and devices that are able to directly 
modulate autonomic afferents and efferents such are renal nerve denervation 
(Myat et al. 2013), baroreceptor (Heusser et al. 2010) and vagal nerve 
stimulation devices (De Ferrari at al. 2011), there is a pressing need to 
understand better the autonomic pathways that regulate cardiovascular 
function in disease and health. 
 
My work has shown that perturbations of inhibitory signalling in the 
presympathetic area of the brainstem results in sympathetic overactivity 
under conditions of stress but not during normal resting conditions. This has 
implications to cardiovascular disease where sympathetic overactivity is 
known to drive disease progression. Indeed, there is good preclinical 
(Geraldes et al. 2014, Marina et al. 2013) and clinical data (Smith et al. 2004, 
Malpas 2010) that attenuation of sympathetic activity can help arrest the 
development of hypertension and heart failure. The inhibitory circuits in the 
brainstem are hence potential druggable targets to attenuate sympathetic 
overactivity. 
 
In addition, our mouse model can also be used to study the contributory 
effect of increased sympathetic activity of central origin on the development 
of cardiac pathologies. One example would be to study the incidence of 
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ventricular arrhythmias post coronary ligation to induce myocardial infarction 
in mice with GαO deletion in the brainstem compared to controls to study the 
effect of increased sympathetic activity on arrhythmogenesis post myocardial 
infarction. 
 
7.4 Limitations 
 
I sought to study whether targeted deletion of different inhibitory G protein 
subtypes along the neuro-cardiac autonomic axis would lead to changes in 
cardiovascular reflexes and cardiac electrophysiology in an intact whole 
animal in both the conscious and anaesthetised state. The techniques used 
are inherently challenging and there are a number of limitations associated 
with the approaches used. 
 
Firstly, conditional gene deletion strategy was achieved using an inducible 
HCN4 promoter at the level of the pacemaking tissue of the heart and by 
targeted delivery of an adenoviral vector to the medullary brainstem region of 
interest. The use of inducible HCN4 promoter has been previously validated 
in other experimental models to study cardiac pacemaking function. 
However, as HCN4 is also expressed in other areas of the heart (Herrmann 
et al. 2011) and also in extracardiac tissues (Brewster et al. 2007, Cho et al. 
2009) including the spinal cord interneurons (Hughes et al. 2013), this may 
potentially confound our interpretation of results. The use of a non-specific 
CMV promoter to drive Cre expression in the CNS is potentially more 
problematic. The A1 and A5 cell groups and the vagal preganglionic 
neurones lie in close proximity in the medullary brainstem region (Strack et 
al. 1989, Dampney 1994). Great care was taken to target delivery to the 
RVLM area but it is likely that some of the neurones in the neighbouring 
regions would have undergone Cre mediated deletion of GαO. In any case, 
we have shown that inhibitory signalling via GαO in the medullary brainstem 
region is important. Given that the subsequent histological studies of mice 
included in the study has shown that expression of GFP is mainly 
concentrated in Th-ir cells in the RVLM region, the observed phenotype is 
likely to be due mainly to loss of GαO in the RVLM.  
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I studied the cardiovascular phenotype of mice by measuring HR and BP 
profile under different conditions, and computation of baroreflex sensitivity 
from baroreflex HR-BP responses. The relative contributions of the 
sympathetic and parasympathetic influences were assessed by 
pharmacological blockade. These are indirect measures of autonomic 
function. A more direct approach would involve direct recordings of efferent 
nerve activity such as of the renal sympathetic nerve (Ma et al. 2002) or 
other experimental paradigms such as in the working heart brainstem 
preparations (Paton 1996). These are technically very challenging and 
although I did explore these approaches, I was unable to get them to work 
consistently. On the other hand, although the approaches I used are indirect 
measures, they are methods which are clinically applicable and have been 
shown to be prognostic (Nolan 1998). The complexity of the experimental 
paradigm used meant that there was a limit to the number of interventions 
that could be performed. As a result, some of the obvious control 
experiments such as autonomic blockade during hypoxic and hypercapnic 
challenges were not performed. 
 
The precise mechanism by which loss of GαO at the RVLM results in 
alterations in autonomic tone remains unknown. We attempted to study this 
in vitro by patch-clamping brainstem slices transfected with Cre AVV but this 
proved technically challenging. We suggest that GαO is important in 
mediating inhibitory influences on the RVLM with loss of this resulting in 
disinhibition and increased sympathetic outflow. GαO coupled receptors can 
cause pre- or post-synaptic inhibition either via GIRK channels or by 
inhibiting calcium channels. The precise neurotransmitter or neuromodulator 
involved is unknown. 
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7.5 Future directions 
 
Future studies should aim to investigate the mechanisms underlying the 
cardiovascular phenotype observed. Use of more specific promoters to drive 
Cre expression would help to identify the precise cellular population for which 
GαO signalling is important in the brainstem. Refinement of in vivo 
experimental preparation may also allow more direct assessment of 
autonomic function and direct stimulation and recording from pre-ganglionic 
neurones of interest in the brainstem. The use of indirect measures of 
neuronal activity such as calcium imaging in brainstem slices may also allow 
for in vitro study to elucidate the mechanism of inhibitory G protein signalling 
responsible for the phenotype seen. 
 
It would also be interesting to study mice with conditional deletion of GαO in 
the RVLM in other models of disease or pathology for example the 
myocardial infarction model of heart failure to study the role played by 
increased sympathetic tone in progression of this disease. This may lead to 
further insight in central mechanisms of autonomic regulation of the heart 
that may lead to translatable therapies in the future. 
 
7.5 Conclusion 
 
The data obtained in this study suggest that GαO-mediated signalling within 
the presympathetic circuits of the RVLM contributes to the autonomic control 
of the heart. GαO–mediated signalling plays no significant role at the level of 
cardiac conduction system. GαO deficiency in the RVLM is associated with 
exaggerated cardiovascular responses to stress, altered cardiovascular 
reflexes and electrical properties of the heart. 
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Appendix 1  
MatLab script developed by Varuna De Silva used to obtain best fit sigmoidal 
baroreflex curve 
 
function varargout = Logistic(varargin) 
% LOGISTIC M-file for Logistic.fig 
% 
% Copyright 2011 Varuna De Silva 
% I-Lab, CVSSP, University of Surrey 
% Guildford 
% GU2-7XH 
% UK 
% 
% Email: varunax@gmail.com 
% 
% 
% This work is based on the excellent tutorial by David Arnold 
% 
http://online.redwoods.cc.ca.us/instruct/darnold/diffeq/logistic/log
istic 
% .pdf 
gui_Singleton = 1; 
gui_State = struct('gui_Name',       mfilename, ... 
                   'gui_Singleton',  gui_Singleton, ... 
                   'gui_OpeningFcn', @Logistic_OpeningFcn, ... 
                   'gui_OutputFcn',  @Logistic_OutputFcn, ... 
                   'gui_LayoutFcn',  [] , ... 
                   'gui_Callback',   []); 
if nargin && ischar(varargin{1}) 
    gui_State.gui_Callback = str2func(varargin{1}); 
end 
  
if nargout 
    [varargout{1:nargout}] = gui_mainfcn(gui_State, varargin{:}); 
else 
    gui_mainfcn(gui_State, varargin{:}); 
end 
% End initialization code - DO NOT EDIT 
  
  
% --- Executes just before Logistic is made visible. 
function Logistic_OpeningFcn(hObject, eventdata, handles, varargin) 
% This function has no output args, see OutputFcn. 
% hObject    handle to figure 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
% varargin   command line arguments to Logistic (see VARARGIN) 
  
% Choose default command line output for Logistic 
handles.output = hObject; 
handles.numFrames = 14; 
% Update handles structure 
guidata(hObject, handles); 
  
% UIWAIT makes Logistic wait for user response (see UIRESUME) 
% uiwait(handles.figure1); 
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% --- Outputs from this function are returned to the command line. 
function varargout = Logistic_OutputFcn(hObject, eventdata, handles)  
% varargout  cell array for returning output args (see VARARGOUT); 
% hObject    handle to figure 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Get default command line output from handles structure 
varargout{1} = handles.output; 
  
  
  
function C_INP1_Path_Callback(hObject, eventdata, handles) 
% hObject    handle to C_INP1_Path (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'String') returns contents of C_INP1_Path as 
text 
%        str2double(get(hObject,'String')) returns contents of 
C_INP1_Path as a double 
  
  
% --- Executes during object creation, after setting all properties. 
function C_INP1_Path_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to C_INP1_Path (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns 
called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc 
    set(hObject,'BackgroundColor','white'); 
else 
    
set(hObject,'BackgroundColor',get(0,'defaultUicontrolBackgroundColor
')); 
end 
  
  
  
function C_INP2_Path_Callback(hObject, eventdata, handles) 
% hObject    handle to C_INP2_Path (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'String') returns contents of C_INP2_Path as 
text 
%        str2double(get(hObject,'String')) returns contents of 
C_INP2_Path as a double 
  
  
% --- Executes during object creation, after setting all properties. 
function C_INP2_Path_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to C_INP2_Path (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
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% handles    empty - handles not created until after all CreateFcns 
called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc 
    set(hObject,'BackgroundColor','white'); 
else 
    
set(hObject,'BackgroundColor',get(0,'defaultUicontrolBackgroundColor
')); 
end 
  
  
% --- Executes on button press in C_INP1_Browse. 
function C_INP1_Browse_Callback(hObject, eventdata, handles) 
% hObject    handle to C_INP1_Browse (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
[FileName,PathName] = uigetfile('*.txt','Select the MOS File'); 
handles.C_INP1 = fullfile(PathName,FileName); 
set(handles.C_INP1_Path,'String',handles.C_INP1); 
handles.MOS = dlmread(handles.C_INP1) 
guidata(hObject, handles); 
  
  
% --- Executes on button press in C_INP2_Browse. 
function C_INP2_Browse_Callback(hObject, eventdata, handles) 
% hObject    handle to C_INP2_Browse (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
[FileName,PathName] = uigetfile('*.txt','Select the METRIC File'); 
handles.C_INP2 = fullfile(PathName,FileName); 
set(handles.C_INP2_Path,'String',handles.C_INP2); 
handles.METRIC = dlmread(handles.C_INP2) 
guidata(hObject, handles); 
  
  
  
% --- Executes on button press in resetBut. 
function resetBut_Callback(hObject, eventdata, handles) 
% hObject    handle to resetBut (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
cla(handles.axes1,'reset'); 
set(handles.final_params,'String',''); 
set(handles.final_params2,'String',''); 
set(handles.min_r,'String','0'); 
set(handles.max_r,'String','0'); 
set(handles.est_r,'String','0'); 
set(handles.est_t0,'String','0'); 
guidata(hObject, handles); %updates the handles 
  
  
% --- Executes on button press in plotBut. 
function plotBut_Callback(hObject, eventdata, handles) 
% hObject    handle to plotBut (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
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axes(handles.axes1) 
  
plot(handles.METRIC,handles.MOS,'o') 
%adds a title, x-axis description, and y-axis description 
  
  
est_t0 = median(handles.METRIC); 
xx = handles.METRIC-est_t0; 
title('MOS Vs. METRIC') 
ylabel('MOS') 
xlabel('METRIC') 
  
[max_xx down_idx]= min(xx);  
for idx = 1:size(xx) 
    if(xx(idx)<0) 
        if(xx(idx)>max_xx) 
            max_xx=xx(idx); down_idx = idx; 
        end 
    end 
end 
[min_xx up_idx]= max(xx); for idx = 1:size(xx) 
    if(xx(idx)>0) 
        if(xx(idx)<min_xx) 
            min_xx=xx(idx); up_idx = idx; 
        end 
    end 
end 
  
mt0 = (handles.MOS(up_idx)-
handles.MOS(down_idx))/(handles.METRIC(up_idx)-
handles.METRIC(down_idx)); 
  
est_r = 4*mt0; 
  
min_r = est_r/10; 
max_r = est_r*10; 
  
set(handles.min_r,'String',num2str(min_r)); 
set(handles.max_r,'String',num2str(max_r)); 
set(handles.est_r,'String',num2str(est_r)); 
set(handles.est_t0,'String',num2str(est_t0)); 
  
%Calculate the estimates 
guidata(hObject, handles); %updates the handles 
  
  
  
  
function edit5_Callback(hObject, eventdata, handles) 
% hObject    handle to edit5 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'String') returns contents of edit5 as text 
%        str2double(get(hObject,'String')) returns contents of edit5 
as a double 
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% --- Executes during object creation, after setting all properties. 
function edit5_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to edit5 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns 
called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc 
    set(hObject,'BackgroundColor','white'); 
else 
    
set(hObject,'BackgroundColor',get(0,'defaultUicontrolBackgroundColor
')); 
end 
  
  
  
function est_t0_Callback(hObject, eventdata, handles) 
% hObject    handle to est_t0 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'String') returns contents of est_t0 as text 
%        str2double(get(hObject,'String')) returns contents of 
est_t0 as a double 
  
  
% --- Executes during object creation, after setting all properties. 
function est_t0_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to est_t0 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns 
called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc 
    set(hObject,'BackgroundColor','white'); 
else 
    
set(hObject,'BackgroundColor',get(0,'defaultUicontrolBackgroundColor
')); 
end 
  
  
  
function est_r_Callback(hObject, eventdata, handles) 
% hObject    handle to est_r (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'String') returns contents of est_r as text 
%        str2double(get(hObject,'String')) returns contents of est_r 
as a double 
  
  
% --- Executes during object creation, after setting all properties. 
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function est_r_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to est_r (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns 
called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc 
    set(hObject,'BackgroundColor','white'); 
else 
    
set(hObject,'BackgroundColor',get(0,'defaultUicontrolBackgroundColor
')); 
end 
  
  
  
function min_r_Callback(hObject, eventdata, handles) 
% hObject    handle to min_r (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'String') returns contents of min_r as text 
%        str2double(get(hObject,'String')) returns contents of min_r 
as a double 
  
  
% --- Executes during object creation, after setting all properties. 
function min_r_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to min_r (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns 
called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc 
    set(hObject,'BackgroundColor','white'); 
else 
    
set(hObject,'BackgroundColor',get(0,'defaultUicontrolBackgroundColor
')); 
end 
  
  
  
function max_r_Callback(hObject, eventdata, handles) 
% hObject    handle to max_r (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'String') returns contents of max_r as text 
%        str2double(get(hObject,'String')) returns contents of max_r 
as a double 
  
  
% --- Executes during object creation, after setting all properties. 
function max_r_CreateFcn(hObject, eventdata, handles) 
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% hObject    handle to max_r (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns 
called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc 
    set(hObject,'BackgroundColor','white'); 
else 
    
set(hObject,'BackgroundColor',get(0,'defaultUicontrolBackgroundColor
')); 
end 
  
  
% --- Executes on button press in FindFit. 
function FindFit_Callback(hObject, eventdata, handles) 
% hObject    handle to FindFit (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
est_r = str2num(get(handles.est_r,'String')); 
est_t0 = str2num(get(handles.est_t0,'String')); 
  
min_x = min(handles.METRIC); 
max_x = max(handles.METRIC); 
  
min_r = est_r/10; 
max_r = est_r*10; 
  
r=linspace(min_r,max_r,40); 
t0=linspace(min_x,max_x,40); 
[r,t0]=meshgrid(r,t0); 
  
[m,n]=size(r); 
e=zeros(size(r)); 
  
for i=1:m 
for j=1:n 
e(i,j)=myerror([r(i,j);t0(i,j)],handles.METRIC,handles.MOS); 
end 
end 
  
[row col] = find(min(min(e))); 
  
  
min2=fminsearch(@myerror,[r(col);t0(row)],[],handles.METRIC,handles.
MOS); 
  
r=min2(1); 
t0=min2(2); 
  
H=1./(1+exp(-r*(handles.METRIC-t0))); 
  
K=(H'*handles.MOS)/(H'*H) 
  
t=linspace(min(handles.METRIC),max(handles.METRIC)); 
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y=K./(1+exp(-r*(t-t0))); 
plot(handles.METRIC,handles.MOS,'o',t,y) 
  
s_sq_e = sum_sq_e([r; t0; K;],handles.METRIC,handles.MOS) 
y1 = K./(1+exp(-r*(handles.METRIC-t0))); 
R = corrcoef(handles.MOS,y1); 
C_cof = R(1,2); 
RMSE = sqrt(s_sq_e/size(handles.METRIC,1)); 
finalparams = ['K = ',num2str(K), '  G = ', num2str(r), '  Dm = ', 
num2str(t0)]; 
set(handles.final_params,'String',finalparams); 
finalparams = ['C = ',num2str(C_cof), '  SSE = ', num2str(s_sq_e), '  
RMSE = ', num2str(RMSE)]; 
set(handles.final_params2,'String',finalparams); 
  
title('Y Vs. X') 
ylabel('Y - Values') 
xlabel('X - Values') 
  
  
guidata(hObject, handles); %updates the handles 
 
